
<html lang="en"     class="pb-page"  data-request-id="85cbb474-83ee-4708-9ef8-c79b040ecf0e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.5b01416;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones" /></meta><meta name="dc.Creator" content="Xudong  Cao" /></meta><meta name="dc.Creator" content="Yin  Chen" /></meta><meta name="dc.Creator" content="Yifang  Zhang" /></meta><meta name="dc.Creator" content="Yu  Lan" /></meta><meta name="dc.Creator" content="Juecheng  Zhang" /></meta><meta name="dc.Creator" content="Xiangqing  Xu" /></meta><meta name="dc.Creator" content="Yinli  Qiu" /></meta><meta name="dc.Creator" content="Song  Zhao" /></meta><meta name="dc.Creator" content="Xin  Liu" /></meta><meta name="dc.Creator" content="Bi-Feng  Liu" /></meta><meta name="dc.Creator" content="Guisen  Zhang" /></meta><meta name="dc.Description" content="By use of the 6-hydroxypyridazinone framework, a new series of potent σ1 receptor ligands associated with pharmacological antineuropathic pain activity was synthesized and is described in this arti..." /></meta><meta name="Description" content="By use of the 6-hydroxypyridazinone framework, a new series of potent σ1 receptor ligands associated with pharmacological antineuropathic pain activity was synthesized and is described in this arti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 29, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01416" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01416" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01416" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01416" /></link>
        
    
    

<title>Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01416" /></meta><meta property="og:title" content="Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0019.jpeg" /></meta><meta property="og:description" content="By use of the 6-hydroxypyridazinone framework, a new series of potent σ1 receptor ligands associated with pharmacological antineuropathic pain activity was synthesized and is described in this article. In vitro receptor binding studies revealed high σ1 receptor affinity (Ki σ1 = 1.4 nM) and excellent selectivity over not only σ2 receptor (1366-fold) but also other CNS targets (adrenergic, μ-opioid, sertonerigic receptors, etc.) for 2-(3,4-dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2H)-one (compound 54). Compound 54 exhibited dose-dependent antiallodynic properties in mouse formalin model and rats chronic constriction injury (CCI) model of neuropathic pain. In addition, functional activity of compound 54 was evaluated using phenytoin and indicated that the compound was a σ1 receptor antagonist. Moreover, no motor impairments were found in rotarod tests at antiallodynic doses and no sedative side effect was evident in locomotor activity tests. Last but not least, good safety and favorable pharmacokinetic properties were also noted. These profiles suggest that compound 54 may be a member of a novel class of candidate drugs for treatment of neuropathic pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01416"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01416">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01416&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01416&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01416&amp;href=/doi/10.1021/acs.jmedchem.5b01416" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2942-2961</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01376" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01549" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biological Evaluation of Novel σ<sub>1</sub> Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xudong++Cao">Xudong Cao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yin++Chen">Yin Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yifang++Zhang">Yifang Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Lan">Yu Lan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juecheng++Zhang">Juecheng Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiangqing++Xu">Xiangqing Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yinli++Qiu">Yinli Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Song++Zhao">Song Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Liu">Xin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bi-Feng++Liu">Bi-Feng Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guisen++Zhang">Guisen Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Jiangsu Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#83e4f0f9ebe2ede4c3eee2eaefadebf6f0f7ade6e7f6ade0ed"><span class="__cf_email__" data-cfemail="bed9cdc4d6dfd0d9fed3dfd7d290d6cbcdca90dbdacb90ddd0">[email protected]</span></a>. Phone: +86-27-87792235. Fax: +86-27-87792170.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01416&amp;href=/doi/10.1021%2Facs.jmedchem.5b01416" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2942–2961</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 22, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 September 2015</li><li><span class="item_label"><b>Published</b> online</span>29 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01416" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01416</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01416"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2256</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01416" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xudong&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Yin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yifang&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Lan&quot;},{&quot;first_name&quot;:&quot;Juecheng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xiangqing&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Yinli&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Song&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Bi-Feng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guisen&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2942-2961&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01416&quot;},&quot;abstract&quot;:&quot;By use of the 6-hydroxypyridazinone framework, a new series of potent σ1 receptor ligands associated with pharmacological antineuropathic pain activity was synthesized and is described in this article. In vitro receptor binding studies revealed high σ1 receptor affinity (Ki σ1 = 1.4 nM) and excellent selectivity over not only σ2 receptor (1366-fold) but also other CNS targets (adrenergic, μ-opioid, sertonerigic receptors, etc.) for 2-(3,4-dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2H)-one (compound 54). Compound 54 exhibited dose-dependent antiallodynic properties in mouse formalin model and rats chronic constriction injury (CCI) model of neuropathic pain. In addition, functional activity of compound 54 was evaluated using phenytoin and indicated that the compound was a σ1 receptor antagonist. Moreover, no motor impairments were found in rotarod tests at antiallodynic doses and no sedative side effect was evident in locomotor activity tests. Last but not least, good safety and favorable pharmaco&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01416&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01416" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01416&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01416" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01416&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01416" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01416&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01416&amp;href=/doi/10.1021/acs.jmedchem.5b01416" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01416" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01416" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01416%26sid%3Dliteratum%253Aachs%26pmid%3D27003636%26genre%3Darticle%26aulast%3DCao%26date%3D2016%26atitle%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2B%25CF%25831%2BReceptor%2BLigands%2Bfor%2BTreating%2BNeuropathic%2BPain%253A%2B6-Hydroxypyridazinones%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D2942%26epage%3D2961%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">By use of the 6-hydroxypyridazinone framework, a new series of potent σ<sub>1</sub> receptor ligands associated with pharmacological antineuropathic pain activity was synthesized and is described in this article. In vitro receptor binding studies revealed high σ<sub>1</sub> receptor affinity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 1.4 nM) and excellent selectivity over not only σ<sub>2</sub> receptor (1366-fold) but also other CNS targets (adrenergic, μ-opioid, sertonerigic receptors, etc.) for 2-(3,4-dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (compound <b>54</b>). Compound <b>54</b> exhibited dose-dependent antiallodynic properties in mouse formalin model and rats chronic constriction injury (CCI) model of neuropathic pain. In addition, functional activity of compound <b>54</b> was evaluated using phenytoin and indicated that the compound was a σ<sub>1</sub> receptor antagonist. Moreover, no motor impairments were found in rotarod tests at antiallodynic doses and no sedative side effect was evident in locomotor activity tests. Last but not least, good safety and favorable pharmacokinetic properties were also noted. These profiles suggest that compound <b>54</b> may be a member of a novel class of candidate drugs for treatment of neuropathic pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neuropathic pain is serious and chronic and thus greatly impacts quality of life, which can be relieved but cannot be cured.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Its exact incidence and prevalence are unknown, but overall prevalence is conservatively estimated at 3–8% of the general population in developed countries.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Unfortunately, all currently available treatments afford only modest alleviation of pain and minimal improvements in physical and emotional functioning.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Although very intensive research efforts have improved our understanding of the mechanisms that cause pain, those efforts have not yet yielded new antineuropathic pain drugs.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In the absence of any real breakthrough in antiallodynic drugs development, current guidelines for the management of neuropathic pain feature only incremental improvements in existing therapies, including combination treatments, new formulations of existing drugs, me-too drugs, and refinements based on supposed drug mechanisms of action.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> Among these, tricyclic antidepressants, dual serotonin–norepinephrine reuptake inhibitors (duloxetine), calcium channel α<sub>2</sub>-δ ligands (gabapentin and prebagalin), and topical lidocaine are recommended as first-line therapy for neuropathic pain.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Opioid antiallodynic drugs are typically recommended for patients who have not responded to first-line medications.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Although these medications are effective in reducing pain in neuropathic pain disorders, they may cause serious side effects such as weight gain and hyperalgesia and carry significant risk of addiction.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Thus, the new antineuropathic pain agents with novel mechanisms of action that improved the efficacy of existing therapies and reduced the adverse effects are wanted.</div><div class="NLM_p">Pharmacological studies and biochemical analyses have shown that σ receptors represent a unique, non-opioid, non-phencyclidine, haloperidol-sensitive receptor family.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Two distinct subtypes, termed the σ<sub>1</sub> and σ<sub>2</sub> receptors, have been characterized. The σ<sub>1</sub> receptor has been cloned from several species and various tissues; the protein is 223 amino acids long and has a molecular weight of 25.3 kDa.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Functionally, σ<sub>1</sub> receptor interacts physically with several receptors and ion channels, or elements of their transduction machineries, to modulate receptor/ion channel activities.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The receptor behaves as a unique ligand-regulated molecular chaperone modulating the activities of various proteins and ion channels, including the K<sup>+</sup> and Ca<sup>2+</sup> channels, and the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDAR) and opioid receptors, all of which are involved in pain.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> σ<sub>1</sub> receptor is expressed in regions important in terms of pain control; these include dorsal root ganglion neurons, the dorsal spinal cord, the periaqueductal gray matter, and the rostroventral medulla.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Receptor expression in the spinal cord is upregulated during the induction phase of neuropathic pain.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> The pharmacological profiles of σ<sub>1</sub> receptor and σ<sub>2</sub> receptor differ, and both proteins may serve as biomarkers of tumor cell proliferation and proapoptotic tendencies.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The proteins may thus play roles in cancer imaging and treatment.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a></div><div class="NLM_p">To date, mounting evidence indicates that targeting σ receptors may be particularly beneficial in a number of neurodegenerative conditions including Alzheimer’s disease, Parkinson’s disease, stroke, methamphetamine neurotoxicity, Huntington’s disease, amyotrophic lateral sclerosis, and retinal degeneration.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The putative σ<sub>1</sub> receptor antagonist, SN79 (6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(<i>3H</i>)-one), can attenuate psychostimulant effects.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The selective σ receptor ligand, AC927 (1-(2-phenethyl)piperidine oxalate), can block several cocaine effects that are related to its abuse and excessive intake.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Various 2(3<i>H</i>)-benzoxazolones and 2(<i>3H</i>)-benzothiazolones have been reported as highly selective σ<sub>1</sub> receptor ligands, and <sup>18</sup>F-labeled 2(<i>3H</i>)-benzothiazolones were developed as potential positron emission tomography (PET) candidate radioligands for imaging σ receptors in the central nervous system (CNS).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In addition, many selective σ<sub>1</sub> receptor ligands have been tested as treatments for CNS disorders in clinical studies.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35">(31-35)</a> Moreover, based on the recent preclinical data, selective σ<sub>1</sub> receptor antagonists may be both efficacious and safe when used to counter difficult-to-treat chronic pain (including neuropathic pain) and to enhance (or maintain) antiallodynic efficacy and increase the safety margins of opioid doses.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> BD-1063 (<b>1</b>) is a typical σ<sub>1</sub> receptor antagonist, inhibiting mechanical allodynia induced by capsaicin.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> The recently described σ<sub>1</sub> receptor antagonists, S1RA (<b>2</b>), have good safety, tolerability, and pharmacokinetic profiles and are currently in phase II clinical trials for treatment of neuropathic pain.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> Recently, a series of 4-aminotriazoles (<b>3</b>) exhibiting nanomolar potency for σ<sub>1</sub> receptor and good selectivity (compared to σ<sub>2</sub> receptor) has been reported<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative σ<sub>1</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our interest has focused on the development of novel ligands with high affinity to the σ<sub>1</sub> receptor and selectivity over the σ<sub>2</sub> receptor subtype.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> Recently, the pharmacophoric model of Glennon et al.,<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) was used to build a 3D pharmacophore model allowing virtual drug screening. Hit analysis showed that a pyrimidine scaffold was important, and we prepared a series of such compounds. Compound <b>4</b> exhibited a good pharmacophoric profile, binding to σ<sub>1</sub> receptor, implicated in pain.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Glennon’s pharmacophoric σ<sub>1</sub> receptor model (A) and general structure of the new pyridazinone derivative (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pyridazine and pyrimidine are isomeric compounds in which two nitrogen atoms differ in position. Pyridazine and its oxygenated derivative pyridazinone contain well-studied six-membered heterocyclic rings. These compounds exhibit various pharmacological activities and are present in many natural sources.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> The compounds based on pyridazine or pyridazinone scaffold have recently been shown to increase CNS activity. Specifically, selective histamine H<sub>3</sub> receptor ligands contained the pyridazinones were reported as lead candidates for potential use in the treatment of chronic pain and cognitive disorders.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>A novel series of phosphodiesterase 10A inhibitors based on pyridazine or pyridazinone rings were reported as clinical candidate for the treatment of schizophrenia.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> To further explore novel σ<sub>1</sub> ligands, we focused on ring bioisosteres of the pyrimidine moiety.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> We introduced the pyridazinone ring 6-hydroxy-2-phenylpyridazinone, combined with the basic amino moiety, by molecular hybridization<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> to form a new series of ligands (<b>5</b>) with high affinity to the σ<sub>1</sub> receptor and selectivity over the σ<sub>2</sub> receptor subtype (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of new pyridazinone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This strategy yielded a series of new compounds (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), which were used in SAR (structure–activity relationship) studies to evaluate their pharmacological efficacy and in competitive receptor-binding assays to determine relative affinity for σ<sub>1</sub> and σ<sub>2</sub> receptors. Among the derivatives prepared, compound <b>54</b> exhibited high affinity for the σ<sub>1</sub> receptor and low affinity for the σ<sub>2</sub> receptor. Further, compound <b>54</b> exerted dose-dependent antiallodynic effects in the mouse formalin-induced pain model and the rats CCI model. In addition, function activity of compound <b>54</b> was evaluated using phenytoin and indicated that the compound was a σ<sub>1</sub> receptor antagonist. Moreover, no motor impairments were found in rotarod tests at antiallodynic doses and no sedative side effects were evident in locomotor activity tests, and the pharmacokinetic properties were favorable. Thus, compound <b>54</b> is a novel compound with great potential for the treatment of neuropathic pain.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>12</b>–<b>23</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ<sub>1</sub> receptors.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">The values are the mean ± SEM of three experiments performed in duplicate.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds were synthesized according to the reaction pathways illustrated in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a><b>–</b><a class="ref internalNav" href="#sch3" aria-label="3">3</a>. As depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, phenylaminoalkoxypyridazinone derivatives were prepared using two alternative procedures. The key intermediate 6-hydroxy-2-phenylpyridazin-3(2<i>H</i>)-one <b>8</b> was obtained via one-step cyclization with phenylhydrazine hydrochloride <b>6</b> and maleic anhydride <b>7</b>. According to the substitution pattern, the final compounds <b>9</b> and <b>12</b>–<b>26</b> were prepared using method A or the two-step procedure, method B (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In method A, <b>8</b> was reacted with commercially available 1-(2-chloroethyl)piperidine under basic conditions to obtain compound <b>9</b> in high yield. In method B, the intermediates <b>10</b> and <b>11</b> were produced by the alkylation with <b>8</b> and <b>1</b>, <i>n</i>-dibromoalkanes, and then reacted with the corresponding amines under mild basic conditions to afford the final compounds <b>12</b>–<b>26</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) H<sub>2</sub>O, conc HCl, reflux; (II) Br(CH<sub>2</sub>)<sub><i>n</i>+1</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) HNRR, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux; (IV) K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>9</b>, <b>13</b>, <b>14</b>, and <b>24</b>–<b>26</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ<sub>1</sub> receptors.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">The values are the mean ± SEM of three experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">The route depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> was used to prepare substituted pyridazinone scaffold compounds <b>50</b>–<b>60</b> and <b>62</b>–<b>72</b>. The intermediates <b>27</b>–<b>38</b> were obtained using the cyclization procedure with substituted phenylhydrazine hydrochloride, which was reacted with maleic anhydride <b>7</b>, depending on the substitution pattern of the final pyridazinone. Next, standard alkylation with 1,3-dibromopropane was conducted to produce <b>39</b>–<b>49</b>, and then reaction with the piperidine or 4-methylpiperidine afforded the final compounds <b>50</b>–<b>60</b> and <b>62</b>–<b>72</b>, respectively, in moderate yields (<a class="ref internalNav" href="#tbl3" aria-label="Tables 3">Tables 3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>61</b> was obtained by reaction with commercially available 1-(3-chloropropyl)piperidine, and intermediate <b>38</b>, under basic conditions (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) H<sub>2</sub>O, conc HCl, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux; (IV) 4-methylpiperidine, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux; (V) K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>13</b> and <b>50</b>–<b>61</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>1</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>2</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity (σ<sub>2</sub>/σ<sub>1</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">21.4 ± 2.5<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1074 ± 96</td><td class="colsep0 rowsep0" align="char" char=".">50.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">4-methylphenyl</td><td class="colsep0 rowsep0" align="left">69.0 ± 7.2</td><td class="colsep0 rowsep0" align="left">1280 ± 120</td><td class="colsep0 rowsep0" align="char" char=".">18.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">2-naphthyl</td><td class="colsep0 rowsep0" align="left">74.1 ± 8.9</td><td class="colsep0 rowsep0" align="left">895 ± 95</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">17.0 ± 2.0</td><td class="colsep0 rowsep0" align="left">>2000</td><td class="colsep0 rowsep0" align="char" char=".">−</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="left">9.8 ± 1.4</td><td class="colsep0 rowsep0" align="left">1573 ± 127</td><td class="colsep0 rowsep0" align="char" char=".">160.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">3,4-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">1912 ± 210</td><td class="colsep0 rowsep0" align="char" char=".">1365.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">2,3-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">48 ± 2.1</td><td class="colsep0 rowsep0" align="left">1617 ± 184</td><td class="colsep0 rowsep0" align="char" char=".">33.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">3,5-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">30 ± 1.2</td><td class="colsep0 rowsep0" align="left">1301 ± 89</td><td class="colsep0 rowsep0" align="char" char=".">43.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">2,4-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">25 ± 2.1</td><td class="colsep0 rowsep0" align="left">809 ± 15</td><td class="colsep0 rowsep0" align="char" char=".">32.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">2,5-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">45 ± 2.3</td><td class="colsep0 rowsep0" align="left">902 ± 10</td><td class="colsep0 rowsep0" align="char" char=".">20.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">3-chloro-4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">10 ± 1.3</td><td class="colsep0 rowsep0" align="left">1581 ± 120</td><td class="colsep0 rowsep0" align="char" char=".">158.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">3,4-difluorophenyl</td><td class="colsep0 rowsep0" align="left">8 ± 1.9</td><td class="colsep0 rowsep0" align="left">1908 ± 130</td><td class="colsep0 rowsep0" align="char" char=".">238.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">>2000</td><td class="colsep0 rowsep0" align="left">>2000</td><td class="colsep0 rowsep0" align="char" char=".">−</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ<sub>1</sub> receptors.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">The values are the mean ± SEM of three experiments performed in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>14</b> and <b>62</b>–<b>72</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0017.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>1</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>2</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity (σ<sub>2</sub>/σ<sub>1</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">28.0 ± 3.4<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1464 ± 101</td><td class="colsep0 rowsep0" align="char" char=".">52.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">4-methylphenyl</td><td class="colsep0 rowsep0" align="left">61.6 ± 65</td><td class="colsep0 rowsep0" align="left">1549 ± 135</td><td class="colsep0 rowsep0" align="char" char=".">25.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">2-naphthyl</td><td class="colsep0 rowsep0" align="left">84.1 ± 9.1</td><td class="colsep0 rowsep0" align="left">913 ± 10.4</td><td class="colsep0 rowsep0" align="char" char=".">10.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">19.8 ± 2.4</td><td class="colsep0 rowsep0" align="left">1619 ± 147</td><td class="colsep0 rowsep0" align="char" char=".">81.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="left">9.5 ± 1.2</td><td class="colsep0 rowsep0" align="left">1783 ± 210</td><td class="colsep0 rowsep0" align="char" char=".">187.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">3,4-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">1742 ± 198</td><td class="colsep0 rowsep0" align="char" char=".">348.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">2,3-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">55 ± 2.3</td><td class="colsep0 rowsep0" align="left">1201 ± 34</td><td class="colsep0 rowsep0" align="char" char=".">21.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">3,5-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">43 ± 1.4</td><td class="colsep0 rowsep0" align="left">1321 ± 57</td><td class="colsep0 rowsep0" align="char" char=".">30.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">2,4-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">35 ± 2.6</td><td class="colsep0 rowsep0" align="left">1100 ± 23</td><td class="colsep0 rowsep0" align="char" char=".">31.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">2,5-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">60 ± 3.4</td><td class="colsep0 rowsep0" align="left">870 ± 15</td><td class="colsep0 rowsep0" align="char" char=".">14.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">3-chloro-4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">10 ± 1.4</td><td class="colsep0 rowsep0" align="left">1627 ± 36</td><td class="colsep0 rowsep0" align="char" char=".">162.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">3,4-difluorophenyl</td><td class="colsep0 rowsep0" align="left">15 ± 1.2</td><td class="colsep0 rowsep0" align="left">1701 ± 45</td><td class="colsep0 rowsep0" align="char" char=".">113.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ<sub>1</sub> receptors.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">The values are the mean ± SEM of three experiments performed in duplicate.</p></div></div></div><div class="NLM_p">The route depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> was used to prepare the substituted pyridazinone scaffold compounds <b>79</b>–<b>81</b>. Intermediates <b>73</b>–<b>75</b> were obtained by cyclization of 3,4-dichlorophenylhydrazine hydrochloride with various substituted maleic anhydrides, depending on the substitution patterns desired in the final pyridazinones. Next, standard alkylation with 1,3-dibromopropane produced compounds <b>76</b>–<b>78</b>, and reaction with piperidine afforded the final compounds <b>79</b>–<b>81</b>, respectively, in moderate yields (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) H<sub>2</sub>O, conc HCl, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux.</p></p></figure><div class="NLM_p">Indeed, the 1-phenyl-1,2-dihydropyridazine-3,6-dione and 6-hydroxy-2-phenylpyridazin-3(2<i>H</i>)one are ambident tautomeric heterocyclic. They are produced via a cyclization of the phenylhydrazine hydrochloride <b>6</b> and maleic anhydride <b>7</b> in the presence of acetic acid as solvent.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In this paper, 6-hydroxy-2-phenylpyridazin-3(2<i>H</i>)-one (<b>8</b>) was prepared in solution of water and hydrochloric acid. When the tautomeric pyridazinones were reacted with compound <b>1</b>, <i>n</i>-dibromoalkane, chemoselectivity may be in play. The N-alkylation products were obtained when 1-phenyl-1,2-dihydropyridazine-3,6-dione was reacted with <b>1</b>, <i>n</i>-dibromoalkane in the presence of acetonitrile with K<sub>2</sub>CO<sub>3</sub>.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> While acetonitrile was replaced with acetone, 6-hydroxy-2-phenylpyridazin-3(2<i>H</i>)one was treated with <b>1</b>, <i>n</i>-dibromoalkane, and the O-alkylation product may be obtained mainly. To determine the absolute configuration, the most active compound <b>54</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) was subjected to single crystal X-ray diffraction (SCXRD). As no suitable crystals were obtained using the free base, limited salt screening was performed. The hydrochloride yielded crystals suitable for SCXRD, by which a relative configuration was reliably determined. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, this confirmed the selectivity assigned above. The result indicates indirectly that 6-hydroxy-2-phenylpyridazin-3(2<i>H</i>)-one was prepared in solution of water and hydrochloric acid and the O-alkylation product was obtained mainly during the alkylation.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. ORTEP showing the molecular structure of the hydrochloride salt of <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationships</h3><div class="NLM_p">The new series of pyridazinone derivatives was designed to exploit the known pharmacophoric features of σ<sub>1</sub> receptor ligands. As recently summarized by Glennon et al., σ<sub>1</sub> receptor ligands should contain a basic amino group and no fewer than two hydrophobic regions at specified distances from the amino group, thus 2.5–3.9 and 6–10 Å.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a>(<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Compounds of this general structure (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B) were designed in which the pyridazinones served as scaffolds bearing various groups meeting the pharmacophoric requirements; certain variations were also included. In detail, the chemical structures of these pyridazinone derivatives were designed according to the following rationale: we tested various basic amino moieties to fit the amine site and secondary hydrophobic region (NR1R2), changed the distance between the pyridazinone ring and basic amino moiety (carbon chain linker) to meet the pharmacophoric requirements, replaced the 2-phenyl goup of pyridazinone by an aromatic ring or aliphatic ring (R5), and took different substitution on the 4- and 5-positions of the pyridazinone ring (R3 and R4) to find the best conformational fitting to the receptor.</div><div class="NLM_p">The new compounds were first evaluated in vitro by determining their binding affinities for the σ<sub>1</sub> and σ<sub>2</sub> receptors. [<sup>3</sup>H](+)-Pentazocine was used determining binding at σ<sub>1</sub> receptor. Affinity at σ<sub>2</sub> receptor was determined using [<sup>3</sup>H]di-<i>o</i>-tolylguanidine in the presence of (+)-SKF-10047 (to block the σ<sub>1</sub> receptor), respectively.<a onclick="showRef(event, 'ref36 ref54'); return false;" href="javascript:void(0);" class="ref ref36 ref54">(36, 54)</a> The results of these primary assays are shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Effect of the Basic Amino Moiety for Different Amine Moieties</h4><div class="NLM_p">In our previous work, the σ<sub>1</sub> receptor ligands (pyrimidines derivatives and 3,4-dihydroxy-2(1<i>H</i>)-quinolinone derivatives) designed were consistent with the known pharmacophoric features summarized by Glennon et al. Along with full explorations of SAR, the optimal chain length between the pyrimidine ring (or 3,4-dihydroxy-2(1<i>H</i>)-quinolinone scaffold) and the basic amino moiety for high affinity to the σ<sub>1</sub> receptor was determined to be three carbons.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></div><div class="NLM_p">In this work, our initial investigation focused on the effect of various basic amino moieties (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, compounds <b>12</b>–<b>23</b>). First, the morpholine group (<b>12</b>) was used because of its frequent appearance in σ<sub>1</sub> receptor ligands, such as <b>2</b>, yielding moderate affinity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 66.3 ± 6.0 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 502 ± 49.2 nM) to both receptors. Next, the improvements of compounds with regard to hydrophobicity over a morpholino group, piperidine, 4-methylpiperidine, 3,5-dimethylpiperidine (<b>13</b>–<b>15</b>) were selected, resulting in compound <b>13</b>, which showed significantly improved σ<sub>1</sub> receptor binding affinity and selectivity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 21.4 ± 2.5 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1074 ± 96 nM). Increasing the hydrophobicity of piperidinyl by adding a methyl group on the ring (<b>14</b>) led to similar binding affinity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 28.0 ± 3.4 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1464 ± 101 nM) to compound <b>13</b>, as was observed for compound (<b>15</b>), bearing 3,5-dimethylpiperidine (<i>K</i><sub>i</sub> σ<sub>1</sub> = 46.0 ± 4.1 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1822 ± 148 nM). Substituting the oxygen atom of the morpholine with a carbonyl group (<b>16</b>) greatly decreased affinity to the σ<sub>1</sub> receptor.</div><div class="NLM_p">When piperazine was substituted with small alkyl groups (methyl or ethyl), the resulting compounds (<b>17</b>, <b>18</b>) bound with high affinity to the σ<sub>1</sub> receptor but showed weak selectivity over the σ<sub>2</sub> receptor. The same activity was observed in the larger diazepane or smaller pyrolidine derivative, compound <b>19</b> (<i>K</i><sub>i</sub> σ<sub>1</sub> = 30.3 ± 2.8 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 508 ± 54 nM), and compound <b>20</b> (<i>K</i><sub>i</sub> σ<sub>1</sub> = 35.5 ± 3.8 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 458 ± 54 nM). Open-chain amines (<b>21</b>–<b>23</b>) did not enhance binding affinity or σ<sub>1</sub> receptor selectivity.</div><div class="NLM_p last">It is consistent with the previous work that the nature of the surrounding of the tertiary amine nitrogen had a profound impact on affinity.<a onclick="showRef(event, 'cit30c'); return false;" href="javascript:void(0);" class="ref cit30c">(30c)</a></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Effect of the Distance between the Pyridazinone Ring and the Basic Amino Moiety</h4><div class="NLM_p last">The effect of the length of the linker between the pyridazinone and the basic amino moiety was determined. As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, changes in linker length to two (<b>9</b>) or four (<b>24</b>–<b>26</b>) carbon atoms significantly reduced binding to both the σ<sub>1</sub> and σ<sub>2</sub> receptors. Therefore, the binding affinities for both receptors were dependent upon chain length. Compared to compound <b>13</b>, the use of a linker containing two carbon atoms to connect to the piperidine ring (<b>9</b>) inactivated binding to both receptors; replacement of the linker with four carbon atoms (<b>24</b>) reduced the binding affinity for σ<sub>1</sub>. When substituted piperidine rings were used, compounds <b>25</b> and <b>26</b>, with linkers of four carbon atoms, had low σ<sub>1</sub> receptor and σ<sub>2</sub> receptor affinities. Thus, the alkyl chain length appeared to directly affect the affinities for the two receptors. Together, the data show that a linker of three carbon atoms (compounds <b>13</b> and <b>14</b>) was optimal. It is consistent with the previous work that three carbons showed high affinity to the σ<sub>1</sub> receptor and excellent selectivity to σ<sub>2</sub> receptor.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Effect of Substitution on the 2-Position of the Pyridazinone Ring</h4><div class="NLM_p">Compounds exhibiting good binding affinities and selectivities (<b>13</b> and <b>14</b>), containing piperidinyl or 4-methylpiperidinyl groups as amino moieties with three-carbon linker, were selected for further SAR investigation. The effects of replacing the phenyl group at the 2-position of the pyridazinone ring with other aromatic or aliphatic rings were explored (<a class="ref internalNav" href="#tbl3" aria-label="Tables 3">Tables 3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_p">When the amine moiety was piperidine (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), compound <b>50</b> containing electron-donating group (methyl) on the phenyl group retained moderate activity (albeit less than compound <b>13</b>) and exhibited lower selectivity. Compound <b>51</b> was produced by replacing the phenyl with a naphthyl ring, which did not improve the binding affinity or selectivity. Compounds <b>52</b>–<b>54</b> contained halogens substituent on the phenyl group, remarkably increasing binding affinity and selectivity; the fluorine-containing compound’s (<b>52</b>) constants were <i>K</i><sub>i</sub> σ<sub>1</sub> = 17.0 ± 2.0 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> > 2000 nM, while those for the chlorine-bearing molecule (<b>53</b>) were <i>K</i><sub>i</sub> σ<sub>1</sub> = 9.8 ± 1.4 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1573 ± 127 nM. Next, the 3,4-dichlorophenyl group [present in the known σ<sub>1</sub> receptor ligands <b>1</b> and <b>3</b>] was introduced, and compound <b>54</b> had even higher affinity to σ<sub>1</sub> and excellent selectivity over σ<sub>2</sub> (<i>K</i><sub>i</sub> = 1.4 ± 0.1 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1912 ± 210 nM). Substituting other dichlorophenyls for the 3,4-dichlorophenyl group yielded compounds <b>55</b>–<b>58</b>, which showed lower activity than <b>54</b> but with moderate selectivities. Some activity (albeit less than that of compound <b>54</b>) was retained upon replacement of the 3,4-dichloro moiety with 3-chloro-4-fluoro or 3,4-difluoro substituents (<b>59</b>, <b>60</b>); this improved selectivity about 4- to 10-fold compared to compounds <b>55</b>–<b>58</b>. Replacing the aromatic rings at the 2-position with cyclopentyl <b>61</b> resulted in a marked reduction in the affinities for the receptors.</div><div class="NLM_p last">Compounds bearing the amine moiety 4-methylpiperidine (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), <b>62</b> with a methyl on the phenyl group and <b>63</b> with a naphthyl ring, displayed low affinities for the σ<sub>1</sub> receptor. Again, introduction of halogens on the phenyl group remarkably increased binding affinity and selectivity: for fluorine (<b>64</b>), constants were <i>K</i><sub>i</sub> σ<sub>1</sub> = 19.8 ± 2.4 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1619 ± 147 nM, for chlorine (<b>65</b>), <i>K</i><sub>i</sub> σ<sub>1</sub> = 9.5 ± 1.2 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1783 ± 210 nM, and for the 3,4-dichloro (<b>66</b>), <i>K</i><sub>i</sub> σ<sub>1</sub> = 5.0 ± 0.6 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1742 ± 198 nM. Introduction of other dihalophenyl groups yielded compounds <b>67</b>–<b>72</b>, which behaved as did the analogs that contained piperidinyl ring (<b>55</b>–<b>60</b>), confirming the important contribution of the 3,4-dichlorophenyl group to σ receptor affinity.<a onclick="showRef(event, 'ref36 ref39 ref41'); return false;" href="javascript:void(0);" class="ref ref36 ref39 ref41">(36, 39, 41)</a></div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Effect of Replacing Groups on the 4- and 5-Positions of the Pyridazinone Ring</h4><div class="NLM_p">The presence of a 3,4-dichlorophenyl group on the 2-position of the pyridazinone ring afforded the best receptor-binding affinity and selectivity, and a three-carbon linker optimally matched the pharmacophoric requirement. Thus, compound <b>54</b> was selected for further investigation of the SAR.</div><div class="NLM_p">We first explored the effects of replacing the hydrogen atom with a methyl group (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, compound <b>79</b>). Compound <b>79</b> (compared to <b>54)</b> for σ<sub>1</sub> and σ<sub>2</sub> receptors had a detrimental effect on affinities, attributable either to the size of the group or to its hydrophobicity. Substitution of the methyl group with a cyclohexyl (<b>80</b>) or phenyl (<b>81</b>) group significantly decreased receptor affinities even further; large group sizes may have hindered receptor binding.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>54</b> and <b>79</b>–<b>81</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0018.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ<sub>1</sub> receptors.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">The values are the mean ± SEM of three experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p last">Overall, compounds <b>53</b>, <b>54</b>, <b>59</b>, <b>60</b>, <b>65</b>, <b>66</b>, <b>71</b>, and <b>72</b> exhibited affinity for the σ<sub>1</sub> receptor (<i>K</i><sub>i</sub> < 15 nM) with selectivity (compared to σ<sub>2</sub> receptor; >100-fold). Therefore, these compounds were selected for further studies.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Human Ether-a-Go-Go-Related Gene (hERG) Channel Blockade</h3><div class="NLM_p">Recent studies have shown that many medications can prolong the time between the start of the Q wave and the end of the T wave as shown on an electrocardiogram (the QT interval).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Indeed, efforts to predict the risk of long-QT syndrome have focused on assays that explore hERG channel activity.<a onclick="showRef(event, 'cit55a'); return false;" href="javascript:void(0);" class="ref cit55a">(55a)</a> This is because hERG channel blockade is an important indicator of potential proarrhythmic risk.<a onclick="showRef(event, 'cit55b'); return false;" href="javascript:void(0);" class="ref cit55b">(55b)</a> To date, work on hERG channel blockade has been a significant component of drug discovery within the pharmaceutical industry. The eight compounds with <i>K</i><sub>i</sub> σ<sub>1</sub> values of <15 nM and selectivities of >100-fold were evaluated the ability to block hERG through electrophysiological patch-clamp measurements. As shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>, compounds <b>54</b>, <b>71</b>, and <b>72</b> exhibited lower affinities for hERG than did the others (IC<sub>50</sub> > 2000 nM).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Additional Data for Compounds Complying with <i>K</i><sub>i</sub> σ<sub>1</sub> < 15 nM and Selectivity of >100-Fold</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">LD<sub>50</sub> (mg/kg)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">hERG IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">754.5 (654.6–962.5)</td><td class="colsep0 rowsep0" align="left">1.45 ± 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">>2000</td><td class="colsep0 rowsep0" align="left">6.34 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">900 (732.1–1762.5)</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">780 (424.6–1586.2)</td><td class="colsep0 rowsep0" align="left">1.89 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">717.3 (588.8–973.5)</td><td class="colsep0 rowsep0" align="left">1.61 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">574.8 (453.2–769.2)</td><td class="colsep0 rowsep0" align="left">1.46 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">1530 (1398.3–1809.2)</td><td class="colsep0 rowsep0" align="left">2.16 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">1300 (948.5–1723.4)</td><td class="colsep0 rowsep0" align="left">2.68 ± 0.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">95% confidence limits.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Acute Toxicity</h3><div class="NLM_p last">The eight compounds that exhibited high affinities for the σ<sub>1</sub> receptor, with good selectivity compared to σ<sub>2</sub> receptor, were evaluated in terms of acute toxicity (LD<sub>50</sub>) (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Compound <b>54</b> was nontoxic even at the highest dose tested (LD<sub>50</sub> > 2000 mg/kg).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Functional Profile of the σ<sub>1</sub> Receptor</h3><div class="NLM_p">More recent studies using molecular biological tools have clearly demonstrated that σ<sub>1</sub> receptors and associated ligands modulate inositol 1,4,5-trisphosphate (IP3) receptors at the endoplasmic reticulum (ER) membrane. For example, the IP3 receptor-inhibiting protein, ankyrin, was found to be “removed” from IP3 receptors when σ<sub>1</sub> receptor agonists were applied to NG-108 cells, thus enhancing Ca<sup>2+</sup> efflux from the ER into the cytosol.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The same results were observed by Wu and Bowen who found that the C-terminus portion of σ<sub>1</sub> receptors caused the dissociation of ankyrin from IP3 receptors in MCF-7 tumor cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In a study using CHO cells, Hayashi and Su found that σ<sub>1</sub> receptor agonists may activate σ<sub>1</sub> receptor by dissociating σ<sub>1</sub> receptors from binding-immunoglobulin protein (BiP), and σ<sub>1</sub> receptor antagonist did not affect the σ<sub>1</sub> receptor-BiP association and stabilized this complex.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">Recently, phenytoin-media shifts in σ<sub>1</sub> receptor ligand affinities and FRET-based biosensor studies of σ<sub>1</sub> receptor ligands have been used to categorize compounds as agonists or antagonists.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The functional activity of σ<sub>1</sub> receptor ligand was evaluated using phenytoin,<a onclick="showRef(event, 'cit59a'); return false;" href="javascript:void(0);" class="ref cit59a">(59a)</a> a low potency allosteric modulator of σ<sub>1</sub> receptor that shifts known σ<sub>1</sub> receptor agonists to significantly higher affinities (<i>K</i><sub>i</sub> ratios without phenytoin vs with phenytoin of >1), while σ<sub>1</sub> receptor antagonists show small or no shift to lower affinity values (<i>K</i><sub>i</sub> ratios without phenytoin vs with phenytoin of ≤1). In such work, the functional activities of compound <b>54</b> with high-level σ<sub>1</sub> receptor-binding affinities, exhibiting greater selectivity for σ<sub>1</sub> receptor than σ<sub>2</sub> receptor, have been evaluated using phenytoin. Compound <b>54</b> afforded a small shift, lowering affinity when incubated in the presence of phenytoin (<i>K</i><sub>i</sub> ratio without vs with phenytoin, 0.73), thus acting antagonistically on the σ<sub>1</sub> receptor.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Formalin-Induced Nociceptive Behavior</h3><div class="NLM_p">Together, the data indicated that compounds <b>54</b>, <b>71</b>, and <b>72</b> had high affinities for σ<sub>1</sub> receptor, with good selectivities (compared to σ<sub>2</sub> receptor) together with low affinities for hERG and good safety profiles. These compounds were considered promising and were subjected to in vivo activity testing.</div><div class="NLM_p">The classical model of acute and chronic pain, the formalin test, was performed to evaluate the antinociceptive effects. Intraplantar (ipl) injection of formalin elicits a biphasic pain response: early (phase I) and delayed (phase II), characterized by paw licking, biting, and other behaviors. Phase I pain is predominantly caused by direct activation of C-fibers, whereas phase II pain appears to be dependent on a combination of peripheral tissue inflammation and functional changes in the spinal cord, involving both peripheral and central sensitization.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a></div><div class="NLM_p">In the formalin test, pretreatment with compound <b>54</b> (80 mg/kg, ig) inhibited formalin-induced pain responses to a similar degree as 2, reducing licking and biting times in phase II to 45.88 ± 3.54 s and 41.16 ± 5.21 s, respectively. In contrast, the antiallodynic effects of compounds <b>71</b> and <b>72</b> attained statistical significance only when much higher doses (160 mg/kg, ig) were given, reducing licking and biting times to 59.65 ± 6.32 s and 56.43 ± 6.77 s, respectively.</div><div class="NLM_p">To better characterize the antiallodynic effects of <b>54</b>, a wide range of doses was tested. Compound <b>54</b> (20–160 mg/kg) produced dose-dependent antinociception in phase II of the formalin test and was (slightly) more efficacious against delayed-phase pain (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). The ED<sub>50</sub> value was 48.97 ± 3.89 mg/kg for phase II pain.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antiallodynic effect of <b>2</b> and compound <b>54</b> in phase II (15–45 min) of the mice formalin test. Each column and vertical line represent the mean ± SEM of the values obtained in at least 10 animals. Statistically significant differences are the following: (#) <i>p</i> < 0.05, (##) <i>p</i> < 0.01 vs vehicle; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle + formalin (two-way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> CCI (Chronic Constriction Injury) Model</h3><div class="NLM_p">Compound <b>54</b> was evaluated in a representative and frequently used model of neuropathic pain, the rat CCI model. Chronic constriction injury results in the development of allodynia- and spontaneous pain-like behaviors and hyperalgesia, which are normally maximal 10–14 days after surgery.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> CCI rats exhibited signs of allodynia upon mechanical stimulation, and hyperalgesia to thermal stimulation; these are measures of neuropathic pain. Mechanical allodynia was quantified by measuring the hind-paw withdrawal response to von Frey hair stimulation, whereas thermal (heat) hyperalgesia was assessed using a plantar test; this was the hind-paw withdrawal latency in response to radiant heat.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, compound <b>54</b> dose-dependently inhibited both mechanical allodynia and thermal hypersensitivity when given in a single dose (day 15) or in two doses (days 15 and 18); sham-operated rats exhibited no significant changes in mechanical or thermal sensitivity compared to those before surgery (the basal levels). The ED<sub>50</sub> values after single dose treatment in terms of mechanical allodynia and thermal hypersensitivity were 51.88 ± 5.85 and 18.57 ± 2.32 mg/kg, respectively. For the double-dose treatment, the ED<sub>50</sub> values were 40.26 ± 3.52 and 16.93 ± 2.17 mg/kg, respectively.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antiallodynic effects of compound <b>54</b> on the expression of neuropathic pain in CCI and sham operated rats. Data are obtained from 10 rats per group and expressed as the mean ± SEM pressure threshold evoking paw withdrawal or latency to paw withdrawal. Statistically significant differences between the rats before surgery (basal) and surgery groups are the following: (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs basal; (#) <i>p</i> < 0.05; (##) <i>p</i> < 0.01 vs vehicle treatment on days 14, 15, and 18 (two-way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Motor Coordination: Rotarod Test</h3><div class="NLM_p">To investigate the possibility that the observed efficacy of compound <b>54</b> could interfere with motor coordination and thus with the response of mice in the nociceptive and neuropathic pain-related behavioral tests, motor performance was measured in the rotarod test.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, no significant effect of compound <b>54</b> at an antiallodynic dose was observed and no treatment-related adverse effects were found. In contrast, <b>2</b> did a significant reduction in the permanence time on the rotating rod was observed at 80 mg/kg, after single intragastric administration.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response effect of compounds <b>54</b> and <b>2</b> on motor coordination (rotarod test). Data are obtained from 8–10 mice per group and expressed as the mean ± SEM latency to fall down from rod. Statistically significant differences are the following: (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle (two-way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Locomotor Activity Test</h3><div class="NLM_p">In the exploratory locomotor activity test, haloperidol (a known sedative)<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> served as a positive control. Pretreatment with 40, 80, and 160 mg/kg of compound <b>54</b> only mildly reduced exploratory locomotor activity (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>); in comparison, haloperidol significantly reduced spontaneous locomotor activity.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effects of Compound <b>54</b> and Haloperidol on the Spontaneous Locomotor Activity in Mice (Mean ± SD, <i>n</i> = 8)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">total distance (mm)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24881.4 ± 9545.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">haloperidol</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">23540.4 ± 7124.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">8539.4 ± 5329.7*<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1169.7 ± 662.3**<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24881.4 ± 9545.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">22826.6 ± 6293.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">18282.4 ± 7050.5*<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">16458.3 ± 6260.3**<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">(∗∗) <i>p</i> < 0.01. (∗) <i>p</i> < 0.05 vs control.</p></div></div></div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Pharmacokinetic Properties of Compound <b>54</b></h3><div class="NLM_p">We evaluated the in vitro and in vivo efficacies and the safety of compound <b>54</b> in rats (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Intravenous administration (5 mg/kg, <i>n</i> = 3) yielded detectable plasma levels, with a half-life (<i>t</i><sub>1/2</sub>) of 1.39 ± 0.18 h. Oral administration (80 mg/kg, <i>n</i> = 3) was associated with a <i>t</i><sub>1/2</sub> of 2.88 ± 0.36 h. The area under the curve (AUC) was 956 ± 131 ng·h/mL after intravenous administration vs 13390 ± 1568 ng·h/mL after oral administration. After oral administration of 80 mg/mL, the peak serum concentration was 2923 ± 350 ng/mL and the <i>T</i><sub>max</sub> value 0.33 ± 0.04 h. The clearance was 49.3 ± 6.9 mL min<sup>–1</sup> kg<sup>–1</sup> in the intravenous administration. The bioavailability of compound <b>54</b> was 87.5%. Such encouraging preclinical data suggest that compound <b>54</b> has desirable drug-like human pharmacokinetic properties.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Plasma Pharmacokinetic Data after Administration of Compound <b>54</b> in Rats (<i>n</i> = 3/Group)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–last</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–inf</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">80 (po)</td><td class="colsep0 rowsep0" align="left">2923 ± 350</td><td class="colsep0 rowsep0" align="left">0.33 ± 0.04</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.88 ± 0.36</td><td class="colsep0 rowsep0" align="left">11698 ± 1222</td><td class="colsep0 rowsep0" align="left">13390 ± 1568</td><td class="colsep0 rowsep0" align="left">87.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 (iv)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">49.3 ± 6.9</td><td class="colsep0 rowsep0" align="left">1.39 ± 0.18</td><td class="colsep0 rowsep0" align="left">931 ± 125</td><td class="colsep0 rowsep0" align="left">956 ± 131</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Selectivity Profile of Compound <b>54</b></h3><div class="NLM_p last">To assess the interactions of compound <b>54</b> with other receptors or ion channels, a selectivity profile was created using additional receptors (including the μ-opioid, serotoninergic, H<sub>3</sub>, cannabinoid, and NMDA receptors) and ion channels (voltage-gated sodium channel Nav 1.7 and the TRPV-1 protein) implicated in pain. Compound <b>54</b> showed no significant affinity (% inhibition at 1 μM of <50%) to any putative target (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05188" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05188" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This detailed SAR investigation of pyridazinone scaffold derivatives reveals that several factors influence the binding affinity of these compounds to σ<sub>1</sub> and σ<sub>2</sub> receptor. The pyridazinone scaffold was crucial for activity, and a basic amine was necessary, matching the known σ<sub>1</sub> receptor pharmacophoric model. Piperidine was the preferred amino moiety (NRR), greatly improving σ<sub>1</sub> receptor binding affinity and maintaining selectivity. The aromatic group on the 2-position of the pyridazinone was essential for activity, and the introduction of halogens on the aromatic ring led to moderate affinities to σ<sub>1</sub> receptor and increased selectivity to σ<sub>2</sub> receptor.</div><div class="NLM_p last">In this study, a series of pyridazinone derivatives were synthesized via an efficient method, several of which were shown to be potent and selective σ<sub>1</sub> receptor ligands. Compound <b>54</b> appears safe in preliminary tests and exerts clear dose-dependent antiallodynic effects against formalin-induced pain in mice and antinociception (both mechanical allodynia and thermal hypersensitivity) in the rat CCI model. Moreover, compound <b>54</b> exhibited fovorable pharmacokinetic properties and a good selective profile against other specific targets implicated in pain. Thus, compound <b>54</b> may facilitate the development of a novel class of candidate drugs for the treatment of neuropathic pain. Further studies of compound <b>54</b> and this series of derivatives are currently underway in our laboratory and will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Chemistry</h3><div class="NLM_p last">All commercially available chemicals and reagents were used without further purification. Reagents were all of analytical grade or of chemical purity (>95%). Melting points were determined in open capillary tubes and are uncorrected. <sup>1</sup>H NMR spectra was recorded on a Bruker Avance III 600 spectrometer at 600 MHz (<sup>1</sup>H) using CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent. Chemical shifts were given in δ values (ppm), using tetramethylsilane (TMS) as the internal standard; coupling constants (<i>J</i>) were given in Hz. Signal multiplicities were characterized as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad signal). Analytical thin layer chromatography (TLC) was performed on silica gel GF254. Column chromatographic purification was carried out using silica gel. Compound purity is determined by high performance liquid chromatography (HPLC), and all final test compounds display purity higher than 95%. HPLC methods used the following: Agilent 1100 spectrometer; column, InertSustain C18 5.0 mm × 150 mm × 4.6 mm i.d. (SHIMADZU, Japan); mobile phase, 30 mmol NH<sub>4</sub>COOH (ROE SCIENTIFIC INC, USA) aq/acetonitrile (Merck Company, Germany) 45/55; flow rate, 0.6 mL/min; column temperature, 40 °C. UV detection was performed at 210 nm.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 6-Hydroxy-2-phenylpyridazin-3(2<i>H</i>)-one (<b>8</b>)<a onclick="showRef(event, 'cit51b'); return false;" href="javascript:void(0);" class="ref cit51b">(51b)</a></h3><div class="NLM_p last">Phenylhydrazine hydrochloride (<b>6</b>) (55 mmol) was added to maleic anhydride (<b>7</b>, 50 mmol), 400 mL of water, and 40 mL of concentrated hydrochloric acid solution. The mixture was heated at reflux for 9 h. After it was cooled, the resulting solid was collected by filtration, washed with ice–water. The solid was dissolved in saturated sodium bicarbonate solution; after filtration, the resulting filtrate was neutralized with 1 mol/L hydrochloric acid. The precipitate thus formed was filtered and washed with water. The resulting <b>8</b> was a white solid. Yield 79.8%; mp 272–273 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.62 (d, <i>J</i> = 7.5 Hz, 2H), 7.52–7.47 (m, 2H), 7.43–7.38 (m, 1H), 7.10 (q, <i>J</i> = 9.8 Hz, 2H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Preparation of Compounds <b>9</b> and <b>12</b>–<b>26</b>. Method A. 2-Phenyl-6-(2-(piperidin-1-yl)ethoxy)pyridazin-3(2<i>H</i>)-one(<b>9</b>)</h3><div class="NLM_p last">To a suspension of <b>8</b> (10 mmol) and 1-(2-chloroethyl)piperidine (10 mmol) in acetonitrile (100 mL), potassium carbonate (20 mmol) and a catalytic amount of potassium iodide (1% mol) were added. The resulting mixture was heated and refluxed for 6–8 h. The progress of the reaction was monitored by TLC. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield <b>9</b>. Pale yellow oil; yield 81.9%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67–7.65 (m, 2H), 7.43 (dd, <i>J</i> = 10.8, 5.1 Hz, 2H), 7.32 (t, <i>J</i> = 7.4 Hz, 1H), 7.02–6.95 (m, 2H), 4.28 (t, <i>J</i> = 5.9 Hz, 2H), 2.71 (t, <i>J</i> = 5.9 Hz, 2H), 2.46 (s, 4H), 1.63–1.53 (m, 4H), 1.45 (dd, <i>J</i> = 26.5, 5.0 Hz, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 300.1713 (calcd 300.1707 for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Method B. 6-(3-Bromopropoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>10</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added, and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 15/1) to yield <b>10</b>. Pale yellow oil; yield 61.7%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67 (dt, <i>J</i> = 8.7, 1.7 Hz, 2H), 7.49–7.44 (m, 2H), 7.38–7.33 (m, 1H), 7.08–6.99 (m, 2H), 4.32 (t, <i>J</i> = 5.9 Hz, 2H), 3.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.30 (quintet, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 6-(4-Bromobutoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>11</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 66.1%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67 (dt, <i>J</i> = 8.7, 1.7 Hz, 2H), 7.49–7.44 (m, 2H), 7.38–7.33 (m, 1H), 7.08–6.99 (m, 2H), 4.20 (t, <i>J</i> = 6.2 Hz, 2H), 3.47 (t, <i>J</i> = 6.6 Hz, 2H), 2.10–1.98 (m, 2H), 1.97–1.87 (m, 2H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 6-(3-Morpholinopropoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>12</b>)</h3><div class="NLM_p last">To a suspension of <b>10</b> (2 mmol) and morpholine (2.2 mmol), K<sub>2</sub>CO<sub>3</sub> (4 mmol) in acetonitrile (50 mL) and a catalytic amount of KI (1% mol) were added, and the resulting mixture was refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (10.0 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield compound <b>12</b>. Pale yellow oil; yield 89.8%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.65–7.63 (m, 2H), 7.45 (t, <i>J</i> = 7.9 Hz, 2H), 7.34 (t, <i>J</i> = 7.4 Hz, 1H), 7.02–6.95 (m, 2H), 4.32–4.17 (m, 2H), 3.77–3.57 (m, 4H), 2.80–2.62 (m, 1H), 2.53–2.42 (m, 5H), 2.00–1.88 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 316.1657 (calcd 316.1656 for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Phenyl-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>13</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 91.6%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.65 (d, <i>J</i> = 1.1 Hz, 1H), 7.64 (s, 1H), 7.44 (dd, <i>J</i> = 10.8, 5.0 Hz, 2H), 7.35–7.30 (m, 1H), 7.00–6.94 (m, 2H), 4.19 (t, <i>J</i> = 6.4 Hz, 2H), 2.49–2.32 (m, 6H), 2.00–1.90 (m, 2H), 1.64–1.54 (m, 4H), 1.43 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 314.1872 (calcd 314.1863 for C<sub>18</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-(3-(4-Methylpiperidin-1-yl)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>14</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 88.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.66 (d, J = 7.7 Hz, 2H), 7.44 (t, <i>J</i> = 7.9 Hz, 2H), 7.33 (t, <i>J</i> = 7.4 Hz, 1H), 7.01–6.95 (m, 2H), 4.20 (t, <i>J</i> = 6.4 Hz, 2H), 2.90 (d, <i>J</i> = 11.4 Hz, 2H), 2.52–2.39 (m, 2H), 2.01–1.85 (m, 4H), 1.66–1.56 (m, 2H), 1.41–1.30 (m, 1H), 1.24 (qd, <i>J</i> = 12.5, 3.6 Hz, 2H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 328.2021 (calcd 328.2020 for C<sub>19</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 6-(3-(3,5-Dimethylpiperidin-1-yl)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one(<b>15</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 83.5%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.68–7.60 (m, 2H), 7.42 (t, <i>J</i> = 7.0 Hz, 2H), 7.31 (t, <i>J</i> = 7.4 Hz, 1H), 7.00–6.93 (m, 2H), 4.23–4.15 (m, 2H), 2.97–2.87 (m, 2H), 2.59–2.51 (m, 2H), 2.01 (dd, <i>J</i> = 14.5, 7.1 Hz, 2H), 1.81–1.66 (m, 2H), 1.56 (t, <i>J</i> = 11.2 Hz, 2H), 0.83 (d, <i>J</i> = 6.6 Hz, 6H), 0.64–0.49 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 342.2180 (calcd 342.2176 for C<sub>20</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-(3-(4-Oxopiperidin-1-yl)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>16</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 84.1%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.68–7.63 (m, 2H), 7.49–7.42 (m, 2H), 7.36–7.32 (m, 1H), 7.05–6.93 (m, 2H), 4.46–4.20 (m, 4H), 3.76–3.72 (m, 4H), 2.54–2.37 (m, 2H), 2.26–2.09 (m, 2H), 2.02–1.91 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 328.1663 (calcd 328.1656 for C<sub>18</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 6-(3-(4-Methylpiperazin-1-yl)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>17</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 82.9%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.62 (dd, <i>J</i> = 8.5, 1.0 Hz, 2H), 7.43 (dd, <i>J</i> = 11.3, 4.6 Hz, 2H), 7.35–7.31 (m, 1H), 6.98 (q, <i>J</i> = 9.7 Hz, 2H), 4.19 (t, <i>J</i> = 6.3 Hz, 2H), 2.90–2.66 (m, 8H), 2.63–2.54 (m, 2H), 2.50 (s, 3H), 1.99–1.88 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 329.1980 (calcd 329.1972 for C<sub>18</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 6-(3-(4-Ethylpiperazin-1-yl)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 83.6%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.61 (dd, <i>J</i> = 8.5, 1.0 Hz, 2H), 7.41 (t, <i>J</i> = 7.9 Hz, 2H), 7.33–7.29 (m, 1H), 7.01–6.93 (m, 2H), 4.39–4.10 (m, 2H), 2.81–2.39 (m, 12H), 2.02–1.81 (m, 2H), 1.14 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 343.2135 (calcd 343.2129 for C<sub>19</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-(3-(4-Methyl-1,4-diazepan-1-yl)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>19</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 83.0%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.68–7.65 (m, 2H), 7.49 (t, <i>J</i> = 7.4 Hz, 2H), 7.38 (t, <i>J</i> = 7.4 Hz, 1H), 7.05 (d, <i>J</i> = 9.9 Hz, 1H), 7.01 (d, <i>J</i> = 9.8 Hz, 1H), 4.25 (t, <i>J</i> = 6.2 Hz, 2H), 3.39–3.09 (m, 6H), 2.95 (t, <i>J</i> = 5.9 Hz, 2H), 2.82 (dd, <i>J</i> = 15.2, 8.0 Hz, 2H), 2.75 (s, 3H), 2.29 (s, 2H), 2.06–1.98 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 343.2131 (calcd 343.2129 for C<sub>19</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>20</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 83.0%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.69–7.65 (m, 2H), 7.47 (t, <i>J</i> = 7.8 Hz, 2H), 7.36 (t, <i>J</i> = 7.4 Hz, 1H), 7.08–6.94 (m, 2H), 4.24 (t, <i>J</i> = 6.4 Hz, 2H), 2.63–2.58 (m, 2H), 2.54 (t, <i>J</i> = 6.0 Hz, 4H), 2.02–1.95 (m, 2H), 1.85–1.73 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> 300.1715 (calcd 300.1707 for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-(3-(Dimethylamino)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>21</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 63.2%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.66–7.59 (m, 2H), 7.47–7.41 (m, 2H), 7.37–7.31 (m, 1H), 7.07–6.98 (m, 2H), 4.32–4.20 (m, 2H), 3.24–3.17 (m, 2H), 2.80 (br, 6H), 2.35–2.21 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 274.1552 (calcd 274.1550 for C<sub>15</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-(3-(Diethylamino)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>22</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 66.0%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67–7.63 (m, 2H), 7.49–7.44 (m, 2H), 7.35 (dd, <i>J</i> = 10.7, 4.2 Hz, 1H), 7.04–6.98 (m, 2H), 4.25 (t, <i>J</i> = 6.1 Hz, 2H), 3.20–3.15 (m, 2H), 2.96–2.84 (m, 4H), 2.22–2.08 (m, 2H), 1.24 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> 302.1870 (calcd 302.1863 for C<sub>17</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 6-(3-(Diisopropylamino)propoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 64.0%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.63 (d, <i>J</i> = 7.6 Hz, 2H), 7.37 (t, <i>J</i> = 7.9 Hz, 2H), 7.25 (t, <i>J</i> = 7.4 Hz, 1H), 6.96–6.86 (m, 2H), 4.15 (t, <i>J</i> = 6.4 Hz, 2H), 2.49 (t, <i>J</i> = 7.1 Hz, 2H), 2.35–2.28 (m, 4H), 1.86–1.78 (m, 2H), 1.44–1.32 (m, 4H), 0.80 (t, <i>J</i> = 7.4 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> 330.2181 (calcd 330.2176 for C<sub>19</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 6-(4-(4-Piperidin-1-yl)butoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 79.7%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.65 (d, <i>J</i> = 7.6 Hz, 2H), 7.48 (t, <i>J</i> = 8.2 Hz, 2H), 7.33 (t, <i>J</i> = 7.3 Hz, 1H), 7.05–7.02 (m, 2H), 4.25–4.21 (m, 2H), 3.15–3.06 (m, 2H), 2.97–2.88 (m, 2H), 2.78–2.70 (m, 2H), 1.82–1.75 (m, 2H), 1.71–1.57 (m, 4H), 1.38–1.6 (m, 2H), 1.30–1.22 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 328.2029 (calcd 328.2020 for C<sub>19</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 6-(4-(4-Methylpiperidin-1-yl)butoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 82.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.63 (d, <i>J</i> = 7.6 Hz, 2H), 7.37 (t, <i>J</i> = 7.9 Hz, 2H), 7.25 (t, <i>J</i> = 7.4 Hz, 1H), 6.96–6.86 (m, 2H), 4.19 (t, <i>J</i> = 6.4 Hz, 2H), 2.91 (d, <i>J</i> = 11.4 Hz, 2H), 2.41–2.32 (m, 2H), 1.93 (dd, <i>J</i> = 20.6, 8.6 Hz, 2H), 1.82–1.75 (m, 2H), 1.71–1.57 (m, 4H), 1.38–1.6 (m, 1H), 1.30–1.22 (m, 2H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 342.2179 (calcd 342.2176 for C<sub>20</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-(4-(3,5-Dimethylpiperidin-1-yl)butoxy)-2-phenylpyridazin-3(2<i>H</i>)-one (<b>26</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 83.0%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.64 (d, <i>J</i> = 7.6 Hz, 2H), 7.38 (t, <i>J</i> = 7.9 Hz, 2H), 7.25 (t, <i>J</i> = 7.4 Hz, 1H), 6.97–6.88 (m, 2H),4.29–4.16 (m, 2H), 4.16–4.10 (m, 2H), 3.10 (t, <i>J</i> = 20.3 Hz, 2H), 2.74–2.64 (m, 4H), 2.07–1.86 (m, 4H), 1.85–1.61 (m, 2H), 0.97 (d, <i>J</i> = 8.9 Hz, 3H), 0.83 (d, <i>J</i> = 6.6 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 356.2340 (calcd 356.2333 for C<sub>21</sub>H<sub>30</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_19_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> General Procedures for the Preparation of Intermediates <b>27</b>–<b>38</b>. 6-Hydroxy-2-(<i>p</i>-tolyl)pyridazin-3(2<i>H</i>)-one (<b>27</b>)</h3><div class="NLM_p last"><i>p</i>-Tolylhydrazine hydrochloride (55 mmol) was added to maleic anhydride (<b>7</b>, 50 mmol), 400 mL of water, and 40 mL of concentrated hydrochloric acid solution. The mixture was heated at reflux for 9 h. After it was cooled, the resulting solid was collected by filtration, washed with ice–water. The solid was dissolved in saturated sodium bicarbonate solution. After filtration, the resulting filtrate was neutralized with 1 mol/L hydrochloric acid. The precipitate thus formed was filtered and washed with water. The resulting <b>27</b> was a white solid. Yield 80.4%; mp 242–243 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.47 (d, <i>J</i> = 8.3 Hz, 2H), 7.27 (d, <i>J</i> = 8.2 Hz, 2H), 7.13–7.04 (m, 2H), 2.42 (s, 3H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_19_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 6-Hydroxy-2-(naphthalen-2-yl)pyridazin-3(2<i>H</i>)-one (<b>28</b>)</h3><div class="NLM_p last">White solid; yield 78.1%; mp 268–269 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.14 (s, 1H), 7.94 (d, <i>J</i> = 8.9 Hz, 1H), 7.89 (s, 1H), 7.73 (d, <i>J</i> = 6.9 Hz, 1H), 7.57–7.52 (m, 2H), 7.46 (s, 1H), 7.17–7.09 (m, 2H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_19_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(4-Fluorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>29</b>)</h3><div class="NLM_p last">White solid; yield 80.5%; mp 279–281 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.69–7.64 (m, 2H), 7.12–7.09 (m, 2H), 7.03–6.99 (q, <i>J</i> = 9.7 Hz, 2H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_19_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-(4-Chlorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>30</b>)</h3><div class="NLM_p last">White solid; yield 83.0%; mp 281–282 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.62 (d, <i>J</i> = 8.8 Hz, 2H), 7.47–7.43 (m, 2H), 7.10 (d, <i>J</i> = 8.5 Hz, 2H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_19_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(3,4-Dichlorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>31</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 76.2%; mp 291–292 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 2.5 Hz, 1H), 7.65 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.52 (d, <i>J</i> = 8.7 Hz, 1H), 7.01(br, 2H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_19_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-(2,3-Dichlorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>32</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 77.9%; mp 289–292 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.50 (s, 1H), 7.77 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.58 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 7.52 (t, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 9.9 Hz, 1H), 7.08 (d, <i>J</i> = 9.9 Hz, 1H).</div></div><div id="sec5_1_19_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(3,5-Dichlorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>33</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 74.8%; mp 288–289 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.54 (s, 1H), 7.79 (d, <i>J</i> = 1.9 Hz, 2H), 7.62 (t, <i>J</i> = 1.9 Hz, 1H), 7.21 (d, <i>J</i> = 9.8 Hz, 1H), 7.05 (d, <i>J</i> = 9.8 Hz, 1H).</div></div><div id="sec5_1_19_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-(2,4-Dichlorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>34</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 76.9%; mp 279–281 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.49 (s, 1H), 7.85 (d, <i>J</i> = 2.0 Hz, 1H), 7.65–7.55 (m, 2H), 7.24 (d, <i>J</i> = 9.9 Hz, 1H), 7.06 (d, <i>J</i> = 9.9 Hz, 1H).</div></div><div id="sec5_1_19_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-(2,5-Dichlorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>35</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 75.3%; mp 282–284 °C; <sup>1</sup>H NMR (600 MHz, DMSO) δ 11.48 (s, 1H), 7.78 (d, <i>J</i> = 2.5 Hz, 1H), 7.69 (d, <i>J</i> = 8.7 Hz, 1H), 7.60 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.24 (d, <i>J</i> = 9.9 Hz, 1H), 7.07 (d, <i>J</i> = 9.9 Hz, 1H).</div></div><div id="sec5_1_19_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-(3-Chloro-4-fluorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>36</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 76.8%; mp 291–292 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.54 (s, 1H), 7.54–7.44 (m, 2H), 7.29 (tt, <i>J</i> = 9.2, 2.4 Hz, 1H), 7.20 (d, <i>J</i> = 9.8 Hz, 1H), 7.09–7.03 (m, 1H).</div></div><div id="sec5_1_19_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-(3,4-Difluorophenyl)-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>37</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 78.6%; mp 285–287 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.48 (s, 1H), 7.78–7.75 (m, 1H), 7.59–7.49 (m, 2H), 7.22 (d, <i>J</i> = 9.8 Hz, 1H), 7.05 (d, <i>J</i> = 9.8 Hz, 1H).</div></div><div id="sec5_1_19_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Cyclopentyl-6-hydroxypyridazin-3(2<i>H</i>)-one (<b>38</b>)</h3><div class="NLM_p last">Pale white solid; yield 55.9%; mp 231–232 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.06 (d, <i>J</i> = 9.5 Hz, 2H), 5.44–5.25 (m, 1H), 1.93 (t, <i>J</i> = 31.1 Hz, 2H), 1.85–1.70 (m, 4H), 1.58–1.54 (m, 2H). A signal for the OH-proton is not visible.</div></div><div id="sec5_1_20_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> General Procedures for the Preparation of Intermediates <b>39</b>–<b>49</b>. 6-(3-Bromopropoxy)-2-(<i>p</i>-tolyl)pyridazin-3(2<i>H</i>)-one (<b>39</b>)</h3><div class="NLM_p last">To a solution of <b>27</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added, and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 15/1) to yield compound <b>39</b>. Pale yellow oil; yield 75.4%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.54 (d, <i>J</i> = 8.4 Hz, 2H), 7.27 (d, <i>J</i> = 8.2 Hz, 2H), 7.06–6.96 (m, 2H), 4.31 (t, <i>J</i> = 5.9 Hz, 2H), 3.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.36 (s, 3H), 2.29 (quintet, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec5_1_20_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 6-(3-Bromopropoxy)-2-(naphthalen-2-yl)pyridazin-3(2<i>H</i>)-one (<b>40</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 69.8%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.23 (s, 1H), 7.94 (d, <i>J</i> = 8.9 Hz, 1H), 7.93–7.91 (m, 1H), 7.89–7.87 (m, 1H). 7.81 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 7.56–7.49 (m, 2H), 7.07 (d, <i>J</i> = 9.7 Hz, 1H), 7.00 (d, <i>J</i> = 9.7 Hz, 1H), 4.35 (t, <i>J</i> = 5.9 Hz, 2H), 3.56 (t, <i>J</i> = 6.5 Hz, 2H), 2.36–2.24 (m, 2H).</div></div><div id="sec5_1_20_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 6-(3-Bromopropoxy)-2-(4-fluorophenyl)pyridazin-3(2<i>H</i>)-one (<b>41</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 65.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.69–7.64 (m, 2H), 7.15–7.11 (m, 2H), 7.02–6.98 (m, 2H), 4.31 (t, <i>J</i> = 5.9 Hz, 2H), 3.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.30 (quintet, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec5_1_20_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 6-(3-Bromopropoxy)-2-(4-chlorophenyl)pyridazin-3(2<i>H</i>)-one (<b>42</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 71.0%; mp 79–81 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.67 (d, <i>J</i> = 8.7 Hz, 2H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.04–6.97 (m, 2H), 4.32 (t, <i>J</i> = 5.9 Hz, 2H), 3.55 (t, <i>J</i> = 6.4 Hz, 2H), 2.30 (quintet, <i>J</i> = 6.1 Hz, 2H).</div></div><div id="sec5_1_20_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 6-(3-Bromopropoxy)-2-(3,4-dichlorophenyl)pyridazin-3(2<i>H</i>)-one (<b>43</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 71.8%; mp 83–85 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 2.5 Hz, 1H), 7.65 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.52 (d, <i>J</i> = 8.7 Hz, 1H), 7.01(s, 2H), 4.34 (t, <i>J</i> = 5.9 Hz, 2H), 3.57 (t, <i>J</i> = 6.4 Hz, 2H), 2.32 (quintet, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec5_1_20_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 6-(3-Bromopropoxy)-2-(2,3-dichlorophenyl)pyridazin-3(2<i>H</i>)-one (<b>44</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 71.3%; mp 53–55 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.57 (dd, <i>J</i> = 6.5, 3.1 Hz, 1H), 7.40–7.32 (m, 2H), 7.09–7.03 (m, 2H), 4.25 (t, <i>J</i> = 5.9 Hz, 2H), 3.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.60–1.94 (m, 2H).</div></div><div id="sec5_1_20_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 6-(3-Bromopropoxy)-2-(3,5-dichlorophenyl)pyridazin-3(2<i>H</i>)-one (<b>45</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 71.3%; mp 63–64 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J</i> = 1.9 Hz, 2H), 7.35 (t, <i>J</i> = 1.9 Hz, 1H), 7.11–6.96 (m, 2H), 4.35 (t, <i>J</i> = 5.9 Hz, 2H), 3.58 (t, <i>J</i> = 6.4 Hz, 2H), 2.36–2.31 (m, 2H).</div></div><div id="sec5_1_20_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 6-(3-Bromopropoxy)-2-(2,4-dichlorophenyl)pyridazin-3(2<i>H</i>)-one (<b>46)</b></h3><div class="NLM_p last">Pale yellow oil; yield 70.1%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.55 (dd, <i>J</i> = 1.5, 1.0 Hz, 1H), 7.42–7.35 (m, 2H), 7.08–7.01 (m, 2H), 4.24 (t, <i>J</i> = 5.9 Hz, 2H), 3.53 (t, <i>J</i> = 6.5 Hz, 2H), 2.28 (p, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec5_1_20_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 6-(3-Bromopropoxy)-2-(2,5-dichlorophenyl)pyridazin-3(2<i>H</i>)-one (<b>47</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 71.8%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 7.46 (d, <i>J</i> = 2.4 Hz, 1H), 7.39 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 7.09–7.03 (m, 2H), 4.27 (t, <i>J</i> = 5.9 Hz, 2H), 3.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.31–2.28 (m, 2H).</div></div><div id="sec5_1_20_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 6-(3-Bromopropoxy)-2-(3-chloro-4-fluorophenyl)pyridazin-3(2<i>H</i>)-one (<b>48</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 74.8%; mp 73–75 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.53–7.37 (m, 2H), 7.07–6.96 (m, 2H), 6.81 (tt, <i>J</i> = 8.7, 2.3 Hz, 1H), 4.36 (t, <i>J</i> = 5.9 Hz, 2H), 3.58 (t, <i>J</i> = 6.4 Hz, 2H), 2.37–2.31 (m, 2H).</div></div><div id="sec5_1_20_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 6-(3-Bromopropoxy)-2-(3,4-difluorophenyl)pyridazin-3(2<i>H</i>)-one (<b>49</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 69.9%; mp 43–45 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.66–7.63 (m, 1H), 7.55–7.52 (m, 1H), 7.24 (dd, <i>J</i> = 18.5, 8.9 Hz, 1H), 7.05–6.97 (m, 2H), 4.34 (t, <i>J</i> = 5.9 Hz, 2H), 3.57 (t, <i>J</i> = 6.4 Hz, 2H), 2.36–2.28 (m, 2H).</div></div><div id="sec5_1_21_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> General Procedures for the Synthesis of Compounds <b>50</b>–<b>61</b>. Method B. 6-(3-(Piperidin-1-yl)propoxy)-2-(<i>p</i>-tolyl)pyridazin-3(2<i>H</i>)-one (<b>50</b>)</h3><div class="NLM_p last">To a suspension of <b>39</b> (2 mmol) and piperidine (2.2 mmol), K<sub>2</sub>CO<sub>3</sub> (4 mmol) in acetonitrile (50 mL) and a catalytic amount of KI (1% mol) were added, and the resulting mixture was refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (10.0 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate was evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield compound <b>50</b>. Pale yellow oil; yield 81.5%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 7.22 (d, <i>J</i> = 8.1 Hz, 2H), 6.98–6.93 (m, 2H), 4.17 (t, <i>J</i> = 6.2 Hz, 2H), 2.59 (dd, <i>J</i> = 18.2, 10.4 Hz, 6H), 2.35 (s, 3H), 2.09–1.97 (m, 2H), 1.71–1.61 (m, 4H), 1.46 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 328.2027(calcd 328.2020 for C<sub>19</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-(Naphthalen-2-yl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>51</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 87.2%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.20 (d, <i>J</i> = 1.7 Hz, 1H), 7.95–7.85 (m, 3H), 7.79 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.54–7.49 (m, 2H), 7.03 (dd, <i>J</i> = 22.4, 9.7 Hz, 2H), 4.25 (t, <i>J</i> = 6.4 Hz, 2H), 2.45 (dd, <i>J</i> = 24.5, 16.7 Hz, 6H), 2.05–1.92 (m, 2H), 1.66–1.55 (m, 4H), 1.45 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 364.2026(calcd 364.2020 for C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-(4-Fluorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>52</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 80.6%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.65–7.61 (m, 2H), 7.14–7.07 (m, 2H), 6.99 (d, <i>J</i> = 9.7 Hz, 2H), 4.20 (t, <i>J</i> = 6.2 Hz, 2H), 2.66 (dd, <i>J</i> = 17.3, 9.3 Hz, 6H), 2.15–2.00 (m, 2H), 1.75–1.68 (m, 4H), 1.50 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 332.1775 (calcd 332.1769 for C<sub>18</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-(4-Chlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>53</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 86.7%; mp 91–92 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.68–7.64 (m, 2H), 7.42–7.38 (m, 2H), 6.97 (s, 2H), 4.20 (t, <i>J</i> = 6.4 Hz, 2H), 2.42 (dd, <i>J</i> = 22.1, 14.4 Hz, 6H), 2.04–1.86 (m, 2H), 1.65–1.53 (m, 4H), 1.43 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 348.1477(calcd 348.1473 for C<sub>18</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 2-(3,4-Dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>54</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 88.4%; mp 61–62 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 2.4 Hz, 1H), 7.65 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.50 (d, <i>J</i> = 8.7 Hz, 1H), 7.04–6.96 (m, 2H), 4.22 (t, <i>J</i> = 6.4 Hz, 2H), 2.53–2.38 (m, 6H), 2.02–1.92 (m, 2H), 1.66–1.58 (m, 4H), 1.45 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 382.1087 (calcd 382.1084 for C<sub>18</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-(2,3-Dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>55</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 81.5%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.59–7.52 (m, 1H), 7.37–7.32 (m, 2H), 7.07–6.98 (m, 2H), 4.13 (t, <i>J</i> = 6.3 Hz, 2H), 2.43–2.38 (m, 6H), 1.99–1.87 (m, 2H), 1.65–1.49 (m, 4H), 1.43 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 382.1088 (calcd 382.1084 for C<sub>18</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-(3,5-Dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>56</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 82.1%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.70 (d, <i>J</i> = 1.9 Hz, 2H), 7.32 (t, <i>J</i> = 1.9 Hz, 1H), 6.99 (d, <i>J</i> = 1.1 Hz, 2H), 4.22 (t, <i>J</i> = 6.4 Hz, 2H), 2.47–2.41 (m, 6H), 2.03–1.93 (m, 2H), 1.63–1.56 (m, 4H), 1.45 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 382.1079 (calcd 382.1084 for C<sub>18</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-(2,4-Dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>57</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 83.2%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.55 (d, <i>J</i> = 1.6 Hz, 1H), 7.41–7.34 (m, 2H), 7.02 (q, <i>J</i> = 9.9 Hz, 2H), 4.13 (t, <i>J</i> = 6.5 Hz, 2H), 2.44–2.39 (m, 6H), 2.00–1.87 (m, 2H), 1.66–1.52 (m, 4H), 1.44 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 382.1086 (calcd 382.1084 for C<sub>18</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-(2,5-Dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>58</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 85.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.47 (d, <i>J</i> = 8.6 Hz, 1H), 7.44 (d, <i>J</i> = 2.4 Hz, 1H), 7.37 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.03 (q, <i>J</i> = 9.9 Hz, 2H), 4.15 (t, <i>J</i> = 6.5 Hz, 2H), 2.44–2.39 (m, 6H), 2.01–1.88 (m, 2H), 1.63–1.52 (m, 4H), 1.44 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 382.1088 (calcd 382.1084 for C<sub>18</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-(3-Chloro-4-fluorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>59</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 81.6%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.50–7.38 (m, 2H), 7.07–6.93 (m, 2H), 6.80–6.75 (m, 1H), 4.23 (t, <i>J</i> = 6.4 Hz, 2H), 2.47–2.40 (m, 6H), 2.03–1.90 (m, 2H), 1.67–1.54 (m, 4H), 1.44 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 366.1381 (calcd 366.1379 for C<sub>18</sub>H<sub>22</sub>ClFN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-(3,4-Difluorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>60</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 82.4%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.64–7.60 (m, 1H), 7.55–7.45 (m, 1H), 7.21 (dd, <i>J</i> = 18.5, 8.9 Hz, 1H), 7.03–6.93 (m, 2H), 4.20 (t, <i>J</i> = 6.4 Hz, 2H), 2.45–2.39 (m, 6H), 2.01–1.91 (m, 2H), 1.64–1.51 (m, 4H), 1.44 (d, <i>J</i> = 4.6 Hz, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 350.1682 (calcd 350.1675 for C<sub>18</sub>H<sub>22</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_21_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Method A: 2-Cyclopentyl-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>61</b>)</h3><div class="NLM_p last">To a suspension of <b>38</b> (10 mmol) and 1-(3-chloropropyl)piperidine (10 mmol) in acetonitrile (100 mL), potassium carbonate (20 mmol) and a catalytic amount of potassium iodide (1% mol) were added. The resulting mixture was heated and refluxed for 8 h. The progress of the reaction was monitored by TLC. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate was evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield <b>61</b>. Pale yellow oil; yield 64.6%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 6.67–6.50 (m, 2H), 5.19–5.00 (m, 1H), 3.93 (dd, <i>J</i> = 14.8, 8.5 Hz, 2H), 2.19 (dd, <i>J</i> = 22.9, 15.5 Hz, 6H), 1.82–1.51 (m, 8H), 1.35 (dd, <i>J</i> = 23.9, 18.4 Hz, 6H), 1.18 (s, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 306.2183 (calcd 306.2176 for C<sub>17</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> General Procedures for the Synthesis of Compounds <b>62</b>–<b>72</b>. Method B. 6-(3-(4-Methylpiperidin-1-yl)propoxy)-2-(<i>p</i>-tolyl)pyridazin-3(2<i>H</i>)-one (<b>62</b>)</h3><div class="NLM_p last">To a suspension of <b>39</b> (2 mmol) and 4-methylpiperidine (2.2 mmol), K<sub>2</sub>CO<sub>3</sub> (4 mmol) in acetonitrile (50 mL) and a catalytic amount of KI (1% mol) were added, and the resulting mixture was refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (10.0 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate was evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield compound <b>62</b>. Pale yellow oil; yield 82.9%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.52 (d, <i>J</i> = 8.3 Hz, 2H), 7.23 (d, <i>J</i> = 8.2 Hz, 2H), 6.95 (q, <i>J</i> = 9.7 Hz, 2H), 4.18 (t, <i>J</i> = 6.4 Hz, 2H), 2.88 (d, <i>J</i> = 11.3 Hz, 2H), 2.45–2.42 (m, 2H), 2.37 (s, 3H), 1.97–1.86 (m, 4H), 1.60 (d, <i>J</i> = 12.8 Hz, 2H), 1.39–1.31 (m, 1H), 1.28–1.18 (m, 2H), 0.91 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 342.2185(calcd 342.2176 for C<sub>20</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 6-(3-(4-Methylpiperidin-1-yl)propoxy)-2-(naphthalen-2-yl)pyridazin-3(2<i>H</i>)-one (<b>63</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 81.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.20 (d, <i>J</i> = 1.8 Hz, 1H), 7.89 (ddd, <i>J</i> = 16.8, 11.9, 6.1 Hz, 3H), 7.79 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.54–7.47 (m, 2H), 7.03 (dd, <i>J</i> = 23.3, 9.7 Hz, 2H), 4.25 (t, <i>J</i> = 6.4 Hz, 2H), 2.90 (d, <i>J</i> = 11.4 Hz, 2H), 2.53–2.43 (m, 2H), 2.01–1.89 (m, 4H), 1.62 (d, <i>J</i> = 12.8 Hz, 2H), 1.43–1.18 (m, 3H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 378.2180(calcd 378.2176 for C<sub>23</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-(4-Fluorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>64</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 81.9%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.68–7.63 (m, 2H), 7.15–7.09 (m, 2H), 7.01–6.95 (m, 2H), 4.19 (t, <i>J</i> = 6.4 Hz, 2H), 2.88 (d, <i>J</i> = 11.1 Hz, 2H), 2.48–2.40 (m, 2H), 1.98–1.84 (m, 4H), 1.61 (d, <i>J</i> = 12.8 Hz, 2H), 1.35 (d, <i>J</i> = 6.0 Hz, 1H), 1.23 (q, <i>J</i> = 11.4 Hz, 2H), 0.91 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 346.1933(calcd 346.1925 for C<sub>19</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 2-(4-Chlorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>65</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 82.2%; mp 95–96 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.68–7.65 (m, 2H), 7.43–7.39 (m, 2H), 7.01–6.96 (m, 2H), 4.21 (t, <i>J</i> = 6.4 Hz, 2H), 2.89 (d, <i>J</i> = 11.4 Hz, 2H), 2.49–2.43 (m, 2H), 1.99–1.87 (m, 4H), 1.62 (d, <i>J</i> = 12.9 Hz, 2H), 1.42–1.33 (m, 1H), 1.28–1.21 (m, 3.6 Hz, 2H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 362.1633 (calcd 362.1630 for C<sub>19</sub>H<sub>25</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-(3,4-Dichlorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>66</b>)</h3><div class="NLM_p last">Pale white solid; yield 83.7%; mp 54–56 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 2.5 Hz, 1H), 7.65 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.50 (d, <i>J</i> = 8.7 Hz, 1H), 6.99 (d, <i>J</i> = 10.0 Hz, 2H), 4.22 (t, <i>J</i> = 6.4 Hz, 2H), 2.91 (d, <i>J</i> = 11.4 Hz, 2H), 2.49–2.45 (m, 2H), 2.02–1.90 (m, 4H), 1.63 (d, <i>J</i> = 12.8 Hz, 2H), 1.29–1.22 (m, 3H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 396.1246 (calcd 396.1240 for C<sub>19</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-(2,3-Dichlorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>67</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 82.1%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.61–7.52 (m, 1H), 7.38–7.30 (m, 2H), 7.04 (q, <i>J</i> = 9.9 Hz, 2H), 4.14 (t, <i>J</i> = 6.3 Hz, 2H), 2.88 (d, <i>J</i> = 11.5 Hz, 2H), 2.44 (t, <i>J</i> = 6.3 Hz, 2H), 2.00–1.85 (m, 4H), 1.61 (d, <i>J</i> = 13.0 Hz, 2H), 1.41–1.30 (m, 1H), 1.26–1.20 (m, 2H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 396.1242 (calcd 396.1240 for C<sub>19</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 2-(3,5-Dichlorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>68</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 81.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.71 (d, <i>J</i> = 1.9 Hz, 2H), 7.34 (t, <i>J</i> = 1.9 Hz, 1H), 7.05–6.95 (m, 2H), 4.23 (t, <i>J</i> = 6.4 Hz, 2H), 2.91 (d, <i>J</i> = 11.5 Hz, 2H), 2.50–2.45 (m, 2H), 2.02–1.89 (m, 4H), 1.64 (d, <i>J</i> = 12.9 Hz, 2H), 1.44–1.32 (m, 1H), 1.30–1.20 (m, 2H), 0.94 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 396.1243 (calcd 396.1240 for C<sub>19</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-(2,4-Dichlorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>69</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 81.2%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.56–7.54 (m, 1H), 7.40–7.33 (m, 2H), 7.02 (q, <i>J</i> = 9.9 Hz, 2H), 4.13 (t, <i>J</i> = 6.5 Hz, 2H), 2.88 (d, <i>J</i> = 11.5 Hz, 2H), 2.49–2.41 (m, 2H), 1.99–1.80 (m, 4H), 1.61 (d, <i>J</i> = 13.0 Hz, 2H), 1.43–1.29 (m, 1H), 1.29–1.15 (m, 2H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 396.1248 (calcd 396.1240 for C<sub>19</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 2-(2,5-Dichlorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>70</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 80.7%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.47–7.44 (m, 1H), 7.43 (d, <i>J</i> = 2.4 Hz, 1H), 7.36 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.08–6.98 (m, 2H), 4.14 (t, <i>J</i> = 6.5 Hz, 2H), 2.87 (d, <i>J</i> = 11.5 Hz, 2H), 2.47–2.37 (m, 2H), 1.98–1.85 (m, 4H), 1.60 (d, <i>J</i> = 13.5 Hz, 2H), 1.34 (ddd, <i>J</i> = 11.2, 6.9, 4.0 Hz, 1H), 1.22 (ddd, <i>J</i> = 15.5, 12.3, 3.7 Hz, 2H), 0.91 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 396.1244 (calcd 396.1240 for C<sub>19</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 2-(3-Chloro-4-fluorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>71</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 78.9%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.55–7.39 (m, 2H), 7.00–6.97 (m, 2H), 6.80–6.75 (m, 1H), 4.23 (t, <i>J</i> = 6.4 Hz, 2H), 2.90 (d, <i>J</i> = 11.5 Hz, 2H), 2.56–2.41 (m, 2H), 2.02–1.86 (m, 4H), 1.71–1.57 (m, 2H), 1.39–1.33 (m, 1H), 1.27–1.21 (m, 2H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 380.1542 (calcd 380.1536 for C<sub>19</sub>H<sub>24</sub>ClFN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_22_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 2-(3,4-Difluorophenyl)-6-(3-(4-methylpiperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>72</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 79.3%;<sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.65–7.61 (m, 1H), 7.54–7.51 (m, 1H), 7.23 (dd, <i>J</i> = 18.4, 9.0 Hz, 1H), 7.05–6.96 (m, 2H), 4.22 (t, <i>J</i> = 6.4 Hz, 2H), 2.90 (d, <i>J</i> = 11.5 Hz, 2H), 2.50–2.41 (m, 2H), 2.05–1.84 (m, 4H), 1.63 (d, <i>J</i> = 13.1 Hz, 2H), 1.44–1.30 (m, 1H), 1.28–1.21 (m, 2H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> 364.1838 (calcd 364.1831 for C<sub>19</sub>H<sub>24</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_23_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> General Procedures for the Preparation of Intermediates <b>73</b>–<b>75</b>. 2-(3,4-Dichlorophenyl)-6-hydroxy-4,5-dimethylpyridazin-3(2<i>H</i>)-one (<b>73</b>)</h3><div class="NLM_p last">3,4-Dicholrophenylhydrazine hydrochloride (55 mmol) was added to 3,4-dimethylfuran-2,5-dione (50 mmol), 400 mL of water, and 40 mL of 35% hydrochloric acid solution. The mixture was heated at reflux for 9 h. After it was cooled, the resulting solid was collected by filtration, washed with ice–water. The solid was dissolved in saturated sodium bicarbonate solution, and after filtration, the resulting filtrate was neutralized with 1 mol/L hydrochloric acid. The precipitate thus formed was filtered and washed with water. The resulting <b>73</b> was a white solid. Yield 77.4%; mp 255–257 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42 (s, 1H), 7.97 (d, <i>J</i> = 2.4 Hz, 1H), 7.74–7.59 (m, 2H), 2.09 (s, 6H).</div></div><div id="sec5_1_23_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 2-(3,4-Dichlorophenyl)-4-hydroxy-5,6,7,8-tetrahydrophthalazin-1(2<i>H</i>)-one (<b>74</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 79.1%; mp 261–263 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.41 (s, 1H), 7.97 (d, <i>J</i> = 2.4 Hz, 1H), 7.71 (dt, <i>J</i> = 8.8, 5.6 Hz, 2H), 3.35 (s, 2H), 2.56–2.46 (m, 2H), 2.44 (s, 2H), 1.69 (s, 2H).</div></div><div id="sec5_1_23_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 2-(3,4-Dichlorophenyl)-4-hydroxyphthalazin-1(2<i>H</i>)-one (<b>75</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 78.2%; mp 271–272 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.45 (s, 1H), 8.51–8.44 (m, 1H), 8.06–8.01 (m, 1H), 7.99 (d, <i>J</i> = 2.5 Hz, 1H), 7.89–7.85 (m, 2H), 7.74 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.54 (d, <i>J</i> = 8.7 Hz, 1H)</div></div><div id="sec5_1_24_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> General Procedures for the Preparation of Intermediates <b>76</b>–<b>78</b>. 6-(3-Bromopropoxy)-2-(3,4-dichlorophenyl)-4,5-dimethylpyridazin-3(2<i>H</i>)-one (<b>76</b>)</h3><div class="NLM_p last">To a solution of <b>73</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added, and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 15/1) to yield compound <b>76</b>. Pale yellow oil; yield 71.8%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.93 (dd, <i>J</i> = 2.3, 1.0 Hz, 1H), 7.67 (ddd, <i>J</i> = 8.7, 2.4, 1.0 Hz, 1H), 7.51 (dd, <i>J</i> = 8.7, 0.9 Hz, 1H), 4.40–4.27 (m, 2H), 3.59 (td, <i>J</i> = 6.4, 0.7 Hz, 2H), 2.36 (p, <i>J</i> = 5.8 Hz, 2H), 2.23 (s, 3H), 2.17 (s, 3H).</div></div><div id="sec5_1_24_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 4-(3-Bromopropoxy)-2-(3,4-dichlorophenyl)-5,6,7,8-tetrahydrophthalazin-1(2<i>H</i>)-one (<b>77</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 72.4%; mp 45–46 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.93 (d, <i>J</i> = 2.5 Hz, 1H), 7.68 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.50 (d, <i>J</i> = 8.7 Hz, 1H), 4.33 (t, <i>J</i> = 5.9 Hz, 2H), 3.58 (t, <i>J</i> = 6.5 Hz, 2H), 2.61 (t, <i>J</i> = 4.7 Hz, 2H), 2.53 (dd, <i>J</i> = 5.4, 3.9 Hz, 2H), 2.34 (p, <i>J</i> = 6.2 Hz, 2H), 1.89–1.74 (m, 4H).</div></div><div id="sec5_1_24_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 4-(3-Bromopropoxy)-2-(3,4-dichlorophenyl)phthalazin-1(2<i>H</i>)-one (<b>78</b>)</h3><div class="NLM_p last">Pale yellow solid; yield 72.4%; mp 48–50 °C; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.51–8.44 (m, 1H), 8.06–8.01 (m, 1H), 7.99 (d, <i>J</i> = 2.5 Hz, 1H), 7.89–7.85 (m, 2H), 7.74 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.54 (d, <i>J</i> = 8.7 Hz, 1H), 4.54 (t, <i>J</i> = 5.9 Hz, 2H), 3.66 (t, <i>J</i> = 6.5 Hz, 2H), 2.46 (p, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec5_1_25_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> General Procedures for the Synthesis of Compounds <b>79</b>–<b>81</b>. Method B. 2-(3,4-Dichlorophenyl)-4,5-dimethyl-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2<i>H</i>)-one (<b>79</b>)</h3><div class="NLM_p last">To a suspension of <b>73</b> (2 mmol) and piperidine (2.2 mmol), K<sub>2</sub>CO<sub>3</sub> (4 mmol) in acetonitrile (50 mL) and a catalytic amount of KI (1% mol) were added, and the resulting mixture was refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (10.0 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate was evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield compounds <b>79</b>. Pale yellow oil; yield 82.1%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 2.5 Hz, 1H), 7.76–7.64 (m, 1H), 7.49 (dd, <i>J</i> = 7.7, 3.4 Hz, 1H), 4.21 (t, <i>J</i> = 6.3 Hz, 2H), 2.50–2.43 (m, 6H), 2.24–2.21 (m, 3H), 2.20–2.13 (m, 3H), 2.04–1.94 (m, 2H), 1.68–1.58 (m, 4H), 1.46 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 410.1405 (calcd 410.1397 for C<sub>20</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_25_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 2-(3,4-Dichlorophenyl)-4-(3-(piperidin-1-yl)propoxy)-5,6,7,8-tetrahydrophthalazin-1(2<i>H</i>)-one (<b>80</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 79.8%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 2.5 Hz, 1H), 7.67 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.48 (d, <i>J</i> = 8.7 Hz, 1H), 4.21 (t, <i>J</i> = 6.3 Hz, 2H), 2.64–2.29 (m, 10H), 2.05–1.92 (m, 2H), 1.83–1.71 (m, 4H), 1.66–1.53 (m, 4H), 1.46 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 463.1557 (calcd 436.1553 for C<sub>22</sub>H<sub>28</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_25_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 2-(3,4-Dichlorophenyl)-4-(3-(piperidin-1-yl)propoxy)phthalazin-1(2<i>H</i>)-one (<b>81</b>)</h3><div class="NLM_p last">Pale yellow oil; yield 80.3%; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.49–8.43 (m, 1H), 8.06–8.00 (m, 1H), 7.98 (d, <i>J</i> = 2.5 Hz, 1H), 7.86–7.73 (m, 2H), 7.74 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.52 (d, <i>J</i> = 8.7 Hz, 1H), 4.41 (t, <i>J</i> = 6.3 Hz, 2H), 2.58–2.47 (m, 6H), 2.20–2.06 (m, 2H), 1.66–1.57 (m, 4H), 1.47 (br, 2H). HRMS (ESI) <i>m</i>/<i>z</i> 432.1249 (calcd 432.1240 for C<sub>22</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec5_1_26_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Single Crystal X-ray Structure Determination of <b>54</b>. Crystallization and Sample Preparation</h3><div class="NLM_p last">Crystals of the hydrochloride salt of <b>54</b> were obtained by slow evaporation of cosolvent of methanol and acetone solution of the compound.</div></div><div id="sec5_1_26_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Data Collection</h3><div class="NLM_p last">Crystal structure determination for the hydrochloride salt of <b>54</b> was carried out using Bruker SMART APEX II.</div></div><div id="sec5_1_26_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Structure Solution and Refinement</h3><div class="NLM_p last">Crystal structure solution was achieved using direct methods as implemented in SHELXTL<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and visualized using the program XP. Missing atoms were subsequently located from difference Fourier synthesis and added to the atom list. Least-squares refinement on <i>F</i><sup>2</sup> using all measured intensities was carried out using the program SHELXTL. All non-hydrogen atoms were refined, including anisotropic displacement parameters. The chlorine anion corresponding to one cationic molecule is distributed in two half-positions located on 2-fold rotation axes and shared with the neighboring cationic molecules.</div></div><div id="sec5_1_26_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Crystal Data at sf20150715_zyc_0m</h3><div class="NLM_p last">C<sub>18</sub>H<sub>26</sub>Cl<sub>3</sub>N<sub>3</sub>O<sub>4</sub>, crystal size 0.39 × 0.32 × 0.3 mm<sup>3</sup>, 454.77 g mol<sup>–1</sup>, triclinic, <i>P</i>1, <i>a</i> = 8.7813(3) Å, <i>b</i> = 10.4026(3) Å, <i>c</i> = 12.2094(4) Å, α = 97.6772(14)°, β = 91.8626(13)°, γ = 105.0210(12)°, <i>V</i> = 1064.92(6) Å<sup>3</sup>, <i>Z</i> = 2, ρ<sub>calcd</sub> =1.418 Mg/m<sup>3</sup>, R1 = 0.0364 (0.0427), wR2 = 0.1002 (0.1063), absorption coefficient is 0.459 mm<sup>–1</sup>, <i>F</i>(000) = 476, goodness-of-fit on <i>F</i><sup>2</sup> is 1.028, largest difference peak (hole) is 0.337 (−0.289) e Å<sup>–3</sup>.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Receptor Binding Studies. Materials</h3><div class="NLM_p last">The following specific radioligands and tissue sources were used: (a) σ<sub>1</sub> receptor, [<sup>3</sup>H]-(+)-pentazocine (250 μCi, PerkinElmer, NET-1056250UC), and male Dunkin Hartley guinea pig brain membrane; (b) σ<sub>2</sub> receptor, [<sup>3</sup>H]-di-<i>o</i>-tolylguanidine ([<sup>3</sup>H]-DTG, 250 μCi, PerkinElmer, NET-986250UC), (+)-SKF-10047 (Sigma-Aldrich), and male Dunkin Hartley guinea pig brain membrane. Chemicals and reagents were purchased from different commercial sources and of analytical grade.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Membrane Preparation</h3><div class="NLM_p last">Membrane preparation was performed by previously reported method.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Crude P2 membranes were prepared from frozen guinea pig brains minus cerebellum. Tissues were homogenized in ice-cold 10 mmol Tris-sucrose buffer (0.32 mol sucrose in 10 mmol Tris-HCl, pH 7.4) using an ULTRA TURAX homogenizer. The homogenates were centrifuged at 4 °C at 1000<i>g</i> for 10 min, and the supernatant was saved. The resulting pellet was then resuspended in the same buffer, incubated for 10 min at 4 °C, and centrifuged at 1000<i>g</i> for 10 min. After that, the pellet was discarded and the supernatants were combined and centrifuged at 31 000<i>g</i> for 15 min. The pellets were resuspended in 10 mL of Tris-HCl, pH 7.4, in a volume of 3 mL/g, and the suspension was allowed to incubate at 25 °C for 30 min. Following centrifuging at 31 000<i>g</i> for 15 min, the pellet was resuspended by gentle homogenization in 10 mmol of Tris-HCl, pH 7.4, in a final volume of 1.53 mL/g tissue and aliquots were stored at −80 °C until used. The protein concentration of the suspension was determined by the method of Bradford.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Subsequently, the preparation contained 4 mg protein/mL.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> General Procedures for the Binding Assays</h3><div class="NLM_p">All the test compounds were prepared by dissolving in 5% DMSO. The filter mats were presoaked in 0.5% polyethylenimine solution for 2 h at room temperature before use. The following specific radioligands and tissue sources were used: (a) σ<sub>1</sub> receptor, [<sup>3</sup>H]-(+)-pentazocine, guinea pig brain membranes; (b) σ<sub>2</sub> receptor, [<sup>3</sup>H]-DTG, (+)-SKF-10047 (blocked the σ<sub>1</sub> receptor) guinea pig brain membranes.</div><div class="NLM_p">For the σ<sub>1</sub> receptor binding assays, the total binding (TB) was determined in the presence of the radioligand [<sup>3</sup>H]-(+)-pentazocine. Nonspecific binding (NB) was determined in the presence of the radioligand [<sup>3</sup>H]-(+)-pentazocine and haloperidol, while the compound binding (CB) was determined in the presence of the radioligand [<sup>3</sup>H]-(+)-pentazocine and the determining compound. Specific binding (SB) is calculated by the total binding (TB) minus the nonspecific binding (NB) at a particular concentration of radioligand. Percentage of inhibition (%) was calculated as the following equation: percentage of inhibition (%) = [(TB – CB)/(TB – NB)] × 100.</div><div class="NLM_p last">Blank experiments were carried out to determine the effect of 5% DMSO on the binding, and no effects were observed. Compounds were tested at least three times over a 6 concentration range (10<sup>–5</sup> mol to 10<sup>–10</sup> mol), and IC<sub>50</sub> values were determined by nonlinear regression analysis using Hill equation curve fitting. <i>K</i><sub>i</sub> values were calculated based on the Cheng and Prusoff equation: <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + <i>C</i>/<i>K</i><sub>d</sub>). In the equation, <i>C</i> represents the concentration of the hot ligand used, and <i>K</i><sub>d</sub>, its receptor dissociation constant, was calculated for each labeled ligand (for [<sup>3</sup>H]-(+)-pentazocine, <i>K</i><sub>d</sub> was 1.53 ± 0.30 nM (<i>n</i> = 3), and for [<sup>3</sup>H]-DTG, <i>K</i><sub>d</sub> was 6.76 ± 0.94 nM (<i>n</i> = 3)). Mean <i>K</i><sub>i</sub> values and SEM are reported for at least three independent experiments.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> σ<sub>1</sub> Receptor Binding Assays</h3><div class="NLM_p last">Binding of [<sup>3</sup>H]-(+)-pentazocine at σ<sub>1</sub> receptor was performed according to D. L. Dehaven-Hudkins et al.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> with minor modifications.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> The binding properties of the test compounds to guinea pig σ<sub>1</sub> receptor were studied in guinea pig brain membranes using [<sup>3</sup>H]-(+)-pentazocine as the radioligand. To each total binding assay tube were added 900 μL of the tissue suspension, 50 μL of 4.0 nM [<sup>3</sup>H]-(+)-pentazocine, 50 μL Tris-HCl buffer, pH 8.0. To nonspecific binding each assay tube were added 900 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-(+)-pentazocine, 50 μL of 10 μM haloperidol. To each specific binding assay tube were added 900 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-(+)-pentazocine, 50 μL of reference drug or test compounds solution in various concentrations (10<sup>–5</sup> mol to 10<sup>–10</sup> mol). The tubes were incubated at 25 °C for 180 min. The incubation was followed by a rapid vacuum filtration through Whatman GF/B glass filters, and the filtrates were washed twice with 5 mL of cold buffer and transferred to scintillation vials. Scintillation fluid (2.0 mL) was added, and the radioactivity bound was measured using a Beckman LS 6500 liquid scintillation counter.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> σ<sub>2</sub> Receptor Binding Assays</h3><div class="NLM_p last">Binding assays were performed as described by Ronsisvalle et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> with minor modifications.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The binding properties of the test compounds to guinea pig σ<sub>2</sub> receptor were studied in guinea pig brain membranes using [<sup>3</sup>H]-DTG. The membranes were incubated with 3 nM [<sup>3</sup>H]-DTG in the presence of 400 nM (+)-SKF-10047 to block σ<sub>1</sub> sites. To each total binding assay tube were added 850 μL of the tissue suspension, 50 μL of 3.0 nM [<sup>3</sup>H]-DTG, 50 μL of 400 nM (+)-SKF-10047, 50 μL Tris-HCl buffer, pH 8.0. To each nonspecific binding assay tube were added 850 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-DTG, 50 μL of 400 nM (+)-SKF-10047, 50 μL of 10 μM DTG. To each specific binding assay tube were added 850 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-DTG, 50 μL of 400 nM (+)-SKF-10047, 50 μL of reference drug or test compounds solution in various concentrations (10<sup>–5</sup> mol to 10<sup>–10</sup> mol). The tubes were incubated at 25 °C for 120 min. The incubation was followed by a rapid vacuum filtration through Whatman GF/B glass filters, and the filtrates were washed twice with 5 mL of cold buffer and transferred to scintillation vials. Scintillation fluid (2.0 mL) was added, and the radioactivity bound was measured using a Beckman LS 6500 liquid scintillation counter.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Functional Profile on σ<sub>1</sub> Receptor</h3><div class="NLM_p last">The functional activity of compound <b>54</b> was evaluated by using guinea pig brain membranes binding assays for σ<sub>1</sub> receptor. The binding affinities in either the absence or presence of 1 mM phenytoin were measured to identify the functional (agonistic or antagonistic) nature.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div></div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> In Vivo Test. Animals</h3><div class="NLM_p last">Chinese Kun Ming (KM) mice (20 ± 2.0 g) and Sprague–Dawley (SD) rats (250 ± 5.0 g) were used as experimental animals in this study. All the animals were housed under standardized conditions for light, temperature, and humidity and received standard rat chow and tap water and libitum. Animals were assigned to different experimental groups randomly, each kept in a separate cage. All studies involving animals in this research follow the guidelines of the bylaw of experiments on animals and have been approved by the Ethics and Experimental Animal Committee of Jiangsu Nhwa Pharmaceutical Co., Ltd.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Acute Toxicity</h3><div class="NLM_p last">Mice (10 mice for each group) were orally dosed with po administration of a 10 mL/kg volume of vehicle 0.5% methylcellulose (Sigma-Aldrich) or increasing dose of test compounds (200, 500, 1000, 1500, and 2000 mg/kg). The number of surviving animals was recorded after 24 h of drug administration. The percent mortality in each group was calculated. The LD<sub>50</sub> values were calculated by using Statistical Package for Social Sciences (SPSS) program.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> hERG Affinity</h3><div class="NLM_p">Ability to block hERG potassium channels was determined using the whole-cell patch clamp method and cloned hERG potassium channels (expressed in HEK 293 cells) as biological material.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> For this purpose, the patch clamp amplifier (Axopatch 200B, Molecular Devices) and digital converter (Digidata 1440A, Molecular Devices) were used. Recording electrodes were made from borosilicate glass with filament (BF120-94-15, Sutter Instrument Company). Creation of voltage-clamp command pulse protocols and data acquisition were controlled by pCLAMP software (version 10.1, Molecular Devices).</div><div class="NLM_p">The bath solution consisted of 137 mM NaCl, 5.4 mM KCl, 10 mM glucose, 10 mM HEPES, and 2 mM CaCl<sub>2</sub>. The pH was adjusted to 7.5 by addition of NaOH. The pipet filling solution consisted of 140 mM KCl, 1 mM MgCl<sub>2</sub>, 5 mM EGTA, 10 mM HEPES, and 5 mM Na<sub>2</sub>ATP. The pH was adjusted to 7.2 by addition of KOH.</div><div class="NLM_p last">To study voltage dependence of steady-state block of hERG channels on different drug concentrations (0.3, 1, 3, and 10 μM) in HEK cells, the holding membrane potential was switched from −80 to +50 mV for 2 s following return to −50 mV for 3 s (sampling rate of 4 kHz, low-pass filtered at 1 kHz) in intervals of 30 s. Tail currents were measured at −50 mV in control and in the presence of the drug at concentrations determined empirically. All raw measurements were performed using Clampfit (version 10.2), a part of pCLAMP software (version 10.1). Results were transferred to the program Statistical Package for the Social Sciences (SPSS) spreadsheets for further analysis.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Formalin Test</h3><div class="NLM_p">Formalin tests were performed as described by Cendán et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> with minor modifications. A diluted formalin solution (20 μL of a 2.5% formalin solution, 0.92% formaldehyde) was injected into the dorsal surface of the right hind paw of the mouse. Immediately thereafter, the mouse was put into a glass cylinder and the observation period started. A mirror was placed behind the glass cylinder to allow clear observation of the paws. Nociceptive behavior induced by formalin was quantified as the time spent licking or biting the injected paw during two different periods individually recorded: the first period was recorded 0–5 min after the injection of formalin and was considered indicative of formalin-evoked nociception phase I; the second period was recorded 15–45 min after formalin injection and was considered indicative of formalin-voked nociception phase II.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The mice (<i>n</i> = 10–12 per group) received ip administration of a 10 mL/kg volume of vehicle 30% PEG 400 (Sigma-Aldrich) or test compound 15 min before intraplantar (ipl) formalin injection.</div><div class="NLM_p last">The antinociceptive effect induced by the different treatments in the formalin test was calculated by the following formula: antinociceptive effect (%) = [(LT<sub>V</sub> – LT<sub>D</sub>)/LT<sub>V</sub>] × 100, where LT<sub>V</sub> represent the licking time in vehicle injected animals, LT<sub>D</sub> means licking time in drug-injected animals.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> CCI Model<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a></h3><div class="NLM_p">The CCI of the sciatic nerve as an animal model was used to study the efficacy of treatments in neuropathic pain. Rats were randomly separated into several groups: sham control and vehicle- and drug-treated groups, and each group contained 10 rats. Pain threshold base values of each group were measured 1–2 days before surgery, and those with the value of 2 days were picked. The pain thresholds were measured again 14 days after surgery to check whether the model was successful. Drugs were dose orally with po administration of a 10 mL/kg volume of vehicle 0.5% methylcellulose (Sigma-Aldrich) or increasing dose of test compounds twice a day for 4 days (15th, 16th, 17th, and 18th day). Each group was measured after first administration on the 15th day and the last administration on the 18th day, which resulted in the single administration and repeated administration, respectively.</div><div class="NLM_p last">The CCI of the sciatic nerve surgery was performed as described by Bennett and Xie<a onclick="showRef(event, 'cit62a'); return false;" href="javascript:void(0);" class="ref cit62a">(62a)</a> with minor modification. Briefly, the SD rats were anesthetized with chloral hydrate (5%) and the right common sciatic nerve was exposed at the level of the midthigh of the right hind paw. At about 1 cm proximal to the nerve trifurcation, about 7 mm of the nerve was freed and four ligatures (4–0 silk tread) were tight loosely with a distance of ∼1.0 mm. The nerve was only barely constricted. The muscle was than stitched and the skin incision closed with wound clips. The rats with sciatic nerve exposure without ligation served as the sham control group. Two tests were performed: the von Frey test (electronic von Frey rigid tips with 90 g range (IITC Life Science Inc., U.S.A, 2390)) and the plantar test. Allodynia to mechanical stimuli and hyperalgesia to noxious thermal stimulus were used as outcome measures of neuropathic pain by using the von Frey and plantar tests, respectively. In the von Frey test, briefly, animals were placed in a transparent test chamber with a wire-mesh grid floor through which von Frey monofilaments were applied. The monofilaments were applied in increasing force until the rats withdrew the ipsilateral, nerve injury paw using an up–down paradigm. Clear paw withdrawal, sharking, or licking was considered as nociceptive-lick response to determine the mechanical withdrawal threshold (MWT). Animals were adapted to the testing situation for at least 30 min before the sessions started. For each measurement, the paw was sampled four times and a mean calculated. At least 3 min elapsed between. Thermal hyperalgesia was assessed through the plantar test by measuring hind paw latency in response to radiant heat. Briefly, rats were placed in a clear plastic chamber with a glass floor and allowed to acclimate to the environment for 30 min. A radiant heat source (BMC-410A) was then positioned under the plantar surface of the hind paw. The latency for the withdrawal reflex was recorded as thermal withdrawal latency (TWL). A cutoff time of 30 s was imposed to prevent tissue damage in the absence of response. For each measurement, the paw was sampled four times and a mean calculated. At least 3 min elapsed between.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Motor Coordination (Rotarod Test)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></h3><div class="NLM_p last">The motor performance of mice was assessed by means of an automated rotarod (YLS-4C, China). Mice were trained, and those that could not stay moving on the rod for 300 s in 10 rpm were discarded from the study before drug treatment. In the test, mice were required to walk against the motion of an elevated rotating drum at 10 rpm and the latencies to fall-down were recorded. With the selected animals, rotarod latencies were measured 30, 60, 90, and 120 min after ig administration of drugs.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> Locomotor Activity Test</h3><div class="NLM_p last">Locomotor activity was assessed in 14 automated activity frames equipped with infrared photobeam emitters and sensors. To assess drug effect on exploratory locomotor activity, the mice were transferred to new home cages immediately before test start and activity was measured for 30 min. Test or reference compounds were orally administered 30 min before test start at the following doses of 40, 80, 160 mg/kg; haloperidol was at 0.1, 0.3, 1 mg/kg. The average speed was measured before and 30, 60, 90, and 120 min after treatment.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Pharmacokinetics Study in Rats</h3><div class="NLM_p last">The HPLC conditions were as follows: column, XSELECT CSH XP C18 (2.1 mm × 50 mm, 2.5 μm); mobile phase, 0.025% FA and 1 mM NH<sub>4</sub>OAc (ROE SCIENTIFIC INC, USA) in water/acetonitrile (Merck Company, Germany) (v:v, 45:55); flow rate, 0.6 mL/min; column temperature, 50 °C. UV detection was performed at 210 nm. For routine compound <b>54</b> screening, rats (<i>n</i> = 3/group) were dosed via the lateral tail vein at the indicated dose for iv administration (5 mg/kg, 100% saline) or via oral gavage (80 mg/kg, suspension in 0.5% methylcellulose). At 30 min and 1, 2, 3, 4, 5, 6, 8 and 24 h after administration, serial blood samples were collected from the lateral tail vein into heparinized collection tubes (approximately 0.25 mL). The plasma was separated by centrifugation, and the sample was prepared for LC/MS analysis by protein precipitation with acetonitrile. The plasma samples were analyzed for drug and internal standard via the LC–MS/MS protocol.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Statistics</h3><div class="NLM_p last">To estimate the potency of test and reference compounds, the ED<sub>50</sub> values and their 95% confidence limits were calculated by using the program SPSS (Statistical Package for the Social Science).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01416">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01416" class="ext-link">10.1021/acs.jmedchem.5b01416</a>. CCDC 1423214 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via <a href="http://www.ccdc.cam.ac.uk/conts/retrieving.html" class="extLink">www.ccdc.cam.ac.uk/conts/retrieving.html</a> (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, U.K. (fax (+44) 1223-336-033, e-mail <a href="/cdn-cgi/l/email-protection#dabebfaab5a9b3ae9ab9b9beb9f4b9bbb7f4bbb9f4afb1"><span class="__cf_email__" data-cfemail="4723223728342e3307242423246924262a69262469322c">[email protected]</span></a>). <ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Inhibition curves of functional profile of σ<sub>1</sub> receptor; additional receptors binding affinities of compound <b>54</b>; data of compound 54 in phase I of the mouse formalin test; <sup>1</sup>H NMR, HR-MS, and HPLC of compound <b>54</b>; X-ray crystal data of compound <b>54</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_001.pdf">jm5b01416_si_001.pdf (666.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_002.csv">jm5b01416_si_002.csv (2.93 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01416" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guisen Zhang</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2146525b49404f46614c40484d0f495452550f4445540f424f"><span class="__cf_email__" data-cfemail="94f3e7eefcf5faf3d4f9f5fdf8bafce1e7e0baf1f0e1baf7fa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xudong Cao</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yin Chen</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yifang Zhang</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Lan</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juecheng Zhang</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiangqing Xu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinli Qiu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Song Zhao</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Liu</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bi-Feng Liu</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>X.C. and Y.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e7286-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i124">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful for financial support from the NSFC (Grant 81573291) and the National Science and Technology Major Project “Key New Drug Creation and Manufacturing Program” (Grant 2012ZX09103-101-010). The authors thank Prof. Liangren Zhang, Zhenming Liu, and Hongwei Jin of State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, for performing HRMS.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i125" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i125"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i126" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i126"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">ig</td><td class="NLM_def"><p class="first last">intragastric administration</p></td></tr><tr><td class="NLM_term">CCI</td><td class="NLM_def"><p class="first last">chronic constriction injury</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective dose</p></td></tr><tr><td class="NLM_term">LD<sub>50</sub></td><td class="NLM_def"><p class="first last">median lethal dose</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i127">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jongen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzon, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huygen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartrick, C. T.</span><span> </span><span class="NLM_article-title">Neuropathic pain and pharmacological treatment</span> <span class="citation_source-journal">Pain. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1111/papr.12085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1111%2Fpapr.12085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=23750502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=283-295&author=J.+L.+Jongenauthor=G.+Hansauthor=H.+T.+Benzonauthor=F.+Huygenauthor=C.+T.+Hartrick&title=Neuropathic+pain+and+pharmacological+treatment&doi=10.1111%2Fpapr.12085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain and pharmacological treatment</span></div><div class="casAuthors">Jongen Joost L M; Hans Guy; Benzon Honorio T; Huygen Frank; Hartrick Craig T</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is a serious chronic condition strongly affecting quality of life, which can be relieved but cannot be cured.  Apart from symptomatic management, treatment should focus on the underlying disorder.  The estimated prevalence is at least 1% to 5% of the general population.  Neuropathic pain is characterized both by spontaneous and evoked pain.  A diagnosis of neuropathic pain can usually be established based solely on history and neurological examination.  Ancillary investigations may include EMG and computerized tomography/magnetic resonance imaging scans, depending on the localization of the suspected lesion.  A limited number of agents, primarily directed at symptom control, are currently approved for use in neuropathic pain.  A mechanism-based approach to pharmacological intervention supports the use of polypharmacy in neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCgdyy7ehY67qxQ2mb9Pu8fW6udTcc2eZaUySk3qZvtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D&md5=66f491a169f5c3b2fe5b6078346d31da</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fpapr.12085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpapr.12085%26sid%3Dliteratum%253Aachs%26aulast%3DJongen%26aufirst%3DJ.%2BL.%26aulast%3DHans%26aufirst%3DG.%26aulast%3DBenzon%26aufirst%3DH.%2BT.%26aulast%3DHuygen%26aufirst%3DF.%26aulast%3DHartrick%26aufirst%3DC.%2BT.%26atitle%3DNeuropathic%2520pain%2520and%2520pharmacological%2520treatment%26jtitle%3DPain.%2520Pract.%26date%3D2014%26volume%3D14%26spage%3D283%26epage%3D295%26doi%3D10.1111%2Fpapr.12085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">van Hecke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, N.</span><span> </span><span class="NLM_article-title">Neuropathic pain in the general population: a systematic review of epidemiological studies</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pain.2013.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24291734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC2c3itVOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=654-662&author=O.+van+Heckeauthor=S.+K.+Austinauthor=R.+A.+Khanauthor=B.+H.+Smithauthor=N.+Torrance&title=Neuropathic+pain+in+the+general+population%3A+a+systematic+review+of+epidemiological+studies&doi=10.1016%2Fj.pain.2013.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain in the general population: a systematic review of epidemiological studies</span></div><div class="casAuthors">van Hecke O; Austin Sophie K; Khan Rafi A; Smith B H; Torrance N</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">654-662</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Most patients with neuropathic pain symptoms present and are managed in primary care, with only a minority being referred for specialist clinical assessment and diagnoses.  Previous reviews have focused mainly on specific neuropathic pain conditions based in specialist settings.  This is the first systematic review of epidemiological studies of neuropathic pain in the general population.  Electronic databases were searched from January 1966 to December 2012, and studies were included where the main focus was on neuropathic pain prevalence and/or incidence, either as part of a specific neuropathic pain-related condition or as a global entity in the general population.  We excluded studies in which data were extracted from pain or other specialist clinics or focusing on specific population subgroups.  Twenty-one articles were identified and underwent quality assessment and data extraction.  Included studies differed in 3 main ways: method of data retrieval, case ascertainment tool used, and presentation of prevalence/incidence rates.  This heterogeneity precluded any meta-analysis.  We categorised comparable incidence and prevalence rates into 2 main subgroups: (1) chronic pain with neuropathic characteristics (range 3-17%), and (2) neuropathic pain associated with a specific condition, including postherpetic neuralgia (3.9-42.0/100,000 person-years [PY]), trigeminal neuralgia (12.6-28.9/100,000 PY), painful diabetic peripheral neuropathy (15.3-72.3/100,000 PY), glossopharyngeal neuralgia (0.2-0.4/100,000 PY).  These differences highlight the importance of a standardised approach for identifying neuropathic pain in future epidemiological studies.  A best estimate of population prevalence of pain with neuropathic characteristics is likely to lie between 6.9% and 10%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcdtpdgNQC5D69zv1FsJFMfW6udTcc2eZaUySk3qZvtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3itVOguw%253D%253D&md5=6d7456ae9aedd996fac515a1c683c83a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.11.013%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHecke%26aufirst%3DO.%26aulast%3DAustin%26aufirst%3DS.%2BK.%26aulast%3DKhan%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DTorrance%26aufirst%3DN.%26atitle%3DNeuropathic%2520pain%2520in%2520the%2520general%2520population%253A%2520a%2520systematic%2520review%2520of%2520epidemiological%2520studies%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D654%26epage%3D662%26doi%3D10.1016%2Fj.pain.2013.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A. H.</span><span> </span><span class="NLM_article-title">Emerging drugs for neuropathic pain</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1517/14728214.2014.915025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F14728214.2014.915025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24793304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=329-341&author=I.+Gilronauthor=A.+H.+Dickenson&title=Emerging+drugs+for+neuropathic+pain&doi=10.1517%2F14728214.2014.915025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs for neuropathic pain</span></div><div class="casAuthors">Gilron, Ian; Dickenson, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-341</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Neuropathic pain is a costly and disabling condition, which affects up to 8% of the population.  Available therapies often provide incomplete pain relief and treatment-related side effects are common.  Preclin. neuropathic pain models have facilitated identification of several promising targets, which have progressed to human clin. phases of evaluation.  Areas covered: A systematic database search yielded 25 new mol. entities with specified pharmacol. mechanisms that have reached Phase II or III clin. trials.  These include calcium channel antagonists, vanilloid receptor antagonists, potassium channel agonists, NMDA antagonists, novel opioid receptor agonists, histamine H3 receptor antagonists, a novel sodium channel antagonist, serotonin modulators, a novel acetylcholine receptor agonist, α-2b adrenoreceptor agonist, cannabinoid CB2 receptor agonist, nitric oxide synthase inhibitor, orexin receptor antagonist, angiotensin II 2 antagonist, imidazoline I2 receptor agonist, apoptosis inhibitor and fatty acid amide hydrolase inhibitor.  Expert opinion: Although the diversity of pharmacol. mechanisms of interest emphasize the complexity of neuropathic pain transmission, the considerable no. of agents under development reflect a continued enthusiasm in drug development for neuropathic pain.  Ongoing enhancements in methodol. of both preclin. and clin. research and closer translation in both directions are expected to more efficiently identify new agents, which will improve the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJawa4UZNs67Vg90H21EOLACvtfcHk0lgnnhx8DfVBFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjtb3J&md5=b2f98de7e03fb2835986a1b232ab7000</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728214.2014.915025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2014.915025%26sid%3Dliteratum%253Aachs%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26atitle%3DEmerging%2520drugs%2520for%2520neuropathic%2520pain%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2014%26volume%3D19%26spage%3D329%26epage%3D341%26doi%3D10.1517%2F14728214.2014.915025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahana, A.</span><span> </span><span class="NLM_article-title">Treatment of chronic non-cancer pain</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">2226</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60402-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2FS0140-6736%2811%2960402-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=21704872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=2226-2235&author=D.+C.+Turkauthor=H.+D.+Wilsonauthor=A.+Cahana&title=Treatment+of+chronic+non-cancer+pain&doi=10.1016%2FS0140-6736%2811%2960402-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of chronic non-cancer pain</span></div><div class="casAuthors">Turk, Dennis C.; Wilson, Hilary D.; Cahana, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">9784</span>),
    <span class="NLM_cas:pages">2226-2235</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Chronic pain is a pervasive problem that affects the patient, their significant others, and society in many ways.  The past decade has seen advances in our understanding of the mechanisms underlying pain and in the availability of tech. advanced diagnostic procedures; however, the most notable therapeutic changes have not been the development of novel evidenced-based methods, but rather changing trends in applications and practices within the available clin. armamentarium.  We provide a general overview of empirical evidence for the most commonly used interventions in the management of chronic non-cancer pain, including pharmacol., interventional, phys., psychol., rehabilitative, and alternative modalities.  Overall, currently available treatments provide modest improvements in pain and min. improvements in phys. and emotional functioning.  The quality of evidence is mediocre and has not improved substantially during the past decade.  There is a crucial need for assessment of combination treatments, identification of indicators of treatment response, and assessment of the benefit of matching of treatments to patient characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCxyG7QutTErVg90H21EOLACvtfcHk0liKrusS4VtFBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejsbg%253D&md5=55b3b3e920ec253406736fcee3337754</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960402-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960402-9%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DH.%2BD.%26aulast%3DCahana%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520chronic%2520non-cancer%2520pain%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D2226%26epage%3D2235%26doi%3D10.1016%2FS0140-6736%2811%2960402-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kissin, I.</span><span> </span><span class="NLM_article-title">The development of new analgesics over the past 50 years: a lack of real breakthrough drugs</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1213/ANE.0b013e3181cde882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1213%2FANE.0b013e3181cde882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=20185657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFejs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=780-789&author=I.+Kissin&title=The+development+of+new+analgesics+over+the+past+50+years%3A+a+lack+of+real+breakthrough+drugs&doi=10.1213%2FANE.0b013e3181cde882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The Development of New Analgesics Over the Past 50 Years: A Lack of Real Breakthrough Drugs</span></div><div class="casAuthors">Kissin, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia & Analgesia (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">AACRAT</span>;
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Fifty-nine drugs identified as analgesics were introduced from 1960 to 2009 and remain in use.  Seven can be regarded as having novel mol. targets; however, only one, sumatriptan, was sufficiently effective to motivate the introduction of many similar drugs acting at the same target (triptans).  Publication productivity in the area of pain grew exponentially during this period.  Pain-related publications on morphine were dominant among other analgesics.  Very intensive research efforts directed at diverse mol. targets related to pain mechanisms produced thousands of publications, but those efforts have not yet yielded new analgesics with sufficient effectiveness to change the share of publications on opioids or nonsteroidal antiinflammatory drugs.  Morphine and aspirin, introduced for the treatment of pain more than a century ago, continue to dominate biomedical publications despite their limited effectiveness in many areas (e.g., neuropathic pain) and multiple serious adverse effects.  The present assessment reveals the lack of real breakthroughs in analgesic drug development despite intense research efforts.  Possible factors contributing to the apparent drought of novel analgesics are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsccjveSEq7Vg90H21EOLACvtfcHk0liKrusS4VtFBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFejs70%253D&md5=a96605c8f1c3a55f84c2605f0917273b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1213%2FANE.0b013e3181cde882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252FANE.0b013e3181cde882%26sid%3Dliteratum%253Aachs%26aulast%3DKissin%26aufirst%3DI.%26atitle%3DThe%2520development%2520of%2520new%2520analgesics%2520over%2520the%2520past%252050%2520years%253A%2520a%2520lack%2520of%2520real%2520breakthrough%2520drugs%26jtitle%3DAnesth.%2520Analg.%26date%3D2010%26volume%3D110%26spage%3D780%26epage%3D789%26doi%3D10.1213%2FANE.0b013e3181cde882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burgess, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span> </span><span class="NLM_article-title">The discovery and development of analgesics: new mechanisms, new modalities</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3753</span><span class="NLM_x">–</span> <span class="NLM_lpage">3759</span><span class="refDoi"> DOI: 10.1172/JCI43195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1172%2FJCI43195" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=3753-3759&author=G.+Burgessauthor=D.+Williams&title=The+discovery+and+development+of+analgesics%3A+new+mechanisms%2C+new+modalities&doi=10.1172%2FJCI43195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1172%2FJCI43195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI43195%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520analgesics%253A%2520new%2520mechanisms%252C%2520new%2520modalities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2010%26volume%3D120%26spage%3D3753%26epage%3D3759%26doi%3D10.1172%2FJCI43195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Investigational sigma-1 receptor antagonists for the treatment of pain</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1048334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F13543784.2015.1048334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=883-896&author=J.+M.+Velaauthor=M.+Merlosauthor=C.+Almansa&title=Investigational+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.1517%2F13543784.2015.1048334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1048334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1048334%26sid%3Dliteratum%253Aachs%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DInvestigational%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D883%26epage%3D896%26doi%3D10.1517%2F13543784.2015.1048334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davis, M. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors and animal studies centered on pain and analgesia</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span><span class="refDoi"> DOI: 10.1517/17460441.2015.1051961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F17460441.2015.1051961" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=885-900&author=M.+P.+Davis&title=Sigma-1+receptors+and+animal+studies+centered+on+pain+and+analgesia&doi=10.1517%2F17460441.2015.1051961"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1051961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1051961%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BP.%26atitle%3DSigma-1%2520receptors%2520and%2520animal%2520studies%2520centered%2520on%2520pain%2520and%2520analgesia%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D885%26epage%3D900%26doi%3D10.1517%2F17460441.2015.1051961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backonja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnerup, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portenoy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. S.</span><span> </span><span class="NLM_article-title">Pharmacologic management of neuropathic pain: evidence-based recommendations</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1016/j.pain.2007.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pain.2007.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=17920770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=237-251&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=M.+Backonjaauthor=J.+T.+Farrarauthor=N.+B.+Finnerupauthor=T.+S.+Jensenauthor=E.+A.+Kalsoauthor=J.+D.+Loeserauthor=C.+Miaskowskiauthor=T.+J.+Nurmikkoauthor=R.+K.+Portenoyauthor=A.+S.+Riceauthor=B.+R.+Staceyauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=M.+S.+Wallace&title=Pharmacologic+management+of+neuropathic+pain%3A+evidence-based+recommendations&doi=10.1016%2Fj.pain.2007.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic management of neuropathic pain: Evidence-based recommendations</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Backonja, Miroslav; Farrar, John T.; Finnerup, Nanna B.; Jensen, Troels S.; Kalso, Eija A.; Loeser, John D.; Miaskowski, Christine; Nurmikko, Turo J.; Portenoy, Russell K.; Rice, Andrew S. C.; Stacey, Brett R.; Treede, Rolf-Detlef; Turk, Dennis C.; Wallace, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-251</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Patients with neuropathic pain (NP) are challenging to manage and evidence-based clin. recommendations for pharmacol. management are needed.  Systematic literature reviews, randomized clin. trials, and existing guidelines were evaluated at a consensus meeting.  Medications were considered for recommendation if their efficacy was supported by at least one methodol.-sound, randomized clin. trial (RCT) demonstrating superiority to placebo or a relevant comparison treatment.  Recommendations were based on the amt. and consistency of evidence, degree of efficacy, safety, and clin. experience of the authors.  Available RCTs typically evaluated chronic NP of moderate to severe intensity.  Recommended first-line treatments include certain antidepressants (i.e., tricyclic antidepressants and dual reuptake inhibitors of both serotonin and norepinephrine), calcium channel α2-δ ligands (i.e., gabapentin and pregabalin), and topical lidocaine.  Opioid analgesics and tramadol are recommended as generally second-line treatments that can be considered for first-line use in select clin. circumstances.  Other medications that would generally be used as third-line treatments but that could also be used as second-line treatments in some circumstances include certain antiepileptic and antidepressant medications, mexiletine, N-methyl-D-aspartate receptor antagonists, and topical capsaicin.  Medication selection should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary.  To date, no medications have demonstrated efficacy in lumbosacral radiculopathy, which is probably the most common type of NP.  Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examg. treatment of central NP are lacking and should be a priority for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNM2xlrhF4ZrVg90H21EOLACvtfcHk0lhLzEzZvnZBnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN&md5=dfa9749c8bb2a828419a7d0cfd62c9b4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2007.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2007.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DBackonja%26aufirst%3DM.%26aulast%3DFarrar%26aufirst%3DJ.%2BT.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26aulast%3DLoeser%26aufirst%3DJ.%2BD.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DNurmikko%26aufirst%3DT.%2BJ.%26aulast%3DPortenoy%26aufirst%3DR.%2BK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DStacey%26aufirst%3DB.%2BR.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWallace%26aufirst%3DM.%2BS.%26atitle%3DPharmacologic%2520management%2520of%2520neuropathic%2520pain%253A%2520evidence-based%2520recommendations%26jtitle%3DPain%26date%3D2007%26volume%3D132%26spage%3D237%26epage%3D251%26doi%3D10.1016%2Fj.pain.2007.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Attal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruccu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">European Federation of Neurological Societies.</span><span> </span><span class="NLM_article-title">EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1111/j.1468-1331.2010.02999.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1111%2Fj.1468-1331.2010.02999.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=20402746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC3cjls1ymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1113-1123&author=N.+Attalauthor=G.+Cruccuauthor=R.+Baronauthor=M.+Haanp%C3%A4%C3%A4author=P.+Hanssonauthor=T.+S.+Jensenauthor=T.+Nurmikkoauthor=European+Federation+of+Neurological+Societies.&title=EFNS+guidelines+on+the+pharmacological+treatment+of+neuropathic+pain%3A+2010+revision&doi=10.1111%2Fj.1468-1331.2010.02999.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision</span></div><div class="casAuthors">Attal N; Cruccu G; Baron R; Haanpaa M; Hansson P; Jensen T S; Nurmikko T</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1113-e88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVES:  This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005.  METHODS:  Studies were identified using the Cochrane Database and Medline.  Trials were classified according to the aetiological condition.  All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies.  Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting.  RESULTS:  Most large RCTs included patients with diabetic polyneuropathies and post-herpetic neuralgia, while an increasing number of smaller studies explored other conditions.  Drugs generally have similar efficacy in various conditions, except in trigeminal neuralgia, chronic radiculopathy and HIV neuropathy, with level A evidence in support of tricyclic antidepressants (TCA), pregabalin, gabapentin, tramadol and opioids (in various conditions), duloxetine, venlafaxine, topical lidocaine and capsaicin patches (in restricted conditions).  Combination therapy appears useful for TCA-gabapentin and gabapentin-opioids (level A).  CONCLUSIONS:  There are still too few large-scale comparative studies.  For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuuyCz0eaE0e-MdeMhXAHkfW6udTcc2eZC_LRA8GUflrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjls1ymsg%253D%253D&md5=13990136dfe522922579642e2c3d7b57</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2010.02999.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2010.02999.x%26sid%3Dliteratum%253Aachs%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DCruccu%26aufirst%3DG.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DNurmikko%26aufirst%3DT.%26aulast%3D%26atitle%3DEFNS%2520guidelines%2520on%2520the%2520pharmacological%2520treatment%2520of%2520neuropathic%2520pain%253A%25202010%2520revision%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2010%26volume%3D17%26spage%3D1113%26epage%3D1123%26doi%3D10.1111%2Fj.1468-1331.2010.02999.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Moulin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furlan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley-Forster, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessle, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taenzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, O. D.</span><span> </span><span class="NLM_article-title">Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society</span> <span class="citation_source-journal">Pain. Res. Manag.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1155/2014/754693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1155%2F2014%2F754693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25479151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC2Mzmt1SgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=328-335&author=D.+Moulinauthor=A.+Boulangerauthor=A.+J.+Clarkauthor=H.+Clarkeauthor=T.+Daoauthor=G.+A.+Finleyauthor=A.+Furlanauthor=I.+Gilronauthor=A.+Gordonauthor=P.+K.+Morley-Forsterauthor=B.+J.+Sessleauthor=P.+Squireauthor=J.+Stinsonauthor=P.+Taenzerauthor=A.+Vellyauthor=M.+A.+Wareauthor=E.+L.+Weinbergauthor=O.+D.+Williamson&title=Pharmacological+management+of+chronic+neuropathic+pain%3A+revised+consensus+statement+from+the+Canadian+Pain+Society&doi=10.1155%2F2014%2F754693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society</span></div><div class="casAuthors">Moulin Dwight; Boulanger Aline; Clark A J; Clarke Hance; Dao Thuan; Finley G A; Furlan Andrea; Gilron Ian; Gordon Allan; Morley-Forster Patricia K; Sessle Barry J; Squire Pamela; Stinson Jennifer; Taenzer Paul; Velly Ana; Ware Mark A; Weinberg Erica L; Williamson Owen D</div><div class="citationInfo"><span class="NLM_cas:title">Pain research & management</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">328-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians.  OBJECTIVE:  To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence-based consensus statement on its management.  METHODS:  RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013.  Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group.  Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use.  RESULTS:  Analgesic agents recommended for first-line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors.  Tramadol and controlled-release opioid analgesics are recommended as second-line treatments for moderate to severe pain.  Cannabinoids are now recommended as third-line treatments.  Recommended fourth-line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacosamide), tapentadol and botulinum toxin.  There is support for some analgesic combinations in selected NeP conditions.  CONCLUSIONS:  These guidelines provide an updated, stepwise approach to the pharmacological management of NeP.  Treatment should be individualized for each patient based on efficacy, side-effect profile and drug accessibility, including cost.  Additional studies are required to examine head-to-head comparisons among analgesics, combinations of analgesics, long-term outcomes and treatment of pediatric, geriatric and central NeP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJ0cKBpOR1j7HHuJhbyicZfW6udTcc2eZC_LRA8GUflrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mzmt1SgtA%253D%253D&md5=cb2a7af345f10b7b7b78a13c475ae024</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2014%2F754693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F754693%26sid%3Dliteratum%253Aachs%26aulast%3DMoulin%26aufirst%3DD.%26aulast%3DBoulanger%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DClarke%26aufirst%3DH.%26aulast%3DDao%26aufirst%3DT.%26aulast%3DFinley%26aufirst%3DG.%2BA.%26aulast%3DFurlan%26aufirst%3DA.%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DMorley-Forster%26aufirst%3DP.%2BK.%26aulast%3DSessle%26aufirst%3DB.%2BJ.%26aulast%3DSquire%26aufirst%3DP.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DTaenzer%26aufirst%3DP.%26aulast%3DVelly%26aufirst%3DA.%26aulast%3DWare%26aufirst%3DM.%2BA.%26aulast%3DWeinberg%26aufirst%3DE.%2BL.%26aulast%3DWilliamson%26aufirst%3DO.%2BD.%26atitle%3DPharmacological%2520management%2520of%2520chronic%2520neuropathic%2520pain%253A%2520revised%2520consensus%2520statement%2520from%2520the%2520Canadian%2520Pain%2520Society%26jtitle%3DPain.%2520Res.%2520Manag.%26date%3D2014%26volume%3D19%26spage%3D328%26epage%3D335%26doi%3D10.1155%2F2014%2F754693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cohen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span> </span><span class="NLM_article-title">Neuropathic pain: mechanisms and their clinical implications</span> <span class="citation_source-journal">BMJ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">f7656</span><span class="refDoi"> DOI: 10.1136/bmj.f7656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1136%2Fbmj.f7656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=f7656&author=S.+P.+Cohenauthor=J.+Mao&title=Neuropathic+pain%3A+mechanisms+and+their+clinical+implications&doi=10.1136%2Fbmj.f7656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f7656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f7656%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BP.%26aulast%3DMao%26aufirst%3DJ.%26atitle%3DNeuropathic%2520pain%253A%2520mechanisms%2520and%2520their%2520clinical%2520implications%26jtitle%3DBMJ.%26date%3D2014%26volume%3D348%26spage%3Df7656%26doi%3D10.1136%2Fbmj.f7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourlay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walco, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span> </span><span class="NLM_article-title">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">s3</span><span class="NLM_x">–</span> <span class="NLM_lpage">s14</span><span class="refDoi"> DOI: 10.4065/mcp.2009.0649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.4065%2Fmcp.2009.0649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=20194146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=s3-s14&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=J.+Audetteauthor=R.+Baronauthor=G.+K.+Gourlayauthor=M.+L.+Haanp%C3%A4%C3%A4author=J.+L.+Kentauthor=E.+J.+Kraneauthor=A.+A.+Lebelauthor=R.+M.+Levyauthor=S.+C.+Mackeyauthor=J.+Mayerauthor=C.+Miaskowskiauthor=S.+N.+Rajaauthor=A.+S.+Riceauthor=K.+E.+Schmaderauthor=B.+Staceyauthor=S.+Stanosauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=G.+A.+Walcoauthor=C.+D.+Wells&title=Recommendations+for+the+pharmacological+management+of+neuropathic+pain%3A+an+overview+and+literature+update&doi=10.4065%2Fmcp.2009.0649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C.; Walco, Gary A.; Wells, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S3-S14</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Dowden Health Media, Inc.</span>)
        </div><div class="casAbstract">A review.  The Neuropathic Pain Special Interest Group of the International Assocn. for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacol. treatment of neuropathic pain.  Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (le, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clin. trials.  Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clin. circumstances.  Results of several recent clin. trials have become available since the development of these guidelines.  These studies have examd. botulinum toxin, high-concn. capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions.  The increasing no. of neg. clin. trials of pharmacol. treatments for neuropathic pain and ambiguities in the interpretation of these neg. trials must also be considered in developing treatment guidelines.  The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacol. management of neuropathic pain and to provide a brief overview of these recent studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_qlufOfrkLVg90H21EOLACvtfcHk0liy2MJkhXWMJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D&md5=749b581e00c2be99ae45dbf54de0bca3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2009.0649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2009.0649%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DAudette%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGourlay%26aufirst%3DG.%2BK.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%2BL.%26aulast%3DKent%26aufirst%3DJ.%2BL.%26aulast%3DKrane%26aufirst%3DE.%2BJ.%26aulast%3DLebel%26aufirst%3DA.%2BA.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26aulast%3DMackey%26aufirst%3DS.%2BC.%26aulast%3DMayer%26aufirst%3DJ.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DSchmader%26aufirst%3DK.%2BE.%26aulast%3DStacey%26aufirst%3DB.%26aulast%3DStanos%26aufirst%3DS.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWalco%26aufirst%3DG.%2BA.%26aulast%3DWells%26aufirst%3DC.%2BD.%26atitle%3DRecommendations%2520for%2520the%2520pharmacological%2520management%2520of%2520neuropathic%2520pain%253A%2520an%2520overview%2520and%2520literature%2520update%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26spage%3Ds3%26epage%3Ds14%26doi%3D10.4065%2Fmcp.2009.0649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zukin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balster, R. L.</span><span> </span><span class="NLM_article-title">Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1016/0006-8993(84)91326-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0006-8993%2884%2991326-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=6199090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=1984&pages=174-177&author=S.+R.+Zukinauthor=K.+T.+Bradyauthor=B.+L.+Sliferauthor=R.+L.+Balster&title=Behavioral+and+biochemical+stereoselectivity+of+sigma+opiate%2FPCP+receptors&doi=10.1016%2F0006-8993%2884%2991326-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors</span></div><div class="casAuthors">Zukin, Stephen R.; Brady, Kathleen T.; Slifer, Barbara L.; Balster, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-7</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The relative potencies of (±)-ketamine [(±)-I]  [6740-88-1], (+)-I  [33643-49-1], (-)-I  [33643-46-8], (±)-N-allylnormetazocine [(±)-II]  [7313-95-3], (+)-II  [58640-82-7], (-)-II  [14198-28-8], (±)-cyclazocine [(±)-III]  [7346-09-0], (+)-III  [7313-87-3], and (-)-III  [7313-86-2] at μ opiate receptors and at σ opiate/phencyclidine (PCP)  [77-10-1] receptors were detd. in vitro in rat brain homogenates (displacement of labeled dihydromorphine  [509-60-4] and PCP for the μ and PCP receptors, resp.) and in a discriminative stimulus behavioral paradigm in rats (PCP vs. saline).  In all cases the in vitro and in vivo data were in agreement.  (+)-II and (+)-III were highly specific σ opiate/PCP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7YsmwYzvSm7Vg90H21EOLACvtfcHk0liy2MJkhXWMJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D&md5=06d1ca0c2d406f214ea9fd43b1e9c7c6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2884%2991326-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252884%252991326-X%26sid%3Dliteratum%253Aachs%26aulast%3DZukin%26aufirst%3DS.%2BR.%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DSlifer%26aufirst%3DB.%2BL.%26aulast%3DBalster%26aufirst%3DR.%2BL.%26atitle%3DBehavioral%2520and%2520biochemical%2520stereoselectivity%2520of%2520sigma%2520opiate%252FPCP%2520receptors%26jtitle%3DBrain%2520Res.%26date%3D1984%26volume%3D294%26spage%3D174%26epage%3D177%26doi%3D10.1016%2F0006-8993%2884%2991326-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mendelsohn, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerchner, G. A.</span><span> </span><span class="NLM_article-title">Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2989489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1985&pages=597-602&author=L.+G.+Mendelsohnauthor=V.+Kalraauthor=B.+G.+Johnsonauthor=G.+A.+Kerchner&title=Sigma+opioid+receptor%3A+characterization+and+co-identity+with+the+phencyclidine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma opioid receptor:  characterization and co-identity with the phencyclidine receptor</span></div><div class="casAuthors">Mendelsohn, Laurane G.; Kalra, Vin; Johnson, Bryan G.; Kerchner, Gail A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The properties of the σ opioid receptor of rat brain cortex were characterized using the prototypic ligand 3H-labeled (+)-SKF 10,047  [58640-82-7].  Binding to this receptor was rapid, and equil. was obtained within 30 min at 37°.  Specific binding was linear with protein concn. up to 500 μg/2 mL and was dependent upon protein integrity.  Denaturation by boiling destroyed >95% of the specific binding.  A high-affinity binding site with a dissocn. const. of 150 nM and a max. binding of 2.91 pmol/mg of protein was detd. from a Scatchard plot of the binding data.  The addn. of NaCl or CaCl2 to the buffers markedly decreased binding, with CaCl2 being more potent than NaCl.  A broad pH optimum for specific binding was obsd.; max. binding was at pH 9.0.  The affinity of a no. of ligands for the site and the phencyclidine  [77-10-1] receptor were compared.  The binding (IC50) of 13 ligands to the sigma site showed a correlation of 0.86 with binding to the phencyclidine site.  Thus, the biochem. properties of the σ and phencyclidine receptors are similar, and these receptors may be one and the same site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyw4zOY5vN17Vg90H21EOLACvtfcHk0lgQ0PpYN2l1PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D&md5=20db7f5ed4690c03d95050799953f992</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendelsohn%26aufirst%3DL.%2BG.%26aulast%3DKalra%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26atitle%3DSigma%2520opioid%2520receptor%253A%2520characterization%2520and%2520co-identity%2520with%2520the%2520phencyclidine%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D233%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hellewell, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1016/0006-8993(90)91143-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0006-8993%2890%2991143-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2174717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=1990&pages=244-253&author=S.+B.+Hellewellauthor=W.+D.+Bowen&title=A+sigma-like+binding+site+in+rat+pheochromocytoma+%28PC12%29+cells%3A+decreased+affinity+for+%28%2B%29-benzomorphans+and+lower+molecular+weight+suggest+a+different+sigma+receptor+form+from+that+of+guinea+pig+brain&doi=10.1016%2F0006-8993%2890%2991143-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A sigma-like binding site in rat pheochromocytoma (PC12) cells:  decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain</span></div><div class="casAuthors">Hellewell, Susan B.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">527</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">244-53</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Two highly selective radiolabeled probes for sigma receptors were found to bind with high affinity and capacity to membranes from undifferentiated PC12 cells 1,3-di-o-[3H]tolylguanidine ([1H]DTG) bound with Kd = 23.7 nM and Bmax = 2025 fmol/mg protein.  The Kd and Bmax for 3H-labeled (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) were 86.3 nM and 1539 fmol/mg protein, resp.  These binding parameters were comparable to those obsd. in guinea pig brain sites exhibited high affinity for haloperidol, moderate affinity for phencyclidine (PCP), and negligible affinity for MK-801, apomorphine, and (-)-sulpiride.  These data suggest a relationship of the PC12 site to sigma receptors.  However, all (+)-opiates ((+)-benzomorphans and (+)-morphinans) tested bound with markedly lower affinity to the PC12 site compared to guinea pig brain.  These include (+)-N-allylnormetazocine ((+)-SKF 10,047), (+)-pentazocine, and dextrallorphan.  In fact, PC12 sites exhibited preference for (-)-benzomorphans, the reverse stereoselectivity of guinea pig brain sites.  Binding of 3H-labeled N-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP) could not be detected, demonstrating absence of PCP receptors on this cell line.  Differentiation of cells by treatment with nerve growth factor had no effect on sigma binding parameters.  Membranes from guinea pig brain and PC12 cells were photoaffinity-labeled using azido-di-o [3H]tolylguanidine.  In guinea pig brain, a polypeptide of 25 kDa was specifically labeled.  However, label was incorporated into polypeptides of 18 kDa and 21 kDa in membranes from PC12 cells.  In view of the otherwise similar binding characteristics, the marked differences in affinity for (+)-benzomorphans and mol. wt. suggest that PC12 cells contain a mol. form of sigma receptor distinct from that predominant in guinea pig brain.  This raises the possibility of multiple sigma receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSWLms51RjbVg90H21EOLACvtfcHk0lgQ0PpYN2l1PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D&md5=cdb78ce18d40ae20a42e7215a3cbd0a6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2890%2991143-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252890%252991143-5%26sid%3Dliteratum%253Aachs%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DA%2520sigma-like%2520binding%2520site%2520in%2520rat%2520pheochromocytoma%2520%2528PC12%2529%2520cells%253A%2520decreased%2520affinity%2520for%2520%2528%252B%2529-benzomorphans%2520and%2520lower%2520molecular%2520weight%2520suggest%2520a%2520different%2520sigma%2520receptor%2520form%2520from%2520that%2520of%2520guinea%2520pig%2520brain%26jtitle%3DBrain%2520Res.%26date%3D1990%26volume%3D527%26spage%3D244%26epage%3D253%26doi%3D10.1016%2F0006-8993%2890%2991143-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Quirion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzhak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. P.</span><span> </span><span class="NLM_article-title">A proposal for the classification of sigma binding sites</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1016/0165-6147(92)90030-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0165-6147%2892%2990030-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1315463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=85-86&author=R.+Quirionauthor=W.+D.+Bowenauthor=Y.+Itzhakauthor=J.+L.+Junienauthor=J.+M.+Musacchioauthor=R.+B.+Rothmanauthor=T.+P.+Suauthor=S.+W.+Tamauthor=D.+P.+Taylor&title=A+proposal+for+the+classification+of+sigma+binding+sites&doi=10.1016%2F0165-6147%2892%2990030-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A proposal for the classification of sigma binding sites</span></div><div class="casAuthors">Quirion R; Bowen W D; Itzhak Y; Junien J L; Musacchio J M; Rothman R B; Su T P; Tam S W; Taylor D P</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">85-6</span>
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9QiJWG_oOy3p3bfzSLaX5fW6udTcc2ebuW24RYrhQrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D&md5=bdbde1d04c3c3e627e4ff512102ddf5d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2892%2990030-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252892%252990030-A%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DItzhak%26aufirst%3DY.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DMusacchio%26aufirst%3DJ.%2BM.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26atitle%3DA%2520proposal%2520for%2520the%2520classification%2520of%2520sigma%2520binding%2520sites%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1992%26volume%3D13%26spage%3D85%26epage%3D86%26doi%3D10.1016%2F0165-6147%2892%2990030-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">The pharmacology of sigma-1 receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2009.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pharmthera.2009.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=19619582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGktLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=195-206&author=T.+Mauriceauthor=T.+P.+Su&title=The+pharmacology+of+sigma-1+receptors&doi=10.1016%2Fj.pharmthera.2009.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of sigma-1 receptors</span></div><div class="casAuthors">Maurice, Tangui; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-206</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Originally considered an enigmatic protein, the sigma-1 receptor has recently been identified as a unique ligand-regulated mol. chaperone in the endoplasmic reticulum of cells.  This discovery causes us to look back at the many proposed roles of this receptor, even before its mol. function was identified, in many diseases such as methamphetamine or cocaine addiction, amnesia, pain, depression, Alzheimer's disease, stroke, retinal neuroprotection, HIV infection, and cancer.  In this review, we examine the reports that have clearly shown an agonist-antagonist relationship regarding sigma-1 receptors in models of those diseases and also review the relatively known mechanisms of action of sigma-1 receptors in an attempt to spur the speculation of readers on how the sigma-1 receptor at the endoplasmic reticulum might relate to so many diseases.  We found that the most prominent action of sigma-1 receptors in biol. systems including cell lines, primary cultures, and animals is the regulation and modulation of voltage-regulated and ligand-gated ion channels, including Ca2+-, K+-, Na+, Cl-, and SK channels, and NMDA and IP3 receptors.  We found that the final output of the action of sigma-1 receptor agonists is to inhibit all above-mentioned voltage-gated ion channels, while they potentiate ligand-gated channels.  The inhibition or potentiation induced by agonists is blocked by sigma-1 receptor antagonists.  Other mechanisms of action of sigma-1 receptors, and to some extent those of sigma-2 receptors, were also considered.  We conclude that the sigma-1 and sigma-2 receptors represent potential fruitful targets for therapeutic developments in combating many human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4d_UAy6J4KbVg90H21EOLACvtfcHk0lh2JuvoF59g7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGktLnM&md5=7b5e251decc29edef42ffef1d65dd487</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2009.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2009.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DThe%2520pharmacology%2520of%2520sigma-1%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2009%26volume%3D124%26spage%3D195%26epage%3D206%26doi%3D10.1016%2Fj.pharmthera.2009.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma 1 receptor: a new therapeutic target for pain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">716</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2013.01.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+receptor%3A+a+new+therapeutic+target+for+pain&doi=10.1016%2Fj.ejphar.2013.01.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0lh2JuvoF59g7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520receptor%253A%2520a%2520new%2520therapeutic%2520target%2520for%2520pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2013.01.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Monnet, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title">N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1016/0014-2999(90)90186-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0014-2999%2890%2990186-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2163857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1990&pages=441-445&author=F.+P.+Monnetauthor=G.+Debonnelauthor=J.+L.+Junienauthor=C.+De+Montigny&title=N-methyl-D-aspartate-induced+neuronal+activation+is+selectively+modulated+by+sigma+receptors&doi=10.1016%2F0014-2999%2890%2990186-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors</span></div><div class="casAuthors">Monnet, Francois P.; Debonnel, Guy; Junien, Jean Louis; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-5</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of 2 high-affinity σ ligands, DTG (1,3-di(2-tolyl)guanidine) and haloperidol, on the activation of dorsal hippocampus pyramidal neurons induced by microiontophoretic application of N-methyl-D-aspartate (NMDA) were assessed electrophysiol.  Low doses of DTG (0.5-3 μg/kg, i.v.) potentiated the NMDA response.  This effect of DTG was blocked by haloperidol (10 μg/kg i.v.), but not by spiperone, a potent dopamine antagonist with low affinity for σ receptors.  Apparently, σ receptors modulate the NMDA-induced neuronal activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTAVkVDgk_ebVg90H21EOLACvtfcHk0lh2JuvoF59g7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D&md5=415aeb364969efa07c6149f19404209f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2890%2990186-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252890%252990186-A%26sid%3Dliteratum%253Aachs%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26aulast%3DDebonnel%26aufirst%3DG.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DN-methyl-D-aspartate-induced%2520neuronal%2520activation%2520is%2520selectively%2520modulated%2520by%2520sigma%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1990%26volume%3D179%26spage%3D441%26epage%3D445%26doi%3D10.1016%2F0014-2999%2890%2990186-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Cheng, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, P.</span><span> </span><span class="NLM_article-title">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.expneurol.2007.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.expneurol.2007.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=18035354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2008&pages=128-136&author=Z.+X.+Chengauthor=D.+M.+Lanauthor=P.+Y.+Wuauthor=Y.+H.+Zhuauthor=Y.+Dongauthor=L.+Maauthor=P.+Zheng&title=Neurosteroid+dehydroepiandrosterone+sulphate+inhibits+persistent+sodium+currents+in+rat+medial+prefrontal+cortex+via+activation+of+sigma-1+receptors&doi=10.1016%2Fj.expneurol.2007.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span></div><div class="casAuthors">Cheng, Zheng-Xiang; Lan, Dan-Mei; Wu, Pei-Ying; Zhu, Yan-Hua; Dong, Yi; Ma, Lan; Zheng, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-136</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dehydroepiandrosterone sulfate is one of the most important neurosteroids.  In the present paper, we studied the effect of dehydroepiandrosterone sulfate on persistent sodium currents and its mechanism and functional consequence with whole-cell patch clamp recording method combined with a pharmacol. approach in the rat medial prefrontal cortex slices.  The results showed that dehydroepiandrosterone sulfate inhibited the amplitude of persistent sodium currents and the inhibitory effect was significant at 0.1 μM, reached max. at 1 μM and decreased with the increase in the concns. of above 1 μM.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was canceled by the Gi protein inhibitor and the protein kinase C inhibitor, but not by the protein kinase A inhibitor.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was also canceled by the sigma-1 receptor blockers and the sigma-1 receptor agonist could mimic the effect of dehydroepiandrosterone sulfate.  Dehydroepiandrosterone sulfate had no significant influence on neuronal excitability but could significantly inhibit chem. inhibition of mitochondria-evoked increase in persistent sodium currents.  These results suggest that dehydroepiandrosterone sulfate inhibits persistent sodium currents via the activation of sigma-1 receptors-Gi protein-protein kinase C-coupled signaling pathway, and the main functional consequence of this effect of DHEAS is presumably to protect neurons under ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo69uQz-5-SLVg90H21EOLACvtfcHk0lj5Q_2soxDuCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D&md5=c79ecd56505459124cca3431353b9b1e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.%2BX.%26aulast%3DLan%26aufirst%3DD.%2BM.%26aulast%3DWu%26aufirst%3DP.%2BY.%26aulast%3DZhu%26aufirst%3DY.%2BH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DNeurosteroid%2520dehydroepiandrosterone%2520sulphate%2520inhibits%2520persistent%2520sodium%2520currents%2520in%2520rat%2520medial%2520prefrontal%2520cortex%2520via%2520activation%2520of%2520sigma-1%2520receptors%26jtitle%3DExp.%2520Neurol.%26date%3D2008%26volume%3D210%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.expneurol.2007.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Aydar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyachko, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. B.</span><span> </span><span class="NLM_article-title">The sigma receptor as a ligand-regulated auxiliary potassium channel subunit</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span><span class="refDoi"> DOI: 10.1016/S0896-6273(02)00677-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2FS0896-6273%2802%2900677-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=399-410&author=E.+Aydarauthor=C.+P.+Palmerauthor=V.+A.+Klyachkoauthor=M.+B.+Jackson&title=The+sigma+receptor+as+a+ligand-regulated+auxiliary+potassium+channel+subunit&doi=10.1016%2FS0896-6273%2802%2900677-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2802%2900677-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252802%252900677-3%26sid%3Dliteratum%253Aachs%26aulast%3DAydar%26aufirst%3DE.%26aulast%3DPalmer%26aufirst%3DC.%2BP.%26aulast%3DKlyachko%26aufirst%3DV.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26atitle%3DThe%2520sigma%2520receptor%2520as%2520a%2520ligand-regulated%2520auxiliary%2520potassium%2520channel%2520subunit%26jtitle%3DNeuron%26date%3D2002%26volume%3D34%26spage%3D399%26epage%3D410%26doi%3D10.1016%2FS0896-6273%2802%2900677-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Ca<sup>2+</sup> signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca<sup>2+</sup> concentration</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10869377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2000&pages=788-798&author=T.+Hayashiauthor=T.+Mauriceauthor=T.+P.+Su&title=Ca2%2B+signaling+via+sigma%281%29-receptors%3A+novel+regulatory+mechanism+affecting+intracellular+Ca2%2B+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ signaling via σ1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration</span></div><div class="casAuthors">Hayashi, Teruo; Maurice, Tangui; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">788-798</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ1-receptor is a one-transmembrane endoplasmic reticulum protein that binds neurosteroids and dextrorotatory benzomorphans.  The roles of σ1-receptors in regulating intracellular Ca2+ in NG108 cells were examd. in this study.  σ1-Ligands pregnenolone sulfate, (+)-pentazocine, and 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride modulate Ca2+ signaling in NG 108 cells via two modes of action.  First, nanomolar concns. of the ligands, without effect by themselves, potentiated the bradykinin-induced increase of the cytosolic free Ca2+ concn. in a bell-shaped manner.  This effect of σ1-ligands was unaffected by depletion of Ca2+ from perfusion buffer and was blocked by a 21-mer antisense oligodeoxynucleotide against the cloned σ1-receptors.  Second, after the cells were depleted of the endoplasmic reticulum Ca2+ stores, the depolarization (75 mM KCl)-induced increase in cytosolic free Ca2+ was potentiated by 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride, whereas it was inhibited by pregnenolone sulfate and (+)-pentazocine.  These effects, albeit opposite in direction, were blocked by both the 21-mer antisense oligodeoxynucleotide and pertussis toxin.  Western blotting indicates that σ1-receptors are increased on the plasma membrane and the nuclear membrane in the presence of σ1-ligand.  These results suggest that Ca2+ signaling via σ1-receptors may represent a novel mechanism that affects intracellular Ca2+ concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5UrPmwIQdrVg90H21EOLACvtfcHk0lj5Q_2soxDuCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D&md5=de8007846ac5a0a4292c2f501a049a7c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DCa2%252B%2520signaling%2520via%2520sigma%25281%2529-receptors%253A%2520novel%2520regulatory%2520mechanism%2520affecting%2520intracellular%2520Ca2%252B%2520concentration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D293%26spage%3D788%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sánchez-Fernández, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montilla-García, Á.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Cano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artacho-Cordón, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Pastor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span> </span><span class="NLM_article-title">Modulation of peripheral mu-opioid analgesia by σ<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1124/jpet.113.208272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1124%2Fjpet.113.208272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24155346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=32-45&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=%C3%81.+Montilla-Garc%C3%ADaauthor=R.+Gonz%C3%A1lez-Canoauthor=F.+R.+Nietoauthor=L.+Romeroauthor=A.+Artacho-Cord%C3%B3nauthor=R.+Montesauthor=B.+Fern%C3%A1ndez-Pastorauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Modulation+of+peripheral+mu-opioid+analgesia+by+%CF%831+receptors&doi=10.1124%2Fjpet.113.208272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of peripheral μ-opioid analgesia by σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Montilla-Garcia, Angeles; Gonzalez-Cano, Rafael; Nieto, Francisco Rafael; Romero, Lucia; Artacho-Cordon, Antonia; Montes, Rosa; Fernandez-Pastor, Begona; Merlos, Manuel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We evaluated the effects of σ1-receptor inhibition on μ-opioid-induced mech. antinociception and constipation. σ1-Knockout mice exhibited marked mech. antinociception in response to several μ-opioid analgesics (fentanyl, oxycodone, morphine, buprenorphine, and tramadol) at systemic (s.c.) doses that were inactive in wild-type mice and even unmasked the antinociceptive effects of the peripheral μ-opioid agonist loperamide.  Likewise, systemic (s.c.) or local (intraplantar) treatment of wild-type mice with the selective σ1 antagonists BD-1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine dihydrochloride] or S1RA [4-[2-[[5-methyl-1-(2-naphthalenyl)1H-pyrazol-3-yl]oxy]ethyl] morpholine hydrochloride] potentiated μ-opioid antinociception; these effects were fully reversed by the σ1 agonist PRE-084 [2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate) hydrochloride], showing the selectivity of the pharmacol. approach.  The μ-opioid antinociception potentiated by σ1 inhibition (by σ1-receptor knockout or σ1-pharmacol. antagonism) was more sensitive to the peripherally restricted opioid antagonist naloxone methiodide than opioid antinociception under normal conditions, indicating a key role for peripheral opioid receptors in the enhanced antinociception.  Direct interaction between the opioid drugs and σ1 receptor cannot account for our results, since the former lacked affinity for σ1 receptors (labeled with [3H](+)-pentazocine).  A peripheral role for σ1 receptors was also supported by their higher d. (Western blot results) in peripheral nervous tissue (dorsal root ganglia) than in several central areas involved in opioid antinociception (dorsal spinal cord, basolateral amygdala, periaqueductal gray, and rostroventral medulla).  In contrast to its effects on nociception, σ1-receptor inhibition did not alter fentanyl- or loperamide-induced constipation, a peripherally mediated nonanalgesic opioid effect.  Therefore, σ1-receptor inhibition may be used as a systemic or local adjuvant to enhance peripheral μ-opioid analgesia without affecting opioid-induced constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXDUF69QHTL7Vg90H21EOLACvtfcHk0lj6m65tNYco_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D&md5=3448ecaf8c215210a48a8413b89db2a5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.208272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.208272%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3D%25C3%2581.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DMontes%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DModulation%2520of%2520peripheral%2520mu-opioid%2520analgesia%2520by%2520%25CF%25831%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D32%26epage%3D45%26doi%3D10.1124%2Fjpet.113.208272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Roh, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beitz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span> </span><span class="NLM_article-title">Intrathecal injection of the σ<sub>1</sub> receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span><span class="refDoi"> DOI: 10.1097/ALN.0b013e3181895a83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1097%2FALN.0b013e3181895a83" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2008&pages=879-889&author=D.+H.+Rohauthor=H.+W.+Kimauthor=S.+Y.+Yoonauthor=H.+S.+Seoauthor=Y.+B.+Kwonauthor=K.+W.+Kimauthor=H.+J.+Hanauthor=A.+J.+Beitzauthor=H.+S.+Naauthor=J.+H.+Lee&title=Intrathecal+injection+of+the+%CF%831+receptor+antagonist+BD1047+blocks+both+mechanical+allodynia+and+increases+in+spinal+NR1+expression+during+the+induction+phase+of+rodent+neuropathic+pain&doi=10.1097%2FALN.0b013e3181895a83"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2FALN.0b013e3181895a83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FALN.0b013e3181895a83%26sid%3Dliteratum%253Aachs%26aulast%3DRoh%26aufirst%3DD.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26aulast%3DSeo%26aufirst%3DH.%2BS.%26aulast%3DKwon%26aufirst%3DY.%2BB.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DHan%26aufirst%3DH.%2BJ.%26aulast%3DBeitz%26aufirst%3DA.%2BJ.%26aulast%3DNa%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26atitle%3DIntrathecal%2520injection%2520of%2520the%2520%25CF%25831%2520receptor%2520antagonist%2520BD1047%2520blocks%2520both%2520mechanical%2520allodynia%2520and%2520increases%2520in%2520spinal%2520NR1%2520expression%2520during%2520the%2520induction%2520phase%2520of%2520rodent%2520neuropathic%2520pain%26jtitle%3DAnesthesiology%26date%3D2008%26volume%3D109%26spage%3D879%26epage%3D889%26doi%3D10.1097%2FALN.0b013e3181895a83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1002/jlcr.3010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1002%2Fjlcr.3010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24285328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=215-224&author=S.+D.+Banisterauthor=M.+Manoliauthor=M.+Kassiou&title=The+development+of+radiotracers+for+imaging+sigma+%28%CF%83%29+receptors+in+the+central+nervous+system+%28CNS%29+using+positron+emission+tomography+%28PET%29&doi=10.1002%2Fjlcr.3010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)</span></div><div class="casAuthors">Banister, Samuel D.; Manoli, Miral; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">215-224</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors are unique mammalian proteins, distributed in the central nervous system and elsewhere, which are increasingly implicated in the pathophysiol. of virtually all major central nervous system disorders.  The heterogeneous but wide distribution of σ1 in the brain has prompted the development of selective radiotracers for imaging these sites using positron emission tomog. (PET).  To date, some 50 carbon-11-labeled and fluorine-18-labeled candidate PET radioligands targeting σ receptors have been reported.  The historical development of selective σ1 receptor ligands as potential PET imaging agents, as well as the radiochem. and application of the most recently developed examples, is described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0i6wNldBzpLVg90H21EOLACvtfcHk0lj6m65tNYco_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtrw%253D&md5=358f9647c85deedeb2e28ebe0ef844a2</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3010%26sid%3Dliteratum%253Aachs%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DManoli%26aufirst%3DM.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520development%2520of%2520radiotracers%2520for%2520imaging%2520sigma%2520%2528%25CF%2583%2529%2520receptors%2520in%2520the%2520central%2520nervous%2520system%2520%2528CNS%2529%2520using%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D215%26epage%3D224%26doi%3D10.1002%2Fjlcr.3010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">van Waarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybczynska, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A.</span><span> </span><span class="NLM_article-title">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3519</span><span class="NLM_x">–</span> <span class="NLM_lpage">3537</span><span class="refDoi"> DOI: 10.2174/138161210793563365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F138161210793563365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=21050178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3519-3537&author=A.+van+Waardeauthor=A.+A.+Rybczynskaauthor=N.+Ramakrishnanauthor=K.+Ishiwataauthor=P.+H.+Elsingaauthor=R.+A.+Dierckx&title=Sigma+receptors+in+oncology%3A+therapeutic+and+diagnostic+applications+of+sigma+ligands&doi=10.2174%2F138161210793563365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span></div><div class="casAuthors">van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3519-3537</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed throughout the mammalian body.  The endogenous ligand for these sites has not been identified, but steroid hormones (particularly progesterone), sphingolipid-derived amines and N,N-dimethyltryptamine can bind with fairly high affinity.  Sigma receptors are overexpressed in rapidly proliferating cells, like cancer cells.  Particularly the sigma-2 subtype is upregulated when cells divide and down regulated when they become quiescent.  Sigma ligands, esp. sigma-2 agonists, can inhibit proliferation and induce apoptosis by a mechanism involving changes in cytosolic Ca2+, ceramide and sphingolipid levels.  Tumor cells are much more sensitive to such treatment than cells from their tissue of origin.  Sigma ligands induce apoptosis not only in drug-sensitive but also in drug-resistant cancer cells (e.g., cells with p53 mutations, or caspase dysfunction).  Moreover, sigma ligands may abrogate P-glycoprotein-mediated drug resistance and at subtoxic doses, they can potentiate the effect of conventional cytostatics.  Thus, sigma-2 agonists may be developed as antineoplastic agents for the treatment of drug-resistant tumors.  A large no. of radiolabeled sigma ligands has been prepd. for SPECT (single-photon emission computed tomog.) and PET (positron emission tomog.) imaging.  Such radiopharmaceuticals can be used for tumor detection, tumor staging, and evaluation of anti-tumor therapy.  There is still a need for the development of ligands with (1) high selectivity for the sigma-2 subtype, (2) defined action (agonist or antagonist) and (3) optimal pharmacokinetics (low affinity for P-glycoprotein, high and specific tumor uptake, and rapid washout from non-target tissues).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-vSPpRtU37Vg90H21EOLACvtfcHk0lj6m65tNYco_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D&md5=e77adeaf932e2fa8eca70ec0e4e84ec6</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.2174%2F138161210793563365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793563365%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DRybczynska%26aufirst%3DA.%2BA.%26aulast%3DRamakrishnan%26aufirst%3DN.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%26atitle%3DSigma%2520receptors%2520in%2520oncology%253A%2520therapeutic%2520and%2520diagnostic%2520applications%2520of%2520sigma%2520ligands%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3519%26epage%3D3537%26doi%3D10.2174%2F138161210793563365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Crawford, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=11782394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD38XntV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=313-322&author=K.+W.+Crawfordauthor=W.+D.+Bowen&title=Sigma-2+receptor+agonists+activate+a+novel+apoptotic+pathway+and+potentiate+antineoplastic+drugs+in+breast+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines</span></div><div class="casAuthors">Crawford, Keith W.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">313-322</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have reported previously that sigma-2 receptors are expressed in high densities in a variety of tumor cell types and that various sigma ligands have cytotoxic effects.  Other investigators have demonstrated increased expression of sigma-2 receptors in rapidly proliferating tumors and the ability of some sigma ligands to inhibit proliferation.  We demonstrate here the ability of sigma-2 receptor agonists to induce cell death by a mechanism consistent with apoptosis.  In breast tumor cell lines that are sensitive (MCF-7) and resistant (MCF-7/Adr-, T47D, and SKBr3) to antineoplastic agents, incubation with the sigma-2 subtype-selective agonists CB-64D and CB-184 produced dose-dependent cytotoxicity (measured by lactate dehydrogenase release into medium).  The EC50 for this response was similar across cell lines, irresp. of p53 genotype and drug-resistance phenotype.  CB-64D and the subtype nonselective sigma-2 agonists haloperidol and reduced haloperidol induced terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining in MCF-7 and T47D cells, indicating that cell death occurs via apoptosis.  Apoptosis was also indicated by increases in Annexin V binding caused by CB-64D.  In MCF-7 cells, cytotoxicity and Annexin V binding induced by the antineoplastics doxorubicin and actinomycin D was partially or completely abrogated by certain specific and general inhibitors of caspases.  In contrast, caspase inhibitors had no effect on sigma-2 receptor-mediated (CB-64D and CB-184) cytotoxicity or Annexin V binding.  Marked potentiation of cytotoxicity was obsd. when a subtoxic dose of CB-184 was combined with doxorubicin or actinomycin D, both in drug-sensitive (MCF-7) and drug-resistant (MCF-7/Adr-) cell lines.  Haloperidol potentiated doxorubicin only in drug-resistant cells.  These findings suggest the involvement of a novel p53- and caspase-independent apoptotic pathway used by sigma-2 receptors, which is distinct from mechanisms used by some DNA-damaging, antineoplastic agents and other apoptotic stimuli.  These observations further suggest that sigma-2 receptors may be targets that can be therapeutically exploited in the treatment of both drug-sensitive and drug-resistant metastatic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJugG63Xfy7Vg90H21EOLACvtfcHk0liAzGHKgjy_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntV2gug%253D%253D&md5=89feb1caf2fa574ba2f49aff8be7d920</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DK.%2BW.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma-2%2520receptor%2520agonists%2520activate%2520a%2520novel%2520apoptotic%2520pathway%2520and%2520potentiate%2520antineoplastic%2520drugs%2520in%2520breast%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D313%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The sigma-2 receptor: a novel protein for the imaging and treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span><span class="refDoi"> DOI: 10.1021/jm301545c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+Zengauthor=W.+G.+Hawkins&title=The+sigma-2+receptor%3A+a+novel+protein+for+the+imaging+and+treatment+of+cancer&doi=10.1021%2Fjm301545c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520sigma-2%2520receptor%253A%2520a%2520novel%2520protein%2520for%2520the%2520imaging%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160%26doi%3D10.1021%2Fjm301545c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucke-Wold, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookerjee, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavendish, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandinaro, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Role of sigma-1 receptors in neurodegenerative diseases</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.jphs.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.jphs.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25704014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=17-29&author=L.+Nguyenauthor=B.+P.+Lucke-Woldauthor=S.+A.+Mookerjeeauthor=J.+Z.+Cavendishauthor=M.+J.+Robsonauthor=A.+L.+Scandinaroauthor=R.+R.+Matsumoto&title=Role+of+sigma-1+receptors+in+neurodegenerative+diseases&doi=10.1016%2Fj.jphs.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sigma-1 receptors in neurodegenerative diseases</span></div><div class="casAuthors">Nguyen, Linda; Lucke-Wold, Brandon P.; Mookerjee, Shona A.; Cavendish, John Z.; Robson, Matthew J.; Scandinaro, Anna L.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases with distinct genetic etiologies and pathol. phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction.  Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration.  Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biol. mechanisms assocd. with neurodegeneration.  These receptors therefore represent compelling putative targets for pharmacol. treating neurodegenerative disorders.  In this review, we provide an overview of the biol. mechanisms frequently assocd. with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function.  In addn., we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBzbVUAlU9rVg90H21EOLACvtfcHk0liAzGHKgjy_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D&md5=1aa1ab1a9eb49ef2d69eef975a568a2d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DLucke-Wold%26aufirst%3DB.%2BP.%26aulast%3DMookerjee%26aufirst%3DS.%2BA.%26aulast%3DCavendish%26aufirst%3DJ.%2BZ.%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DScandinaro%26aufirst%3DA.%2BL.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D17%26epage%3D29%26doi%3D10.1016%2Fj.jphs.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naser, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1016/j.expneurol.2014.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.expneurol.2014.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24508558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVWgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2014&pages=180-189&author=M.+J.+Robsonauthor=R.+C.+Turnerauthor=Z.+J.+Naserauthor=C.+R.+McCurdyauthor=J.+P.+O%E2%80%99Callaghanauthor=J.+D.+Huberauthor=R.+R.+Matsumoto&title=SN79%2C+a+sigma+receptor+antagonist%2C+attenuates+methamphetamine-induced+astrogliosis+through+a+blockade+of+OSMR%2Fgp130+signaling+and+STAT3+phosphorylation&doi=10.1016%2Fj.expneurol.2014.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation</span></div><div class="casAuthors">Robson, Matthew J.; Turner, Ryan C.; Naser, Zachary J.; McCurdy, Christopher R.; O'Callaghan, James P.; Huber, Jason D.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-189</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Methamphetamine (METH) exposure results in dopaminergic neurotoxicity in striatal regions of the brain, an effect that has been linked to an increased risk of Parkinson's disease.  Various aspects of neuroinflammation, including astrogliosis, are believed to be contributory factors in METH neurotoxicity.  METH interacts with sigma receptors at physiol. relevant concns. and treatment with sigma receptor antagonists has been shown to mitigate METH-induced neurotoxicity in rodent models.  Whether these compds. alter the responses of glial cells within the central nervous system to METH however has yet to be detd.  Therefore, the purpose of the current study was to det. whether the sigma receptor antagonist, SN79, mitigates METH-induced striatal reactive astrogliosis.  Male, Swiss Webster mice treated with a neurotoxic regimen of METH exhibited time-dependent increases in striatal gfap mRNA and concomitant increases in GFAP protein, indicative of astrogliosis.  This is the first report that similar to other neurotoxicants that induce astrogliosis through the activation of JAK2/STAT3 signaling by stimulating gp-130-linked cytokine signaling resulting from neuroinflammation, METH treatment also increases astrocytic oncostatin m receptor (OSMR) expression and the phosphorylation of STAT3 (Tyr-705) in vivo.  Pretreatment with SN79 blocked METH-induced increases in OSMR, STAT3 phosphorylation and astrocyte activation within the striatum.  Addnl., METH treatment resulted in striatal cellular degeneration as measured by Fluoro-Jade B, an effect that was mitigated by SN79.  The current study provides evidence that sigma receptor antagonists attenuate METH-induced astrocyte activation through a pathway believed to be shared by various neurotoxicants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz1dxu9rYPSbVg90H21EOLACvtfcHk0lgxooHRarMN5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVWgu78%253D&md5=8aed60d9e659cbf14050df4e57b5fd4b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2014.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2014.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DNaser%26aufirst%3DZ.%2BJ.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DJ.%2BP.%26aulast%3DHuber%26aufirst%3DJ.%2BD.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DSN79%252C%2520a%2520sigma%2520receptor%2520antagonist%252C%2520attenuates%2520methamphetamine-induced%2520astrogliosis%2520through%2520a%2520blockade%2520of%2520OSMR%252Fgp130%2520signaling%2520and%2520STAT3%2520phosphorylation%26jtitle%3DExp.%2520Neurol.%26date%3D2014%26volume%3D254%26spage%3D180%26epage%3D189%26doi%3D10.1016%2Fj.expneurol.2014.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1038/npp.2012.224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1038%2Fnpp.2012.224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=605-615&author=T.+Hiranitaauthor=M.+Mereuauthor=P.+L.+Sotoauthor=G.+Tandaauthor=J.+L.+Katz&title=Self-administration+of+cocaine+induces+dopamine-independent+self-administration+of+sigma+agonists&doi=10.1038%2Fnpp.2012.224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2012.224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2012.224%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DSelf-administration%2520of%2520cocaine%2520induces%2520dopamine-independent%2520self-administration%2520of%2520sigma%2520agonists%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D605%26epage%3D615%26doi%3D10.1038%2Fnpp.2012.224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dual DAT/σ<sub>1</sub> receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5238</span><span class="NLM_x">–</span> <span class="NLM_lpage">5241</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.bmcl.2008.08.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5238-5241&author=J.+Caoauthor=T.+Kopajticauthor=J.+L.+Katzauthor=A.+H.+Newman&title=Dual+DAT%2F%CF%831+receptor+ligands+based+on+3-%284-%283-%28bis%284-fluorophenyl%29amino%29propyl%29piperazin-1-yl%29-1-phenylpropan-1-ol&doi=10.1016%2Fj.bmcl.2008.08.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDual%2520DAT%252F%25CF%25831%2520receptor%2520ligands%2520based%2520on%25203-%25284-%25283-%2528bis%25284-fluorophenyl%2529amino%2529propyl%2529piperazin-1-yl%2529-1-phenylpropan-1-ol%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5238%26epage%3D5241%26doi%3D10.1016%2Fj.bmcl.2008.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1038/npp.2012.224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1038%2Fnpp.2012.224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=605-615&author=T.+Hiranitaauthor=M.+Mereuauthor=P.+L.+Sotoauthor=G.+Tandaauthor=J.+L.+Katz&title=Self-administration+of+cocaine+induces+dopamine-independent+self-administration+of+sigma+agonists&doi=10.1038%2Fnpp.2012.224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2012.224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2012.224%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DSelf-administration%2520of%2520cocaine%2520induces%2520dopamine-independent%2520self-administration%2520of%2520sigma%2520agonists%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D605%26epage%3D615%26doi%3D10.1038%2Fnpp.2012.224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">James, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavaleta, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesangeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppala, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishback, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, F. T.</span><span> </span><span class="NLM_article-title">New positron emission tomography (PET) radioligand for imaging sigma-1 receptors in living subjects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8272</span><span class="NLM_x">–</span> <span class="NLM_lpage">8282</span><span class="refDoi"> DOI: 10.1021/jm300371c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300371c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8272-8282&author=M.+L.+Jamesauthor=B.+Shenauthor=C.+L.+Zavaletaauthor=C.+H.+Nielsenauthor=C.+Mesangeauauthor=P.+K.+Vuppalaauthor=C.+Chanauthor=B.+A.+Averyauthor=J.+A.+Fishbackauthor=R.+R.+Matsumotoauthor=S.+S.+Gambhirauthor=C.+R.+McCurdyauthor=F.+T.+Chin&title=New+positron+emission+tomography+%28PET%29+radioligand+for+imaging+sigma-1+receptors+in+living+subjects&doi=10.1021%2Fjm300371c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjm300371c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300371c%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DM.%2BL.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DZavaleta%26aufirst%3DC.%2BL.%26aulast%3DNielsen%26aufirst%3DC.%2BH.%26aulast%3DMesangeau%26aufirst%3DC.%26aulast%3DVuppala%26aufirst%3DP.%2BK.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DAvery%26aufirst%3DB.%2BA.%26aulast%3DFishback%26aufirst%3DJ.%2BA.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DChin%26aufirst%3DF.%2BT.%26atitle%3DNew%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520radioligand%2520for%2520imaging%2520sigma-1%2520receptors%2520in%2520living%2520subjects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8272%26epage%3D8282%26doi%3D10.1021%2Fjm300371c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Poupaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yous, S.</span><span> </span><span class="NLM_article-title">2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span><span class="refDoi"> DOI: 10.2174/0929867053507388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F0929867053507388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15853716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVCqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=877-885&author=J.+Poupaertauthor=P.+Caratoauthor=E.+Colacinoauthor=S.+Yous&title=2%283H%29-benzoxazolone+and+bioisosters+as+%22privileged+scaffold%22+in+the+design+of+pharmacological+probes&doi=10.2174%2F0929867053507388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes</span></div><div class="casAuthors">Poupaert, Jacques; Carato, Pascal; Colacino, Evelina</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 2(3H)-benzoxazolone heterocycle and its bioisosteric surrogates (such as 2(3H)-benzothiazolinone, benzoxazinone, etc.) have received considerable attention from the medicinal chemists owing to their capacity to mimic a phenol or a catechol moiety in a metabolically stable template.  These heterocycles and pyrocatechol have indeed similar pKa's, electronic charge distribution, and chem. reactivity.  Therapeutic applications of this template are very broad, and range from analgesic anti-inflammatory compds. (including PPAR-gamma antagonists) to antipsychotic and neuroprotective anticonvulsant compds.  High affinity ligands have been obtained also for dopaminergic (D2 and D4). serotoninergic (5-HT1A and 5-HT-2A), sigma-1 and sigma-2 receptors.  Owing to the high no. of pos. hits encountered with this heterocycle and its congeners, 2(3H)-benzoxazolone template certainly deserves the title of "privileged scaffold" in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0F0n_89K5rVg90H21EOLACvtfcHk0lj4pzjJ9xRVCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVCqur4%253D&md5=0365a0fcfc6ff313369d5686d079a0d7</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F0929867053507388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053507388%26sid%3Dliteratum%253Aachs%26aulast%3DPoupaert%26aufirst%3DJ.%26aulast%3DCarato%26aufirst%3DP.%26aulast%3DColacino%26aufirst%3DE.%26aulast%3DYous%26aufirst%3DS.%26atitle%3D2%25283H%2529-benzoxazolone%2520and%2520bioisosters%2520as%2520%2522privileged%2520scaffold%2522%2520in%2520the%2520design%2520of%2520pharmacological%2520probes%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D877%26epage%3D885%26doi%3D10.2174%2F0929867053507388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belloir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span> </span><span class="NLM_article-title">Novel 2(3H)-benzothiazolones as highly potent and selective sigma-1 receptor ligands</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1007/s00044-005-0131-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1007%2Fs00044-005-0131-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=158-168&author=S.+Yousauthor=V.+Wallezauthor=M.+Belloirauthor=D.+H.+Caignardauthor=C.+R.+McCurdyauthor=J.+H.+Poupaert&title=Novel+2%283H%29-benzothiazolones+as+highly+potent+and+selective+sigma-1+receptor+ligands&doi=10.1007%2Fs00044-005-0131-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2(3H)-benzothiazolones as highly potent and selective sigma-1 receptor ligands</span></div><div class="casAuthors">Yous, Said; Wallez, Valerie; Belloir, Mirabelle; Caignard, Daniel H.; McCurdy, Christopher R.; Poupaert, Jacques H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">158-168</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">In an effort to produce a new pharmacol. probe with high affinity and selectivity for the sigma-1 receptor, we have synthesized a series of original 2(3H)-benzothiazolones utilizing compd. 4 [3-(1-piperidinoethyl)-6-propylbenzothiazolin-2-one] as a lead.  Receptor binding affinities were detd. at sigma-1 and sigma-2 receptors.  The best ligand (I, sigma-1 Ki = 0.56 nM, selectivity ratio >1000) was obtained with an azepine side-chain.  When tested on a wide battery of receptors, including 5HT2A(h), 5HT3(h), α1, α2, β1, β2, H1, H2, opioids, D1(h), D2(h), 5HT uptake, and DOPA uptake, compd. I showed submicromolar affinity only for α2 (Ki = 205 nM) and H1 (Ki = 311 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-b1rFEdR7bVg90H21EOLACvtfcHk0lj4pzjJ9xRVCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVSqtg%253D%253D&md5=afe46b38390ffb821c11798cafe6619b</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1007%2Fs00044-005-0131-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-005-0131-1%26sid%3Dliteratum%253Aachs%26aulast%3DYous%26aufirst%3DS.%26aulast%3DWallez%26aufirst%3DV.%26aulast%3DBelloir%26aufirst%3DM.%26aulast%3DCaignard%26aufirst%3DD.%2BH.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26atitle%3DNovel%25202%25283H%2529-benzothiazolones%2520as%2520highly%2520potent%2520and%2520selective%2520sigma-1%2520receptor%2520ligands%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2005%26volume%3D14%26spage%3D158%26epage%3D168%26doi%3D10.1007%2Fs00044-005-0131-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tsai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokrass, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauer, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Credico, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1476</span><span class="refDoi"> DOI: 10.1517/14728222.2014.972939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F14728222.2014.972939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25331742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGhu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=1461-1476&author=S.+Y.+Tsaiauthor=M.+J.+Pokrassauthor=N.+R.+Klauerauthor=N.+E.+De+Credicoauthor=T.+P.+Su&title=Sigma-1+receptor+chaperones+in+neurodegenerative+and+psychiatric+disorders&doi=10.1517%2F14728222.2014.972939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders</span></div><div class="casAuthors">Tsai, Shang-Yi A.; Pokrass, Michael J.; Klauer, Neal R.; De Credico, Nicole E.; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1461-1476</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Sigma-1 receptors (Sig-1Rs) are mol. chaperones that reside mainly in the endoplasmic reticulum (ER) but exist also in the proximity of the plasma membrane.  Sig-1Rs are highly expressed in the CNS and are involved in many cellular processes including cell differentiation, neuritogenesis, microglia activation, protein quality control, calcium-mediated ER stress and ion channel modulation.  Disturbance in any of the above cellular processes can accelerate the progression of many neurol. disorders; therefore, the Sig-1R has been implicated in several neurol. diseases.  Areas covered: This review broadly covers the functions of Sig-1Rs including several neurodegenerative disorders in humans and drug addiction-assocd. neurol. disturbance in the case of HIV infection.  We discuss how several Sig-1R ligands could be utilized in therapeutic approaches to treat those disorders.  Expert opinion: Emerging understanding of the cellular functions of this unique transmembrane chaperone may lead to the use of new agents or broaden the use of certain available ligands as therapeutic targets in those neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6GRApLYpd7Vg90H21EOLACvtfcHk0lj4pzjJ9xRVCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGhu7bO&md5=f08044c72c2305c1574d2a1c35a643e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.972939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.972939%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BY.%26aulast%3DPokrass%26aufirst%3DM.%2BJ.%26aulast%3DKlauer%26aufirst%3DN.%2BR.%26aulast%3DDe%2BCredico%26aufirst%3DN.%2BE.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520in%2520neurodegenerative%2520and%2520psychiatric%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D1461%26epage%3D1476%26doi%3D10.1517%2F14728222.2014.972939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bermack, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span> </span><span class="NLM_article-title">The role of sigma receptors in depression</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1254/jphs.CRJ04005X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1254%2Fjphs.CRJ04005X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15750289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=317-336&author=J.+E.+Bermackauthor=G.+Debonnel&title=The+role+of+sigma+receptors+in+depression&doi=10.1254%2Fjphs.CRJ04005X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The role of sigma receptors in depression</span></div><div class="casAuthors">Bermack, Jordanna E.; Debonnel, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-336</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  Behavioral models used to test potential antidepressants have shown that ligands that bind to sigma receptors possess "antidepressant-like" properties.  The focus of this review is to discuss the literature concerning sigma receptors and their ligands, with respect to their antidepressants properties.  In addn. to the behavioral data, we discuss electrophysiol. and biochem. models demonstrating sigma receptors' ability to modulate important factors in the pathophysiol. of depression and/or the mechanisms of action of antidepressants such as the serotonergic neurotransmission in the dorsal raphe nucleus (DRN) and the glutamatergic transmission in the hippocampus.  We also discuss the significance of these two systems in the mechanism of action of antidepressants.  Sigma ligands have potential as antidepressant medications with a fast onset of action as they produce a rapid modulation of the serotonergic system in the DRN and the glutamatergic transmission in the hippocampus.  As these effects of sigma ligands may produce antidepressant properties by completely novel mechanisms of action, they may provide an alternative to the antidepressants currently available and may prove to be beneficial for treatment-resistant depressed patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTc8adYlmpSrVg90H21EOLACvtfcHk0lgJuxLYvujaQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D&md5=1cdda174b9b1e5087118ae49526b3eb0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1254%2Fjphs.CRJ04005X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.CRJ04005X%26sid%3Dliteratum%253Aachs%26aulast%3DBermack%26aufirst%3DJ.%2BE.%26aulast%3DDebonnel%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520sigma%2520receptors%2520in%2520depression%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D97%26spage%3D317%26epage%3D336%26doi%3D10.1254%2Fjphs.CRJ04005X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ovalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitart, X.</span><span> </span><span class="NLM_article-title">Effect of the novel σ<sub>1</sub> receptor ligand and putative atypical antipsychotic E-5842 on BDNF mRNA expression in the rat brain</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span><span class="refDoi"> DOI: 10.1097/00001756-200212030-00035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1097%2F00001756-200212030-00035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=2345-2348&author=S.+Ovalleauthor=F.+Andreuauthor=M.+P.+P%C3%A9rezauthor=D.+Zamanilloauthor=X.+Guitart&title=Effect+of+the+novel+%CF%831+receptor+ligand+and+putative+atypical+antipsychotic+E-5842+on+BDNF+mRNA+expression+in+the+rat+brain&doi=10.1097%2F00001756-200212030-00035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1097%2F00001756-200212030-00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200212030-00035%26sid%3Dliteratum%253Aachs%26aulast%3DOvalle%26aufirst%3DS.%26aulast%3DAndreu%26aufirst%3DF.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%2BP.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DGuitart%26aufirst%3DX.%26atitle%3DEffect%2520of%2520the%2520novel%2520%25CF%25831%2520receptor%2520ligand%2520and%2520putative%2520atypical%2520antipsychotic%2520E-5842%2520on%2520BDNF%2520mRNA%2520expression%2520in%2520the%2520rat%2520brain%26jtitle%3DNeuroReport%26date%3D2002%26volume%3D13%26spage%3D2345%26epage%3D2348%26doi%3D10.1097%2F00001756-200212030-00035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span><span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.lfs.2005.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1612-1624&author=T.+Hayashiauthor=T.+P.+Su&title=The+potential+role+of+sigma-1+receptors+in+lipid+transport+and+lipid+raft+reconstitution+in+the+brain%3A+implication+for+drug+abuse&doi=10.1016%2Fj.lfs.2005.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DThe%2520potential%2520role%2520of%2520sigma-1%2520receptors%2520in%2520lipid%2520transport%2520and%2520lipid%2520raft%2520reconstitution%2520in%2520the%2520brain%253A%2520implication%2520for%2520drug%2520abuse%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1612%26epage%3D1624%26doi%3D10.1016%2Fj.lfs.2005.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Meunier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gué, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Récasens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span> </span><span class="NLM_article-title">Attenuation by a sigma-1 (σ<sub>1</sub>) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1038%2Fsj.bjp.0705835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15205309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2004&pages=689-700&author=J.+Meunierauthor=M.+Gu%C3%A9author=M.+R%C3%A9casensauthor=T.+Maurice&title=Attenuation+by+a+sigma-1+%28%CF%831%29+receptor+agonist+of+the+learning+and+memory+deficits+induced+by+a+prenatal+restraint+stress+in+juvenile+rats&doi=10.1038%2Fsj.bjp.0705835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation by a sigma1 (σ1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats</span></div><div class="casAuthors">Meunier, Johann; Gue, Michele; Recasens, Max; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1: Stress during pregnancy results in complex neurochem. and behavioral alterations throughout the offspring lifetime.  We here examd. the impact of prenatal stress (PS) on memory functions in male and female offspring and report the efficacy of a selective sigma1 (σ1) receptor agonist, igmesine, in alleviating the obsd. deficits.  2: Dams received an unpredictable 90-min duration restraint stress from gestational day E17 to E20.  Learning was examd. in offspring between day P24 and P36 using spontaneous alternation in the Y-maze, delayed alternation in the T-maze, water-maze learning and passive avoidance.  3: Both male and female PS rats showed impairments of spontaneous and delayed alternation performances.  Acquisition of a fixed platform position in the water-maze was unchanged in PS rats, but the probe test revealed a diminution of time spent in the training quadrant.  Acquisition of a daily changing platform position demonstrated impaired working memory for male and female PS rats.  Finally, passive avoidance deficits were obsd.  4: Pretreatment with the selective σ1 agonist igmesine (1-10 mg kg-1 i.p.) reversed the PS-induced learning deficits in offspring rats for each test.  The σ1 antagonist BD1063 failed to affect performances alone but blocked the igmesine effect, confirming the involvement of the σ1 receptor.  5: PS thus induces delayed memory deficits, affecting spatial and nonspatial, short- and long-term memories in juvenile male and female offspring rats.  Activation of the σ1 neuromodulatory receptor allows a significant recovery of the memory functions in PS rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhtHAjlawprVg90H21EOLACvtfcHk0lgJuxLYvujaQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D&md5=cc7f51d2bef3acb88732499642b49a77</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705835%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DGu%25C3%25A9%26aufirst%3DM.%26aulast%3DR%25C3%25A9casens%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DAttenuation%2520by%2520a%2520sigma-1%2520%2528%25CF%25831%2529%2520receptor%2520agonist%2520of%2520the%2520learning%2520and%2520memory%2520deficits%2520induced%2520by%2520a%2520prenatal%2520restraint%2520stress%2520in%2520juvenile%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D142%26spage%3D689%26epage%3D700%26doi%3D10.1038%2Fsj.bjp.0705835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ronsisvalle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezzavento, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoto, G. M.</span><span> </span><span class="NLM_article-title">Opioid and sigma receptor studies. New developments in the design of selective sigma ligands</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1509</span><span class="refDoi"> DOI: 10.1351/pac200173091499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1351%2Fpac200173091499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFGls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2001&pages=1499-1509&author=G.+Ronsisvalleauthor=A.+Marrazzoauthor=O.+Prezzaventoauthor=A.+Cagnottoauthor=T.+Menniniauthor=C.+Parentiauthor=G.+M.+Scoto&title=Opioid+and+sigma+receptor+studies.+New+developments+in+the+design+of+selective+sigma+ligands&doi=10.1351%2Fpac200173091499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid and sigma receptor studies. New developments in the design of selective sigma ligands</span></div><div class="casAuthors">Ronsisvalle, Giuseppe; Marrazzo, Agostino; Prezzavento, Orazio; Cagnotto, Alfredo; Mennini, Tiziana; Parenti, Carmela; Scoto, Giovanna M.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1499-1509</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">International Union of Pure and Applied Chemistry</span>)
        </div><div class="casAbstract">New racemic and chiral Me 2-{[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate derivs. were synthesized in order to obtain sigma ligands with increased affinity and selectivity compared to (+)-MPCB and haloperidol.  The cis-(+)-7 racemic mixt. showed a better binding affinity and selectivity than the (±)-8 trans isomers.  Between the two cis enantiomers, (+)-7, with configuration (IR,2S), showed a very high affinity and the best selectivity for σ1.  All compds. synthesized (7-9) showed a reduced or negligible affinity for opioid and dopaminergic D1 and D2 receptors.  Nociceptive in vivo test confirms that (+±)-7 (namely MR200), such as non-selective antagonist haloperidol. increased the analgesic effect induced by the Kt opioid selective ligand U50,4881I and reversed the inhibiting effect of (+)-pentazocine on analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxo_t5PAwF-rVg90H21EOLACvtfcHk0lgJuxLYvujaQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFGls78%253D&md5=3557731c2bb275e5642787ee5a2c5fea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1351%2Fpac200173091499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac200173091499%26sid%3Dliteratum%253Aachs%26aulast%3DRonsisvalle%26aufirst%3DG.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DScoto%26aufirst%3DG.%2BM.%26atitle%3DOpioid%2520and%2520sigma%2520receptor%2520studies.%2520New%2520developments%2520in%2520the%2520design%2520of%2520selective%2520sigma%2520ligands%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2001%26volume%3D73%26spage%3D1499%26epage%3D1509%26doi%3D10.1351%2Fpac200173091499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1021/jm00079a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00079a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1KhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=38-47&author=B.+R.+de+Costaauthor=L.+Radescaauthor=L.+Di+Paoloauthor=W.+D.+Bowen&title=Synthesis%2C+characterization%2C+and+biological+evaluation+of+a+novel+class+of+N-%28arylethyl%29-N-alkyl-2-%281-pyrrolidinyl%29ethylamines%3A+structural+requirements+and+binding+affinity+at+the+sigma+receptor&doi=10.1021%2Fjm00079a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines:  structural requirements and binding affinity at the σ receptor</span></div><div class="casAuthors">De Costa, Brian R.; Radesca, Lilian; Di Paolo, Lisa; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Title compds., e.g. I (R = H, Me, Et, Pr, allyl, Bu, R1 = R2 = Cl; R = Me, R1, R2 = H, Cl; R1R2 = benzo), were prepd. and their binding affinity for σ-, phencyclidine, kappa opiate, and dopamine D2 receptors was measured.  Thus, pyrrolidine II (R3 = Cl) was aminated with H2NR to give II (R3 = NHR) which reacted with 3,4-dichlorophenylacetic acid and was reduced with AlH3/THF to give I (R = H, Me, Et, Pr, allyl, Bu, R1 = R2 = Cl).  When I (R = Me, R1 = R2 = Cl) was tested for its capacity to displace [3H]-(+)-3-PPP (PPP = 1-n-propyl-3-(3-hydroxyphenyl)piperidine) from guinea pig brain membranes, it exhibited a Ki of 0.34 nM.  Structure activity relationships were also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMksg4R4UY9LVg90H21EOLACvtfcHk0lhi38BtMROI9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1KhsLo%253D&md5=47f25860bff66bed7175f73cc44012a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00079a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00079a004%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DRadesca%26aufirst%3DL.%26aulast%3DDi%2BPaolo%26aufirst%3DL.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520class%2520of%2520N-%2528arylethyl%2529-N-alkyl-2-%25281-pyrrolidinyl%2529ethylamines%253A%2520structural%2520requirements%2520and%2520binding%2520affinity%2520at%2520the%2520sigma%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D38%26epage%3D47%26doi%3D10.1021%2Fjm00079a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+Del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lhi38BtMROI9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Díaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuberes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrocal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contijoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of σ<sub>1</sub> receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8211</span><span class="NLM_x">–</span> <span class="NLM_lpage">8224</span><span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+%CF%831+receptor+antagonists%3A+identification+of+4-%7B2-%5B5-methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span></div><div class="casAuthors">Diaz, Jose Luis; Cuberes, Rosa; Berrocal, Joana; Contijoch, Montserrat; Christmann, Ute; Fernandez, Ariadna; Port, Adriana; Holenz, Jorg; Buschmann, Helmut; Laggner, Christian; Serafini, Maria Teresa; Burgueno, Javier; Zamanillo, Daniel; Merlos, Manuel; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8211-8224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-arylpyrazoles as potent σ1 receptor (σ1R) antagonists are reported.  The new compds. were evaluated in vitro in human σ1R and guinea pig σ2 receptor (σ2R) binding assays.  The nature of the pyrazole substituents was crucial for activity, and a basic amine was shown to be necessary, in accordance with known receptor pharmacophores.  A wide variety of amines and spacer lengths between the amino and pyrazole groups was tolerated, but only the ethylenoxy spacer and small cyclic amines provided compds. with sufficient selectivity for σ1R vs σ2R.  The most selective compds. were further profiled, and 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862, I), which showed high activity in the mouse capsaicin model of neurogenic pain, emerged as the most interesting candidate.  In addn., compd. I exerted dose-dependent antinociceptive effects in several neuropathic pain models.  This, together with its good physicochem., safety, and ADME properties, led compd. I to be selected as clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQxd7-vnvc7Vg90H21EOLACvtfcHk0liRIgDDYAgHBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI&md5=0d6a5c8008d27635117c3901ec1db3c4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520%25CF%25831%2520receptor%2520antagonists%253A%2520identification%2520of%25204-%257B2-%255B5-methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arroyos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera-Arconada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segalés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laloya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escriche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plata-Salamán, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2306</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01942.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-2306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+Giraldoauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+R.+Plata-Salam%C3%A1nauthor=J.+M.+Vela&title=Pharmacological+properties+of+S1RA%2C+a+new+sigma-1+receptor+antagonist+that+inhibits+neuropathic+pain+and+activity-induced+spinal+sensitization&doi=10.1111%2Fj.1476-5381.2012.01942.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0liRIgDDYAgHBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DPharmacological%2520properties%2520of%2520S1RA%252C%2520a%2520new%2520sigma-1%2520receptor%2520antagonist%2520that%2520inhibits%2520neuropathic%2520pain%2520and%2520activity-induced%2520spinal%2520sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D2306%26doi%3D10.1111%2Fj.1476-5381.2012.01942.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Diáz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Álvarez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship study of a new series of selective σ<sub>1</sub> receptor ligands for the treatment of pain: 4-aminotriazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span><span class="refDoi"> DOI: 10.1021/jm501920g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501920g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2441-2451&author=J.+L.+Di%C3%A1zauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Torrensauthor=A.+Portauthor=R.+Pascualauthor=I.+%C3%81lvarezauthor=J.+Burgue%C3%B1oauthor=X.+Monroyauthor=A.+Monteroauthor=A.+Baladaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+structure-activity+relationship+study+of+a+new+series+of+selective+%CF%831+receptor+ligands+for+the+treatment+of+pain%3A+4-aminotriazoles&doi=10.1021%2Fjm501920g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm501920g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501920g%26sid%3Dliteratum%253Aachs%26aulast%3DDi%25C3%25A1z%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3D%25C3%2581lvarez%26aufirst%3DI.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DBalada%26aufirst%3DA.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520study%2520of%2520a%2520new%2520series%2520of%2520selective%2520%25CF%25831%2520receptor%2520ligands%2520for%2520the%2520treatment%2520of%2520pain%253A%25204-aminotriazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2441%26epage%3D2451%26doi%3D10.1021%2Fjm501920g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(<i>1H</i>)-quinolinone scaffold as a potential analgesic</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.ejmech.2014.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24735647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=216-230&author=Y.+Lanauthor=Y.+Chenauthor=X.+Xuauthor=Y.+Qiuauthor=S.+Liuauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+a+novel+sigma-1+receptor+antagonist+based+on+3%2C4-dihydro-2%281H%29-quinolinone+scaffold+as+a+potential+analgesic&doi=10.1016%2Fj.ejmech.2014.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Xu, Xiangqing; Qiu, Yinli; Liu, Shicheng; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216-230</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis and sigma-1 receptor (σ1R) antagonist activity of a new series of 3,4-dihydro-2(1H)-quinolinones, e.g. I [R = PhCH2, 4-MeC6H4CH2, 4-FC6H4CH2, etc.] are reported.  The new compds. were evaluated in vitro in sigma-1 and sigma-2 receptor-binding assays in guinea pig brain membranes.  The structure-activity relationship led us to the promising deriv. I [R = 4-FC6H4CH2].  The compds. with highest affinity and greatest selectivity were further profiled, and compd. I [R = 4-FC6H4CH2] had a high binding const. for sigma-1 receptor (Kiσ1 = 1.22 nM) and high sigma-1/2 selectivity (1066-fold).  Thus, this compd., which proved to be an antagonist of sigma-1 receptor, emerged as the most interesting candidate.  In addn., this compd. exerted dose-dependent antinociceptive effects in the formalin test.  These characteristics suggested that the potent and selective compd. I [R = 4-FC6H4CH2] could be a potent candidate for pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo56iTGYzwCw7Vg90H21EOLACvtfcHk0lgCkT2pzKMBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D&md5=04009cdd675bf12a18a5869979c2cf10</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520sigma-1%2520receptor%2520antagonist%2520based%2520on%25203%252C4-dihydro-2%25281H%2529-quinolinone%2520scaffold%2520as%2520a%2520potential%2520analgesic%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D216%26epage%3D230%26doi%3D10.1016%2Fj.ejmech.2014.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10404</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span><span class="refDoi"> DOI: 10.1021/jm501207r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501207r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10404-10423&author=Y.+Lanauthor=Y.+Chenauthor=X.+Caoauthor=J.+Zhangauthor=J.+Wangauthor=X.+Xuauthor=Y.+Qiuauthor=T.+Zhangauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+sigma-1+receptor+antagonists+based+on+pyrimidine+scaffold+as+agents+for+treating+neuropathic+pain&doi=10.1021%2Fjm501207r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Cao, Xudong; Zhang, Juecheng; Wang, Jie; Xu, Xiangqing; Qiu, Yinli; Zhang, Tan; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10404-10423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, assocd. with pharmacol. antineuropathic pain activity, are the focus of this article.  The new compds. were evaluated in vitro in σ-1 and σ-2 receptor binding assays.  The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model.  The most promising deriv. was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (I), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold).  In in vivo tests, I exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain.  In addn., no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted.  These data suggest I may constitute a novel class of drugs for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dkiomNDrPLVg90H21EOLACvtfcHk0lgCkT2pzKMBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE&md5=bd003488b014b40e739cc42c825424ce</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm501207r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501207r%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520sigma-1%2520receptor%2520antagonists%2520based%2520on%2520pyrimidine%2520scaffold%2520as%2520agents%2520for%2520treating%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10404%26epage%3D10423%26doi%3D10.1021%2Fjm501207r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaiel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">el-Ashmawy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howie, K. B.</span><span> </span><span class="NLM_article-title">Structural features important for σ<sub>1</sub> receptor binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span><span class="refDoi"> DOI: 10.1021/jm00034a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1214-1219&author=R.+A.+Glennonauthor=S.+Y.+Ablordeppeyauthor=A.+M.+Ismaielauthor=M.+B.+el-Ashmawyauthor=J.+B.+Fischerauthor=K.+B.+Howie&title=Structural+features+important+for+%CF%831+receptor+binding&doi=10.1021%2Fjm00034a020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features Important for σ1 Receptor Binding</span></div><div class="casAuthors">Glennon, Richard A.; Ablordeppey, Seth Y.; Ismaiel, Abd M.; El-Ashmawy, Mahmoud B.; Fischer, James B.; Howie, Kathleen Burke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1214-19</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Two problems that have hampered σ receptor research are a lack of high-affinity agents and the recent identification of multiple populations of σ receptors (i.e., σ1 and σ2 sites).  Recently, several high-affinity σ ligands have been identified, and the term superpotent σ ligands has been coined to describe agents with Ki values of <1 nM.  It was previously shown that appropriately N-substituted phenylalkylamines bind at σ receptors with high affinity.  The structure-affinity relationships of these phenylalkylamine derivs. for σ1 binding are examd. and some of the first superpotent σ1 ligands described.  A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with σ1 sites.  Some of the amines were prepd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nnZHspQ0MLVg90H21EOLACvtfcHk0lgCkT2pzKMBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D&md5=3c9b4ff203d7c304da3779a874837bf5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a020%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DIsmaiel%26aufirst%3DA.%2BM.%26aulast%3Del-Ashmawy%26aufirst%3DM.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DHowie%26aufirst%3DK.%2BB.%26atitle%3DStructural%2520features%2520important%2520for%2520%25CF%25831%2520receptor%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1214%26epage%3D1219%26doi%3D10.1021%2Fjm00034a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore identification for sigma-1 (σ<sub>1</sub>) receptor binding: application of the “deconstruction-reconstruction-elaboration” approach</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.2174/138955705774329519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F138955705774329519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=16250835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=927-940&author=R.+A.+Glennon&title=Pharmacophore+identification+for+sigma-1+%28%CF%831%29+receptor+binding%3A+application+of+the+%E2%80%9Cdeconstruction-reconstruction-elaboration%E2%80%9D+approach&doi=10.2174%2F138955705774329519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore identification for sigma-1 (σ1) receptor binding: Application of the deconstruction - reconstruction - elaboration approach</span></div><div class="casAuthors">Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-940</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  At least two different types of sigma σ (σ1 and σ2) receptors have been identified.  A structural feature common to high-affinity (Ki <10 nM) σ1 ligands is: C-N(R)-X-Ph; both C and Ph are assocd. with regions of bulk tolerance.  Numerous other ligands bind, but typically do so with lower affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_9JlDBLhrbVg90H21EOLACvtfcHk0ljpJC-4dy82rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM&md5=66ae2e51d57fa97cd3954ae90e7e3167</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F138955705774329519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955705774329519%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DPharmacophore%2520identification%2520for%2520sigma-1%2520%2528%25CF%25831%2529%2520receptor%2520binding%253A%2520application%2520of%2520the%2520%25E2%2580%259Cdeconstruction-reconstruction-elaboration%25E2%2580%259D%2520approach%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D927%26epage%3D940%26doi%3D10.2174%2F138955705774329519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Asif, M.</span><span> </span><span class="NLM_article-title">Some recent approaches of biologically active substituted pyridazine and phthalazine drugs</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2984</span><span class="NLM_x">–</span> <span class="NLM_lpage">2991</span><span class="refDoi"> DOI: 10.2174/092986712800672139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F092986712800672139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=22519394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFersbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=2984-2991&author=M.+Asif&title=Some+recent+approaches+of+biologically+active+substituted+pyridazine+and+phthalazine+drugs&doi=10.2174%2F092986712800672139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Some recent approaches of biologically active substituted pyridazine and phthalazine drugs</span></div><div class="casAuthors">Asif, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2984-2991</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitrogen atom contg. heterocyclic compds., pyridazines, pyridazinones and phthalazines are important structural feature of many biol. active compds. and show diverse pharmacol. properties.  Pyridazines and phthalazines hold considerable interest relative to the prepn. of org. intermediates and physiol. active compds.  On the basis of literature, pyridazines, pyridazinone and phthalazines further focus our attention because of their easy fictionalization at various ring positions, which makes them attractive synthetic compds. for designing and development of the novel pyridazines and phthalazines drugs in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1NS6SepR4RrVg90H21EOLACvtfcHk0ljpJC-4dy82rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFersbc%253D&md5=ee1620d7f24e12f7f2f28e65bc24a806</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F092986712800672139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712800672139%26sid%3Dliteratum%253Aachs%26aulast%3DAsif%26aufirst%3DM.%26atitle%3DSome%2520recent%2520approaches%2520of%2520biologically%2520active%2520substituted%2520pyridazine%2520and%2520phthalazine%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D2984%26epage%3D2991%26doi%3D10.2174%2F092986712800672139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Asif, M.</span><span> </span><span class="NLM_article-title">A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H<sub>3</sub>R</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.2174/1389557514666141127143133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F1389557514666141127143133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25429662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC2MzhtFeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=1093-1103&author=M.+Asif&title=A+mini+review+on+biological+activities+of+pyridazinone+derivatives+as+antiulcer%2C+antisecretory%2C+antihistamine+and+particularly+against+histamine+H3R&doi=10.2174%2F1389557514666141127143133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H3R</span></div><div class="casAuthors">Asif Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Mini reviews in medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1093-103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pyridazinone derivatives and their related analoges were introduced for gastric antiulcer and antisecretory activities.  Selected compounds were applied to ulcer models and showed their antiulcer and anti secretary activities.  Some pyridazinone compounds are recently reported as H3R antagonists.  Some amine analogs of pyridazinones, pyridazinone- phenethylamines and 4,5-fused pyridazinones showed histamine H3R antagonist activity with significant affinity for rat and human H3R.  These pyridazinone analogs also showed excellent selectivity and metabolic stability, with adequate pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwDyBbwL36aC86Js-BCLiifW6udTcc2eaf_TxKZKZdYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzhtFeisA%253D%253D&md5=1b10b8379cca26cc3cffb0dd1701d3f7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F1389557514666141127143133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557514666141127143133%26sid%3Dliteratum%253Aachs%26aulast%3DAsif%26aufirst%3DM.%26atitle%3DA%2520mini%2520review%2520on%2520biological%2520activities%2520of%2520pyridazinone%2520derivatives%2520as%2520antiulcer%252C%2520antisecretory%252C%2520antihistamine%2520and%2520particularly%2520against%2520histamine%2520H3R%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2015%26volume%3D14%26spage%3D1093%26epage%3D1103%26doi%3D10.2174%2F1389557514666141127143133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushimi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span> </span><span class="NLM_article-title">Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyri dazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9627</span><span class="NLM_x">–</span> <span class="NLM_lpage">9643</span><span class="refDoi"> DOI: 10.1021/jm5013648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5013648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9627-9643&author=J.+Kunitomoauthor=M.+Yoshikawaauthor=M.+Fushimiauthor=A.+Kawadaauthor=J.+F.+Quinnauthor=H.+Okiauthor=H.+Kokuboauthor=M.+Kondoauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=K.+Suzukiauthor=H.+Kimuraauthor=T.+Taniguchi&title=Discovery+of+1-%5B2-fluoro-4-%281H-pyrazol-1-yl%29phenyl%5D-5-methoxy-3-%281-phenyl-1H-pyrazol-5-yl%29pyri+dazin-4%281H%29-one+%28TAK-063%29%2C+a+highly+potent%2C+selective%2C+and+orally+active+phosphodiesterase+10A+%28PDE10A%29+inhibitor&doi=10.1021%2Fjm5013648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1021%2Fjm5013648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013648%26sid%3Dliteratum%253Aachs%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DFushimi%26aufirst%3DM.%26aulast%3DKawada%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25201-%255B2-fluoro-4-%25281H-pyrazol-1-yl%2529phenyl%255D-5-methoxy-3-%25281-phenyl-1H-pyrazol-5-yl%2529pyri%2520dazin-4%25281H%2529-one%2520%2528TAK-063%2529%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9627%26epage%3D9643%26doi%3D10.1021%2Fjm5013648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmait, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester-Zeiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Able, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cueva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talreja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornecook, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)e thanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6632</span><span class="NLM_x">–</span> <span class="NLM_lpage">6641</span><span class="refDoi"> DOI: 10.1021/jm500713j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500713j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6632-6641&author=E.+Huauthor=N.+Chenauthor=M.+P.+Bourbeauauthor=P.+E.+Harringtonauthor=K.+Biswasauthor=R.+K.+Kunzauthor=K.+L.+Andrewsauthor=S.+Chmaitauthor=X.+Zhaoauthor=C.+Davisauthor=J.+Maauthor=J.+Shiauthor=D.+Lester-Zeinerauthor=J.+Danaoauthor=J.+Ableauthor=M.+Cuevaauthor=S.+Talrejaauthor=T.+Kornecookauthor=H.+Chenauthor=A.+Porterauthor=R.+Hungateauthor=J.+Treanorauthor=J.+R.+Allen&title=Discovery+of+clinical+candidate+1-%284-%283-%284-%281H-benzo%5Bd%5Dimidazole-2-carbonyl%29phenoxy%29pyrazin-2-yl%29piperidin-1-yl%29e+thanone+%28AMG+579%29%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+phosphodiesterase+10A+%28PDE10A%29&doi=10.1021%2Fjm500713j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1021%2Fjm500713j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500713j%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DDanao%26aufirst%3DJ.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DCueva%26aufirst%3DM.%26aulast%3DTalreja%26aufirst%3DS.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%25284-%25283-%25284-%25281H-benzo%255Bd%255Dimidazole-2-carbonyl%2529phenoxy%2529pyrazin-2-yl%2529piperidin-1-yl%2529e%2520thanone%2520%2528AMG%2520579%2529%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6632%26epage%3D6641%26doi%3D10.1021%2Fjm500713j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lima, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a useful strategy for molecular modification and drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span><span class="refDoi"> DOI: 10.2174/0929867053363540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F0929867053363540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15638729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=23-49&author=L.+M.+Limaauthor=E.+J.+Barreiro&title=Bioisosterism%3A+a+useful+strategy+for+molecular+modification+and+drug+design&doi=10.2174%2F0929867053363540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A useful strategy for molecular modification and drug design</span></div><div class="casAuthors">Lima, Lidia Moreira; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-49</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review aims to demonstrate the role of bioisosterism in rational drug design as well as in the mol. modification and optimization process aiming to improve pharmacodynamic and pharmacokinetic properties of lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7625guUbh7Vg90H21EOLACvtfcHk0lgerkNMUpD3FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D&md5=4836e1d51143b240e357548b39f04251</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2174%2F0929867053363540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053363540%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DL.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520useful%2520strategy%2520for%2520molecular%2520modification%2520and%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D23%26epage%3D49%26doi%3D10.2174%2F0929867053363540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Viegas-Junior, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danuello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Silva Bolzani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A.</span><span> </span><span class="NLM_article-title">Molecular hybridization: a useful tool in the design of new drug prototypes</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span><span class="refDoi"> DOI: 10.2174/092986707781058805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F092986707781058805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=17627520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFanuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1829-1852&author=C.+Viegas-Juniorauthor=A.+Danuelloauthor=V.+da+Silva+Bolzaniauthor=E.+J.+Barreiroauthor=C.+A.+Fraga&title=Molecular+hybridization%3A+a+useful+tool+in+the+design+of+new+drug+prototypes&doi=10.2174%2F092986707781058805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular hybridization: a useful tool in the design of new drug prototypes</span></div><div class="casAuthors">Viegas-Junior, Claudio; Danuello, Amanda; da Silva Bolzani, Vanderlan; Barreiro, Eliezer J.; Fraga, Carlos Alberto Manssour</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1829-1852</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mol. hybridization is a new concept in drug design and development based on the combination of pharmacophoric moieties of different bioactive substances to produce a new hybrid compd. with improved affinity and efficacy, when compared to the parent drugs.  Addnl., this strategy can result in compds. presenting modified selectivity profile, different and/or dual modes of action and reduced undesired side effects.  So, in this paper, we described several examples of different strategies for drug design, discovery and pharmacomodulation focused on new innovative hybrid compds. presenting analgesic, anti-inflammatory, platelet anti-aggregating, anti-infectious, anticancer, cardio- and neuroactive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvbzA71FPqLVg90H21EOLACvtfcHk0lgerkNMUpD3FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFanuro%253D&md5=7d3a16e3deeacb735bc0357fc6a99c37</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2174%2F092986707781058805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707781058805%26sid%3Dliteratum%253Aachs%26aulast%3DViegas-Junior%26aufirst%3DC.%26aulast%3DDanuello%26aufirst%3DA.%26aulast%3Dda%2BSilva%2BBolzani%26aufirst%3DV.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DFraga%26aufirst%3DC.%2BA.%26atitle%3DMolecular%2520hybridization%253A%2520a%2520useful%2520tool%2520in%2520the%2520design%2520of%2520new%2520drug%2520prototypes%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D1829%26epage%3D1852%26doi%3D10.2174%2F092986707781058805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johnston, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allcock, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosair, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, D. R.</span><span> </span><span class="NLM_article-title">Concise routes to pyrazolo[1,5-a]pyridin-3-yl pyridazin-3-ones</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1039/B713638B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1039%2FB713638B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=175-186&author=K.+A.+Johnstonauthor=R.+W.+Allcockauthor=Z.+Jiangauthor=I.+D.+Collierauthor=H.+Blakliauthor=G.+M.+Rosairauthor=P.+D.+Baileyauthor=K.+M.+Morganauthor=Y.+Kohnoauthor=D.+R.+Adams&title=Concise+routes+to+pyrazolo%5B1%2C5-a%5Dpyridin-3-yl+pyridazin-3-ones&doi=10.1039%2FB713638B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51a&amp;dbid=16384&amp;doi=10.1039%2FB713638B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB713638B%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DK.%2BA.%26aulast%3DAllcock%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DCollier%26aufirst%3DI.%2BD.%26aulast%3DBlakli%26aufirst%3DH.%26aulast%3DRosair%26aufirst%3DG.%2BM.%26aulast%3DBailey%26aufirst%3DP.%2BD.%26aulast%3DMorgan%26aufirst%3DK.%2BM.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26atitle%3DConcise%2520routes%2520to%2520pyrazolo%255B1%252C5-a%255Dpyridin-3-yl%2520pyridazin-3-ones%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D175%26epage%3D186%26doi%3D10.1039%2FB713638B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit51b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Druey, J.; Hucni, A.; Ringier, B. H.; Staehelin, A.</span><span> </span><span class="NLM_article-title">Halogen pyridazines</span>. US 2963477 A,<span class="NLM_x"> </span><span class="NLM_year">1960</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1960&author=J.+Druey&author=A.+Hucni&author=B.+H.+Ringier&author=A.+Staehelin&title=Halogen+pyridazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDruey%26aufirst%3DJ.%26atitle%3DHalogen%2520pyridazines%26date%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kowalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrosz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charakchieva-Minol, S.</span><span> </span><span class="NLM_article-title">Biologically active 1-arylpiperazines. synthesis of new N-(4-aryl-1-piperazinyl)alkyl derivatives of quinazolidin-4(<i>3H</i>)-one, 2,3-dihydrophthalazine-1,4-dione and 1,2-dihydropyridazine-3,6-dione as potential serotonin receptor ligands</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span><span class="refDoi"> DOI: 10.3390/60900784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.3390%2F60900784" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=784-795&author=P.+Kowalskiauthor=T.+Kowalskaauthor=M.+J.+Mokroszauthor=A.+J.+Bojarskiauthor=S.+Charakchieva-Minol&title=Biologically+active+1-arylpiperazines.+synthesis+of+new+N-%284-aryl-1-piperazinyl%29alkyl+derivatives+of+quinazolidin-4%283H%29-one%2C+2%2C3-dihydrophthalazine-1%2C4-dione+and+1%2C2-dihydropyridazine-3%2C6-dione+as+potential+serotonin+receptor+ligands&doi=10.3390%2F60900784"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2F60900784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252F60900784%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DP.%26aulast%3DKowalska%26aufirst%3DT.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26atitle%3DBiologically%2520active%25201-arylpiperazines.%2520synthesis%2520of%2520new%2520N-%25284-aryl-1-piperazinyl%2529alkyl%2520derivatives%2520of%2520quinazolidin-4%25283H%2529-one%252C%25202%252C3-dihydrophthalazine-1%252C4-dione%2520and%25201%252C2-dihydropyridazine-3%252C6-dione%2520as%2520potential%2520serotonin%2520receptor%2520ligands%26jtitle%3DMolecules%26date%3D2001%26volume%3D6%26spage%3D784%26epage%3D795%26doi%3D10.3390%2F60900784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszynska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charakchieva-Minol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatarczynska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klodzinska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacka-Wojcik, E.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT<sub>1A</sub>/5-HT<sub>2A</sub> receptor ligand with an anxiolytic-like activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3817</span><span class="NLM_x">–</span> <span class="NLM_lpage">3827</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00349-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2FS0968-0896%2802%2900349-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3817-3827&author=A.+J.+Bojarskiauthor=P.+Kowalskiauthor=T.+Kowalskaauthor=B.+Duszynskaauthor=S.+Charakchieva-Minolauthor=E.+Tatarczynskaauthor=A.+Klodzinskaauthor=E.+Chojnacka-Wojcik&title=Synthesis+and+pharmacological+evaluation+of+new+arylpiperazines.+3-%5B4-%5B4-%283-chlorophenyl%29-1-piperazinyl%5Dbutyl%5D-quinazolidin-4-one+-+a+dual+serotonin+5-HT1A%2F5-HT2A+receptor+ligand+with+an+anxiolytic-like+activity&doi=10.1016%2FS0968-0896%2802%2900349-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900349-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900349-8%26sid%3Dliteratum%253Aachs%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DKowalski%26aufirst%3DP.%26aulast%3DKowalska%26aufirst%3DT.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DKlodzinska%26aufirst%3DA.%26aulast%3DChojnacka-Wojcik%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520new%2520arylpiperazines.%25203-%255B4-%255B4-%25283-chlorophenyl%2529-1-piperazinyl%255Dbutyl%255D-quinazolidin-4-one%2520-%2520a%2520dual%2520serotonin%25205-HT1A%252F5-HT2A%2520receptor%2520ligand%2520with%2520an%2520anxiolytic-like%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3817%26epage%3D3827%26doi%3D10.1016%2FS0968-0896%2802%2900349-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">DeHaven-Hudkins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleissner, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Rice, F. Y.</span><span> </span><span class="NLM_article-title">Characterization of the binding of [<sup>3</sup>H](+)-pentazocine to sigma recognition sites in guinea pig brain</span> <span class="citation_source-journal">Eur. J. Pharmacol., Mol. Pharmacol. Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span><span class="refDoi"> DOI: 10.1016/0922-4106(92)90153-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+binding+of+%5B3H%5D%28%2B%29-pentazocine+to+sigma+recognition+sites+in+guinea+pig+brain&doi=10.1016%2F0922-4106%2892%2990153-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0lgpPigOh5ab_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255D%2528%252B%2529-pentazocine%2520to%2520sigma%2520recognition%2520sites%2520in%2520guinea%2520pig%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378%26doi%3D10.1016%2F0922-4106%2892%2990153-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Balasuriya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Sa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwardson, J. M.</span><span> </span><span class="NLM_article-title">A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF(R))</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">32353</span><span class="NLM_x">–</span> <span class="NLM_lpage">32363</span><span class="refDoi"> DOI: 10.1074/jbc.M114.603506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1074%2Fjbc.M114.603506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=32353-32363&author=D.+Balasuriyaauthor=L.+D%E2%80%99Saauthor=R.+Talkerauthor=E.+Dupuisauthor=F.+Maurinauthor=P.+Martinauthor=F.+Borgeseauthor=O.+Sorianiauthor=J.+M.+Edwardson&title=A+direct+interaction+between+the+sigma-1+receptor+and+the+hERG+voltage-gated+K%2B+channel+revealed+by+atomic+force+microscopy+and+homogeneous+time-resolved+fluorescence+%28HTRF%28R%29%29&doi=10.1074%2Fjbc.M114.603506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.603506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.603506%26sid%3Dliteratum%253Aachs%26aulast%3DBalasuriya%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Sa%26aufirst%3DL.%26aulast%3DTalker%26aufirst%3DR.%26aulast%3DDupuis%26aufirst%3DE.%26aulast%3DMaurin%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DBorgese%26aufirst%3DF.%26aulast%3DSoriani%26aufirst%3DO.%26aulast%3DEdwardson%26aufirst%3DJ.%2BM.%26atitle%3DA%2520direct%2520interaction%2520between%2520the%2520sigma-1%2520receptor%2520and%2520the%2520hERG%2520voltage-gated%2520K%252B%2520channel%2520revealed%2520by%2520atomic%2520force%2520microscopy%2520and%2520homogeneous%2520time-resolved%2520fluorescence%2520%2528HTRF%2528R%2529%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D32353%26epage%3D32363%26doi%3D10.1074%2Fjbc.M114.603506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]<sub>o</sub></span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1016/j.vascn.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5Ddofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+Comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do&doi=10.1016%2Fj.vascn.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55bR"><div class="casContent"><span class="casTitleNuber">55b</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lhic6KirntY_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255Ddofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520Comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ponti, F.</span><span> </span><span class="NLM_article-title">QT prolongation through hERG K (+) channel blockade: current knowledge and strategies for the early prediction during drug development</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1002/med.20019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1002%2Fmed.20019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15389727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlWhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=133-166&author=M.+Recanatiniauthor=E.+Poluzziauthor=M.+Masettiauthor=A.+Cavalliauthor=F.+De+Ponti&title=QT+prolongation+through+hERG+K+%28%2B%29+channel+blockade%3A+current+knowledge+and+strategies+for+the+early+prediction+during+drug+development&doi=10.1002%2Fmed.20019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55cR"><div class="casContent"><span class="casTitleNuber">55c</span><div class="casTitle"><span class="NLM_cas:atitle">QT prolongation through hERG K+ channel blockade: current knowledge and strategies for the early prediction during drug development</span></div><div class="casAuthors">Recanatini, Maurizio; Poluzzi, Elisabetta; Masetti, Matteo; Cavalli, Andrea; de Ponti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-166</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Prolongation of the QT interval of the ECG is a typical effect of Class III antiarrhythmic drugs, achieved through blockade of potassium channels.  In the past decade, evidence has accrued that several classes of drugs used for non-cardiovascular indications may prolong the QT interval with the same mechanism (namely, human ether-a-go-go-related gene (hERG) K+ channel blockade).  The great interest in QT prolongation is because of several reasons.  First, drug-induced QT prolongation increases the likelihood of a polymorphous ventricular arrhythmia (namely, torsades de pointes, TdP), which may cause syncope and degenerate into ventricular fibrillation and sudden death.  Second, the fact that several classes of drugs, such as antihistamines, fluoroquinolones, macrolides, and neuroleptics may cause the long QT syndrome (LQTS) raises the question whether this is a class effect (e.g., shared by all agents of a given pharmacol. class) or a specific effect of single agents within a class.  There is now consensus that, in most cases, only a few agents within a therapeutic class share the ability to significantly affect hERG K+ channels.  These compds. should be identified as early as possible during drug development.  Third, QT prolongation and interaction with hERG K+ channels have become surrogate markers of cardiotoxicity and have received increasing regulatory attention.  This review briefly outlines the mechanisms leading to QT prolongation and the different strategies that can be followed to predict this unwanted effect.  In particular, it will focus on the approaches recently proposed for the in silico screening of new compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7B-6DBAFeLVg90H21EOLACvtfcHk0lhic6KirntY_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlWhs7Y%253D&md5=aa5aea37c667b4f35546259cc2593c6d</span></div><a href="/servlet/linkout?suffix=cit55c&amp;dbid=16384&amp;doi=10.1002%2Fmed.20019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20019%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DPoluzzi%26aufirst%3DE.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DDe%2BPonti%26aufirst%3DF.%26atitle%3DQT%2520prolongation%2520through%2520hERG%2520K%2520%2528%252B%2529%2520channel%2520blockade%253A%2520current%2520knowledge%2520and%2520strategies%2520for%2520the%2520early%2520prediction%2520during%2520drug%2520development%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D133%26epage%3D166%26doi%3D10.1002%2Fmed.20019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Regulating ankyrin dynamics: Roles of sigma-1 receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1073/pnas.98.2.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1073%2Fpnas.98.2.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=11149946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=491-496&author=T.+Hayashiauthor=T.+P.+Su&title=Regulating+ankyrin+dynamics%3A+Roles+of+sigma-1+receptors&doi=10.1073%2Fpnas.98.2.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56aR"><div class="casContent"><span class="casTitleNuber">56a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating ankyrin dynamics: roles of sigma-1 receptors</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ankyrin is a cytoskeletal adaptor protein that controls important cellular functions, including Ca2+ efflux at inositol 1,4,5-trisphosphate receptors (IP3R) on the endoplasmic reticulum.  The present study found that sigma-1 receptors (Sig-1R), unique endoplasmic reticulum proteins that bind certain steroids, neuroleptics, and psychotropic drugs, form a trimeric complex with ankyrin B and IP3R type 3 (IP3R-3) in NG-108 cells.  The trimeric complex could be coimmunopptd. by antibodies against any of the three proteins.  Sig-1R agonists such as pregenolone sulfate and cocaine caused the dissocn. of an ankyrin B isoform (ANK 220) from IP3R-3.  This effect caused by Sig-1R agonists was blocked by a Sig-1R antagonist.  The degree of dissocn. of ANK 220 from IP3R-3 caused by Sig-1R ligands correlates excellently with the ligands' efficacies in potentiating the bradykinin-induced increase in cytosolic free Ca2+ concn.  Immunocytohistochem. showed that Sig-1R, ankyrin B, and IP3R-3 are colocalized in NG-108 cells in perinuclear areas and in regions of cell-to-cell communication.  These results suggest that Sig-1R and assocd. ligands may play important roles in cells by controlling the function of cytoskeletal proteins and that the Sig-1R/ANK220/IP3R-3 complex regulating Ca2+ signaling may represent a site of action for neurosteroids and cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ424uZx5ag7Vg90H21EOLACvtfcHk0lhic6KirntY_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D&md5=2fc5684bc59fa8d0c69494de29847681</span></div><a href="/servlet/linkout?suffix=cit56a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.98.2.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.98.2.491%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DRegulating%2520ankyrin%2520dynamics%253A%2520Roles%2520of%2520sigma-1%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D491%26epage%3D496%26doi%3D10.1073%2Fpnas.98.2.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit56b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tsai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokrass, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauer, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">6742</span><span class="NLM_x">–</span> <span class="NLM_lpage">6747</span><span class="refDoi"> DOI: 10.1073/pnas.1422001112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1073%2Fpnas.1422001112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=6742-6747&author=S.+Y.+Tsaiauthor=M.+J.+Pokrassauthor=N.+R.+Klauerauthor=H.+Noharaauthor=T.+P.+Su&title=Sigma-1+receptor+regulates+Tau+phosphorylation+and+axon+extension+by+shaping+p35+turnover+via+myristic+acid&doi=10.1073%2Fpnas.1422001112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422001112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422001112%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BY.%26aulast%3DPokrass%26aufirst%3DM.%2BJ.%26aulast%3DKlauer%26aufirst%3DN.%2BR.%26aulast%3DNohara%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DSigma-1%2520receptor%2520regulates%2520Tau%2520phosphorylation%2520and%2520axon%2520extension%2520by%2520shaping%2520p35%2520turnover%2520via%2520myristic%2520acid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D6742%26epage%3D6747%26doi%3D10.1073%2Fpnas.1422001112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">28198</span><span class="NLM_x">–</span> <span class="NLM_lpage">28215</span><span class="refDoi"> DOI: 10.1074/jbc.M802099200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1074%2Fjbc.M802099200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=18539593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ans7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=28198-28215&author=Z.+Wuauthor=W.+D.+Bowen&title=Role+of+sigma-1+receptor+C-terminal+segment+in+inositol+1%2C4%2C5-trisphosphate+receptor+activation%3A+constitutive+enhancement+of+calcium+signaling+in+MCF-7+tumor+cells&doi=10.1074%2Fjbc.M802099200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells</span></div><div class="casAuthors">Wu, Zhiping; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">28198-28215</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sigma-1 receptor (sigma-1R) agonists enhance inositol 1,4,5-trisphosphate (IP3)-dependent calcium release from endoplasmic reticulum by inducing dissocn. of ankyrin B 220 (ANK 220) from the IP3 receptor (IP3R-3), releasing it from inhibition.  MCF-7 breast tumor cells express little or no sigma-1R and were used here to investigate the effect of receptor overexpression and the role of its N- and C-terminal segments in function.  The authors stably expressed intact sigma-1R (amino acids (aa) 1-223; lines 11 and 41), N-fragment (aa 1-100; line K3), or C-fragment (aa 102-223; line sg101).  C-fragment expressed as a peripheral membrane-bound protein that was removable from the endoplasmic reticulum membrane by chaotropic salt wash, consistent with lack of a putative transmembrane domain.  The expressed sigma-1R, N-fragment, and C-fragment exhibited normal, low affinity, and no [3H](+)-pentazocine binding activity, resp.  All transfected lines showed constitutive enhancement of bradykinin (BDK)-induced calcium release, because of a decrease in BDK ED50 values.  Interestingly, sigma-1R and C-fragment had high activities, whereas the N-fragment was much less active.  The antagonist BD1063 behaved as an inverse agonist in sigma-1R cells, whereas C-fragment was insensitive to ligand regulation.  Like BDK, vasopressin- and ATP-induced calcium release was enhanced with the same pattern in cell lines.  Anti-IP3R-3 immunoppts. from cells expressing sigma-1R or C-fragment contained significantly less ANK 220 compared with untransfected or N-fragment cells, indicating a higher amt. of ankyrin-free IP3R-3.  Anti-ankyrin B immunoppts. contained sigma-1R or C-fragment, with markedly lower levels of N-fragment present.  These results suggest that sigma-1R overexpression drives sigma agonist-independent dissocn. of ANK 220 from IP3R-3, resulting in activation.  The C-terminal segment plays a key role in the interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGownHr4IKNWMLVg90H21EOLACvtfcHk0liRyleIp2uo5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ans7zJ&md5=d8f6ea2b4e7ee33042d13956f9b38f13</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802099200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802099200%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DRole%2520of%2520sigma-1%2520receptor%2520C-terminal%2520segment%2520in%2520inositol%25201%252C4%252C5-trisphosphate%2520receptor%2520activation%253A%2520constitutive%2520enhancement%2520of%2520calcium%2520signaling%2520in%2520MCF-7%2520tumor%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D28198%26epage%3D28215%26doi%3D10.1074%2Fjbc.M802099200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca<sup>2+</sup> signaling and cell survival</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.+P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-mitochondrion+interface+regulate+Ca2%2B+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0liRyleIp2uo5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-mitochondrion%2520interface%2520regulate%2520Ca2%252B%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma-1 receptors of guinea pig brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma-1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59a&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma-1%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit59b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maricel, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Víctor, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrique, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, C.</span><span> </span><span class="NLM_article-title">Predicting the antinociceptive efficacy of σ1 receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1021/jm401529t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401529t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=238-242&author=G.+S.+Maricelauthor=F.+D.+V%C3%ADctorauthor=P.+S.+Enriqueauthor=P.+Pilarauthor=Z.+Danielauthor=J.+M.+Velaauthor=B.+Javierauthor=C.+Francisco&title=Predicting+the+antinociceptive+efficacy+of+%CF%831+receptor+ligands+by+a+novel+receptor+fluorescence+resonance+energy+transfer+%28FRET%29+based+biosensor&doi=10.1021%2Fjm401529t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59b&amp;dbid=16384&amp;doi=10.1021%2Fjm401529t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401529t%26sid%3Dliteratum%253Aachs%26aulast%3DMaricel%26aufirst%3DG.%2BS.%26aulast%3DV%25C3%25ADctor%26aufirst%3DF.%2BD.%26aulast%3DEnrique%26aufirst%3DP.%2BS.%26aulast%3DPilar%26aufirst%3DP.%26aulast%3DDaniel%26aufirst%3DZ.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DJavier%26aufirst%3DB.%26aulast%3DFrancisco%26aufirst%3DC.%26atitle%3DPredicting%2520the%2520antinociceptive%2520efficacy%2520of%2520%25CF%25831%2520receptor%2520ligands%2520by%2520a%2520novel%2520receptor%2520fluorescence%2520resonance%2520energy%2520transfer%2520%2528FRET%2529%2520based%2520biosensor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D238%26epage%3D242%26doi%3D10.1021%2Fjm401529t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Rosland, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjolsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maehle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hole, K.</span><span> </span><span class="NLM_article-title">The formalin test in mice: effect of formalin concentration</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1016/0304-3959(90)91167-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0304-3959%2890%2991167-H" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=235-242&author=J.+H.+Roslandauthor=A.+Tjolsenauthor=B.+Maehleauthor=K.+Hole&title=The+formalin+test+in+mice%3A+effect+of+formalin+concentration&doi=10.1016%2F0304-3959%2890%2991167-H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2890%2991167-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252890%252991167-H%26sid%3Dliteratum%253Aachs%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DTjolsen%26aufirst%3DA.%26aulast%3DMaehle%26aufirst%3DB.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%2520in%2520mice%253A%2520effect%2520of%2520formalin%2520concentration%26jtitle%3DPain%26date%3D1990%26volume%3D42%26spage%3D235%26epage%3D242%26doi%3D10.1016%2F0304-3959%2890%2991167-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span><span class="refDoi"> DOI: 10.1007/s00213-005-0127-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1007%2Fs00213-005-0127-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=16075285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=485-493&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=J.+M.+Baeyens&title=Antinociceptive+effects+of+haloperidol+and+its+metabolites+in+the+formalin+test+in+mice&doi=10.1007%2Fs00213-005-0127-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span></div><div class="casAuthors">Cendan, Cruz M.; Pujalte, Jose M.; Portillo-Salido, Enrique; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-493</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Formalin-induced pain is reduced in sigma-1 (σ1) receptor knockout mice; therefore, the authors hypothesized that haloperidol and its metabolites I and II, which have affinity for σ1 receptors, may modulate formalin-induced pain.  Results: Intraplantar administration of formalin (2.5%) to CD-1 mice produced a biphasic period of pain.  Haloperidol (0.03-1 mg/kg, s.c.) and reduced haloperidol (metabolite II, 0.25-8 mg/kg, s.c.) dose-dependently inhibited both phases of formalin-induced pain.  Haloperidol metabolite I (4-128 mg/kg, s.c.) also produced dose-dependent antinociception in the second phase of the formalin test, but was less potent and effective against first-phase pain.  Haloperidol metabolite III (16 and 128 mg/kg) and (-)sulpiride (200 mg/kg), which have no affinity for σ1 receptors, did not produce significant antinociception in either phase of the formalin test.  The order of potency of the drugs to produce their antinociceptive effect [haloperidol > metabolite II > metabolite I » metabolite III= (-)sulpiride=inactive] correlated with their affinity for σ1 receptors, but not with their affinity for σ2 or dopamine D2 receptors.  Naloxone (1 mg/kg, s.c.) did not antagonize the antinociception induced by haloperidol and its metabolites.  None of the antinociceptive drugs in the formalin test produced any antinociception in the tail flick test.  Conclusion: These results suggest that the antinociceptive effect of haloperidol and its metabolites in the formalin test is not due to unspecific/generalized inhibition of nociception or modulation of opioid receptors, and that it may be related, at least partially, to the ability of these drugs to interact with σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFuqvqHXFzk7Vg90H21EOLACvtfcHk0lhK68GiYBX-aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP&md5=3d55ac20e082e77f70769659224994f1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-0127-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-0127-z%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DAntinociceptive%2520effects%2520of%2520haloperidol%2520and%2520its%2520metabolites%2520in%2520the%2520formalin%2520test%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D182%26spage%3D485%26epage%3D493%26doi%3D10.1007%2Fs00213-005-0127-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/0304-3959(88)90209-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+peripheral+mononeuropathy+in+rat+that+produces+disorders+of+pain+sensation+like+those+seen+in+man&doi=10.1016%2F0304-3959%2888%2990209-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62aR"><div class="casContent"><span class="casTitleNuber">62a</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett Gary J; Xie Y-K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eZM2R2Dn7tiZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520peripheral%2520mononeuropathy%2520in%2520rat%2520that%2520produces%2520disorders%2520of%2520pain%2520sensation%2520like%2520those%2520seen%2520in%2520man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107%26doi%3D10.1016%2F0304-3959%2888%2990209-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogrel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaksh, T. L.</span><span> </span><span class="NLM_article-title">Quantitative assessment of tactile allodynia in the rat paw</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62bR"><div class="casContent"><span class="casTitleNuber">62b</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eZM2R2Dn7tiZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520assessment%2520of%2520tactile%2520allodynia%2520in%2520the%2520rat%2520paw%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Caspani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span> </span><span class="NLM_article-title">Tramadol reduced anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1016/j.pbb.2014.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pbb.2014.06.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=290-296&author=O.+Caspaniauthor=M.+C.+Reitzauthor=A.+Ceciauthor=A.+Kremerauthor=R.+D.+Treede&title=Tramadol+reduced+anxiety-related+and+depression-associated+behaviors+presumably+induced+by+pain+in+the+chronic+constriction+injury+model+of+neuropathic+pain+in+rats&doi=10.1016%2Fj.pbb.2014.06.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2014.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2014.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DCaspani%26aufirst%3DO.%26aulast%3DReitz%26aufirst%3DM.%2BC.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26atitle%3DTramadol%2520reduced%2520anxiety-related%2520and%2520depression-associated%2520behaviors%2520presumably%2520induced%2520by%2520pain%2520in%2520the%2520chronic%2520constriction%2520injury%2520model%2520of%2520neuropathic%2520pain%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2014%26volume%3D124%26spage%3D290%26epage%3D296%26doi%3D10.1016%2Fj.pbb.2014.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Chou, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czobor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charles, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuma, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winsberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volavka, J.</span><span> </span><span class="NLM_article-title">Acute mania: haloperidol dose and augmentation with lithium or lorazepam</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span><span class="refDoi"> DOI: 10.1097/00004714-199912000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1097%2F00004714-199912000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10587284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK1MXotVertbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=500-505&author=J.+C.+Chouauthor=P.+Czoborauthor=O.+Charlesauthor=I.+Tumaauthor=B.+Winsbergauthor=M.+H.+Allenauthor=M.+Trujilloauthor=J.+Volavka&title=Acute+mania%3A+haloperidol+dose+and+augmentation+with+lithium+or+lorazepam&doi=10.1097%2F00004714-199912000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Acute mania: haloperidol dose and augmentation with lithium or lorazepam</span></div><div class="casAuthors">Chou, James C.-Y.; Czobor, Pal; Charles, Owen; Tuma, Ivan; Winsberg, Bertrand; Allen, Michael H.; Trujillo, Manuel; Volavka, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">500-505</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Antipsychotic dosing for acute mania has not been well studied.  Combined treatment with lithium and an antipsychotic is the most common treatment, but addnl. antimanic efficacy of a lithium-antipsychotic combination beyond that of an antipsychotic alone has not been well demonstrated.  Furthermore, the possibility that lithium could affect antipsychotic dose requirement is believed to have never been studied.  In this study, 63 acutely psychotic bipolar manic inpatients were randomly assigned to receive double-blind treatment with 1 or 2 haloperidol doses, 25 mg/day or 5 mg/day, for 21 days.  In addn. to haloperidol, subjects were randomly assigned to receive concomitant treatment with placebo, std. lithium, or lorazepam 4 mg/day.  The high haloperidol dose produced greater improvement and more side effects than did the low dose.  Lithium added to the low dose produced a markedly greater clin. response than did the low dose alone.  Lorazepam did not improve the outcome for the patients receiving low-dose haloperidol.  The clin. response produced by high-dose haloperidol was not enhanced by adding either lithium or lorazepam.  All treatment effects emerged by the fourth day of treatment and persisted.  Used alone, a haloperidol dose of 5 mg/day is too low for most manic patients, but concomitant lithium produces a dose-dependent enhancement of haloperidol response.  Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdrupkYRajCLVg90H21EOLACvtfcHk0ljQDRaKxV_3Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVertbY%253D&md5=067de789f28fce3bd389993eae0ed7f1</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1097%2F00004714-199912000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199912000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DJ.%2BC.%26aulast%3DCzobor%26aufirst%3DP.%26aulast%3DCharles%26aufirst%3DO.%26aulast%3DTuma%26aufirst%3DI.%26aulast%3DWinsberg%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DM.%2BH.%26aulast%3DTrujillo%26aufirst%3DM.%26aulast%3DVolavka%26aufirst%3DJ.%26atitle%3DAcute%2520mania%253A%2520haloperidol%2520dose%2520and%2520augmentation%2520with%2520lithium%2520or%2520lorazepam%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1999%26volume%3D19%26spage%3D500%26epage%3D505%26doi%3D10.1097%2F00004714-199912000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Kiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daskalakis, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=12921224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BD3szosVOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=293-299&author=M.+Kiangauthor=Z.+J.+Daskalakisauthor=B.+K.+Christensenauthor=G.+Remingtonauthor=S.+Kapur&title=Actigraphic+measurement+of+the+effects+of+single-dose+haloperidol+and+olanzapine+on+spontaneous+motor+activity+in+normal+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects</span></div><div class="casAuthors">Kiang Michael; Daskalakis Z Jeff; Christensen Bruce K; Remington Gary; Kapur Shitij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-9</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">OBJECTIVE:  To quantitatively examine the effects of haloperidol and olanzapine on spontaneous motor activity in normal subjects.  DESIGN:  Randomized, double-blind, placebo-controlled medication study.  PARTICIPANTS:  Normal volunteers (n = 30).  INTERVENTIONS:  Subjects received 1 dose of either haloperidol 2 mg (n = 9), olanzapine 10 mg (n = 10) or placebo (n = 10) and were admitted to hospital for the next 24 hours.  OUTCOME MEASURES:  Subjects wore an actigraphic monitor, which recorded movement in 15-second epochs.  The Simpson-Angus Extrapyramidal Side Effect Scale (SAS) and the Barnes Akathisia Scale (BAS) were administered before and 7 and 24 hours after medication was given.  RESULTS:  Compared with placebo, total motor activity was decreased by 41% with olanzapine (p = 0.004) and by 12% with haloperidol (NS).  There were significantly more epochs with zero movement with olanzapine than with haloperidol or placebo.  For non-zero epochs, the mean activity count and the distribution of activity counts did not differ significantly among groups.  There were no positive findings on the SAS or the BAS.  CONCLUSIONS:  Olanzapine decreased total motor activity by increasing the amount of time during which subjects were immobile, rather than by affecting the magnitude of movement during periods in which there was activity.  This effect occurred at a dose of olanzapine low enough not to cause clinically observed extrapyramidal side effects.  Our results suggest that actigraphy is useful as a sensitive, noninvasive tool for measuring the effect of antipsychotics on spontaneous motor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnV369ou3mIjC850By6mxpfW6udTcc2eYqwkrQA33nf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szosVOnsw%253D%253D&md5=90c78e6941be51b1dc4fb434b9638d93</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiang%26aufirst%3DM.%26aulast%3DDaskalakis%26aufirst%3DZ.%2BJ.%26aulast%3DChristensen%26aufirst%3DB.%2BK.%26aulast%3DRemington%26aufirst%3DG.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DActigraphic%2520measurement%2520of%2520the%2520effects%2520of%2520single-dose%2520haloperidol%2520and%2520olanzapine%2520on%2520spontaneous%2520motor%2520activity%2520in%2520normal%2520subjects%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2003%26volume%3D28%26spage%3D293%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><div class="note"><p class="first last">(SHELXTL versions 6.12 and 6.14)</p></div><span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lj8sO4Cx9FMCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0lj8sO4Cx9FMCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Diáz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrech, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet-Buchholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerón-Bertran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinoso, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández de Henestrosa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective σ<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3656</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span><span class="refDoi"> DOI: 10.1021/jm400181k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400181k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3656-3665&author=J.+L.+Di%C3%A1zauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=M.+Luengoauthor=M.+Bordasauthor=R.+Enrechauthor=M.+Carroauthor=R.+Pascualauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+Benet-Buchholzauthor=J.+Cer%C3%B3n-Bertranauthor=J.+Ram%C3%ADrezauthor=R.+F.+Reinosoauthor=A.+R.+Fern%C3%A1ndez+de+Henestrosaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+a+new+series+of+hexahydro-2H-pyrano%5B3%2C2-c%5Dquinolines+as+novel+selective+%CF%831+receptor+ligands&doi=10.1021%2Fjm400181k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm400181k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400181k%26sid%3Dliteratum%253Aachs%26aulast%3DDi%25C3%25A1z%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DLuengo%26aufirst%3DM.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DEnrech%26aufirst%3DR.%26aulast%3DCarro%26aufirst%3DM.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBenet-Buchholz%26aufirst%3DJ.%26aulast%3DCer%25C3%25B3n-Bertran%26aufirst%3DJ.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DFern%25C3%25A1ndez%2Bde%2BHenestrosa%26aufirst%3DA.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520hexahydro-2H-pyrano%255B3%252C2-c%255Dquinolines%2520as%2520novel%2520selective%2520%25CF%25831%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3656%26epage%3D3665%26doi%3D10.1021%2Fjm400181k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b','cit29c'],'ref30':['cit30a','cit30b','cit30c'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51a','cit51b'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55a','cit55b','cit55c'],'ref56':['cit56a','cit56b'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59a','cit59b'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62a','cit62b'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Youyi Peng, Qiang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">William J. Welsh</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 890-904. <a href="https://doi.org/10.1021/acs.jmedchem.0c01964" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01964%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSigma%252B1%252BReceptor%252BAntagonists%252Bas%252BPotential%252BTherapeutics%252Bfor%252BPain%252BManagement%26aulast%3DPeng%26aufirst%3DYouyi%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D12112020%26date%3D29122020%26volume%3D64%26issue%3D1%26spage%3D890%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A. Wold, Jia Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xue-Chu Zhen</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15187-15217. <a href="https://doi.org/10.1021/acs.jmedchem.0c01192" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01192%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecules%252BSelectively%252BTargeting%252BSigma-1%252BReceptor%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurological%252BDiseases%26aulast%3DYe%26aufirst%3DNa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09072020%26date%3D28102020%26volume%3D63%26issue%3D24%26spage%3D15187%26epage%3D15217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Youyi Peng, Hiep Dong, <span class="NLM_string-name hlFld-ContribAuthor">William J. Welsh</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 486-497. <a href="https://doi.org/10.1021/acs.jcim.8b00521" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00521%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComprehensive%252B3D-QSAR%252BModel%252BPredicts%252BBinding%252BAffinity%252Bof%252BStructurally%252BDiverse%252BSigma%252B1%252BReceptor%252BLigands%26aulast%3DPeng%26aufirst%3DYouyi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01082018%26date%3D14122018%26date%3D29112018%26volume%3D59%26issue%3D1%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Guisen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10017-10039. <a href="https://doi.org/10.1021/acs.jmedchem.8b01096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFused%252BTricyclic%252BHeterocycle%252BPiperazine%252B%252528Piperidine%252529%252BDerivatives%252BAs%252BPotential%252BMultireceptor%252BAtypical%252BAntipsychotics%26aulast%3DCao%26aufirst%3DXudong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D09112018%26date%3D01112018%26volume%3D61%26issue%3D22%26spage%3D10017%26epage%3D10039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zhuang</span>, <span class="hlFld-ContribAuthor ">Jiaying  Xiong</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Hao</span>, <span class="hlFld-ContribAuthor ">Wei  Du</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Bifeng  Liu</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced side effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113658. <a href="https://doi.org/10.1016/j.ejmech.2021.113658" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113658%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252B%2525CE%2525BC%252Bopioid%252Band%252B%2525CF%2525831%252Breceptor%252Bligands%252Bas%252Bnovel%252Banalgesics%252Bwith%252Breduced%252Bside%252Beffects%26aulast%3DZhuang%26aufirst%3DTao%26date%3D2021%26volume%3D223%26spage%3D113658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Besada</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Tamara  Costas</span>, <span class="hlFld-ContribAuthor ">María  Carmen Costas-Lago</span>, <span class="hlFld-ContribAuthor ">Noemí  Vila</span>, <span class="hlFld-ContribAuthor ">Iria  Torres-Terán</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Carmen  Terán</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>17 </em>, 105203. <a href="https://doi.org/10.1016/j.bioorg.2021.105203" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105203%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPyridazinones%252Bcontaining%252Bdithiocarbamoyl%252Bmoieties%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bselective%252BMAO-B%252Binhibitors%26aulast%3DBesada%26aufirst%3DPedro%26date%3D2021%26volume%3D17%26spage%3D105203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hebaalla  Agha</span>, <span class="hlFld-ContribAuthor ">Christopher R.  McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro
              and
              in vivo
              sigma 1 receptor imaging studies in different disease states. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 154-177. <a href="https://doi.org/10.1039/D0MD00186D" title="DOI URL">https://doi.org/10.1039/D0MD00186D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00186D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00186D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bvivo%252Bsigma%252B1%252Breceptor%252Bimaging%252Bstudies%252Bin%252Bdifferent%252Bdisease%252Bstates%26aulast%3DAgha%26aufirst%3DHebaalla%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D2%26spage%3D154%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol  Biernacki</span>, <span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Olga  Ciupak</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (6)
                                     , 111. <a href="https://doi.org/10.3390/ph13060111" title="DOI URL">https://doi.org/10.3390/ph13060111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13060111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13060111%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DNovel%252B1%25252C2%25252C4-Oxadiazole%252BDerivatives%252Bin%252BDrug%252BDiscovery%26aulast%3DBiernacki%26aufirst%3DKarol%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D6%26spage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaying  Xiong</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Lanchang  Gao</span>, <span class="hlFld-ContribAuthor ">Chao  Hao</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi-Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112144. <a href="https://doi.org/10.1016/j.ejmech.2020.112144" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112144%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPiperidine%252Bpropionamide%252Bas%252Ba%252Bscaffold%252Bfor%252Bpotent%252Bsigma-1%252Breceptor%252Bantagonists%252Band%252Bmu%252Bopioid%252Breceptor%252Bagonists%252Bfor%252Btreating%252Bneuropathic%252Bpain%26aulast%3DXiong%26aufirst%3DJiaying%26date%3D2020%26volume%3D191%26spage%3D112144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Ramesh  Neelamegam</span>, <span class="hlFld-ContribAuthor ">Michael S.  Placzek</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Fiedler</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Gengyang  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiying  Qu</span>, <span class="hlFld-ContribAuthor ">Hayden R.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jinchun  Song</span>, <span class="hlFld-ContribAuthor ">Marc D.  Normandin</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (6)
                                     , 1204-1215. <a href="https://doi.org/10.1016/j.apsb.2019.07.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DNovel%252Bradioligands%252Bfor%252Bimaging%252Bsigma-1%252Breceptor%252Bin%252Bbrain%252Busing%252Bpositron%252Bemission%252Btomography%252B%252528PET%252529%26aulast%3DLan%26aufirst%3DYu%26date%3D2019%26volume%3D9%26issue%3D6%26spage%3D1204%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanfei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhao  Chen</span>, <span class="hlFld-ContribAuthor ">Libin  Yang</span>, <span class="hlFld-ContribAuthor ">Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental determination and thermodynamic modeling of solid–liquid-phase equilibrium for the 3-nitrotoluene and 4-nitrotoluene binary system. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thermal Analysis and Calorimetry</span><span> <strong>2019,</strong> <em>138 </em>
                                    (2)
                                     , 1251-1257. <a href="https://doi.org/10.1007/s10973-019-08356-9" title="DOI URL">https://doi.org/10.1007/s10973-019-08356-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10973-019-08356-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10973-019-08356-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thermal%2520Analysis%2520and%2520Calorimetry%26atitle%3DExperimental%252Bdetermination%252Band%252Bthermodynamic%252Bmodeling%252Bof%252Bsolid%2525E2%252580%252593liquid-phase%252Bequilibrium%252Bfor%252Bthe%252B3-nitrotoluene%252Band%252B4-nitrotoluene%252Bbinary%252Bsystem%26aulast%3DWang%26aufirst%3DYanfei%26date%3D2019%26date%3D2019%26volume%3D138%26issue%3D2%26spage%3D1251%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Yin  Fang</span>, <span class="hlFld-ContribAuthor ">L.  Ravindar</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">H.M.  Manukumar</span>, <span class="hlFld-ContribAuthor ">C.S.  Shantharam</span>, <span class="hlFld-ContribAuthor ">Njud S.  Alharbi</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 117-153. <a href="https://doi.org/10.1016/j.ejmech.2019.03.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Band%252Bpharmaceutical%252Bapplications%252Bof%252Bchloro-containing%252Bmolecules%252Bfor%252Bdrug%252Bdiscovery%25253A%252BA%252Bcritical%252Breview%26aulast%3DFang%26aufirst%3DWan-Yin%26date%3D2019%26volume%3D173%26spage%3D117%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zahra  Bahari</span>, <span class="hlFld-ContribAuthor ">Gholam Hossein  Meftahi</span>. </span><span class="cited-content_cbyCitation_article-title">Spinal α
              2
              ‐adrenoceptors and neuropathic pain modulation; therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (14)
                                     , 2366-2381. <a href="https://doi.org/10.1111/bph.14580" title="DOI URL">https://doi.org/10.1111/bph.14580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14580%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DSpinal%252B%2525CE%2525B1%252B2%252B%2525E2%252580%252590adrenoceptors%252Band%252Bneuropathic%252Bpain%252Bmodulation%25253B%252Btherapeutic%252Btarget%26aulast%3DBahari%26aufirst%3DZahra%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D14%26spage%3D2366%26epage%3D2381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Yao</span>, <span class="hlFld-ContribAuthor ">Fei  Dou</span>, <span class="hlFld-ContribAuthor ">Yifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinli  Qiu</span>, <span class="hlFld-ContribAuthor ">Song  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi‐Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Sigma‐1 (σ
              1
              ) Receptor Ligands Based on Phenyl‐1,2,4‐oxadiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , e1800599. <a href="https://doi.org/10.1002/cbdv.201800599" title="DOI URL">https://doi.org/10.1002/cbdv.201800599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800599%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BSigma%2525E2%252580%2525901%252B%252528%2525CF%252583%252B1%252B%252529%252BReceptor%252BLigands%252BBased%252Bon%252BPhenyl%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590oxadiazole%252BDerivatives%26aulast%3DCao%26aufirst%3DXudong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D3%26spage%3De1800599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  Elissawy</span>, <span class="hlFld-ContribAuthor ">Sherif S.  Ebada</span>, <span class="hlFld-ContribAuthor ">Mohamed L.  Ashour</span>, <span class="hlFld-ContribAuthor ">Mona  El-Neketi</span>, <span class="hlFld-ContribAuthor ">Weaam  Ebrahim</span>, <span class="hlFld-ContribAuthor ">AbdelNasser B.  Singab</span>. </span><span class="cited-content_cbyCitation_article-title">New secondary metabolites from the mangrove-derived fungus Aspergillus sp. AV-2. </span><span class="cited-content_cbyCitation_journal-name">Phytochemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>, 1-5. <a href="https://doi.org/10.1016/j.phytol.2018.10.014" title="DOI URL">https://doi.org/10.1016/j.phytol.2018.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phytol.2018.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phytol.2018.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytochemistry%2520Letters%26atitle%3DNew%252Bsecondary%252Bmetabolites%252Bfrom%252Bthe%252Bmangrove-derived%252Bfungus%252BAspergillus%252Bsp.%252BAV-2%26aulast%3DElissawy%26aufirst%3DAhmed%2BM.%26date%3D2019%26volume%3D29%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bowen  Xu</span>, <span class="hlFld-ContribAuthor ">Jianwei  Han</span>, <span class="hlFld-ContribAuthor ">Limin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Metal- and Base-Free Direct N-Arylation of Pyridazinones by Using Diaryliodonium Salts: An Anion Effect. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (8)
                                     , 1674-1680. <a href="https://doi.org/10.1002/ajoc.201800268" title="DOI URL">https://doi.org/10.1002/ajoc.201800268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201800268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201800268%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-%252Band%252BBase-Free%252BDirect%252BN-Arylation%252Bof%252BPyridazinones%252Bby%252BUsing%252BDiaryliodonium%252BSalts%25253A%252BAn%252BAnion%252BEffect%26aulast%3DXu%26aufirst%3DBowen%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D8%26spage%3D1674%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic journey of pyridazinone. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 256-281. <a href="https://doi.org/10.1016/j.ejmech.2016.07.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Btherapeutic%252Bjourney%252Bof%252Bpyridazinone%26aulast%3DAkhtar%26aufirst%3DWasim%26date%3D2016%26volume%3D123%26spage%3D256%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Yifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinli  Qiu</span>, <span class="hlFld-ContribAuthor ">Minquan  Yu</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi-Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor-targeting atypical antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 713-728. <a href="https://doi.org/10.1016/j.ejmech.2016.09.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B6-hydroxypyridazinone%252Bbenzisoxazoles%25253A%252BPotential%252Bmulti-receptor-targeting%252Batypical%252Bantipsychotics%26aulast%3DCao%26aufirst%3DXudong%26date%3D2016%26volume%3D124%26spage%3D713%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative σ<sub>1</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Glennon’s pharmacophoric σ<sub>1</sub> receptor model (A) and general structure of the new pyridazinone derivative (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of new pyridazinone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) H<sub>2</sub>O, conc HCl, reflux; (II) Br(CH<sub>2</sub>)<sub><i>n</i>+1</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) HNRR, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux; (IV) K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) H<sub>2</sub>O, conc HCl, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux; (IV) 4-methylpiperidine, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux; (V) K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) H<sub>2</sub>O, conc HCl, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. ORTEP showing the molecular structure of the hydrochloride salt of <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antiallodynic effect of <b>2</b> and compound <b>54</b> in phase II (15–45 min) of the mice formalin test. Each column and vertical line represent the mean ± SEM of the values obtained in at least 10 animals. Statistically significant differences are the following: (#) <i>p</i> < 0.05, (##) <i>p</i> < 0.01 vs vehicle; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle + formalin (two-way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antiallodynic effects of compound <b>54</b> on the expression of neuropathic pain in CCI and sham operated rats. Data are obtained from 10 rats per group and expressed as the mean ± SEM pressure threshold evoking paw withdrawal or latency to paw withdrawal. Statistically significant differences between the rats before surgery (basal) and surgery groups are the following: (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs basal; (#) <i>p</i> < 0.05; (##) <i>p</i> < 0.01 vs vehicle treatment on days 14, 15, and 18 (two-way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/medium/jm-2015-014166_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response effect of compounds <b>54</b> and <b>2</b> on motor coordination (rotarod test). Data are obtained from 8–10 mice per group and expressed as the mean ± SEM latency to fall down from rod. Statistically significant differences are the following: (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle (two-way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01416/20160414/images/large/jm-2015-014166_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01416&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i127">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jongen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzon, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huygen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartrick, C. T.</span><span> </span><span class="NLM_article-title">Neuropathic pain and pharmacological treatment</span> <span class="citation_source-journal">Pain. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1111/papr.12085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1111%2Fpapr.12085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=23750502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=283-295&author=J.+L.+Jongenauthor=G.+Hansauthor=H.+T.+Benzonauthor=F.+Huygenauthor=C.+T.+Hartrick&title=Neuropathic+pain+and+pharmacological+treatment&doi=10.1111%2Fpapr.12085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain and pharmacological treatment</span></div><div class="casAuthors">Jongen Joost L M; Hans Guy; Benzon Honorio T; Huygen Frank; Hartrick Craig T</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is a serious chronic condition strongly affecting quality of life, which can be relieved but cannot be cured.  Apart from symptomatic management, treatment should focus on the underlying disorder.  The estimated prevalence is at least 1% to 5% of the general population.  Neuropathic pain is characterized both by spontaneous and evoked pain.  A diagnosis of neuropathic pain can usually be established based solely on history and neurological examination.  Ancillary investigations may include EMG and computerized tomography/magnetic resonance imaging scans, depending on the localization of the suspected lesion.  A limited number of agents, primarily directed at symptom control, are currently approved for use in neuropathic pain.  A mechanism-based approach to pharmacological intervention supports the use of polypharmacy in neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCgdyy7ehY67qxQ2mb9Pu8fW6udTcc2eZpVl8ip28cJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D&md5=66f491a169f5c3b2fe5b6078346d31da</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fpapr.12085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpapr.12085%26sid%3Dliteratum%253Aachs%26aulast%3DJongen%26aufirst%3DJ.%2BL.%26aulast%3DHans%26aufirst%3DG.%26aulast%3DBenzon%26aufirst%3DH.%2BT.%26aulast%3DHuygen%26aufirst%3DF.%26aulast%3DHartrick%26aufirst%3DC.%2BT.%26atitle%3DNeuropathic%2520pain%2520and%2520pharmacological%2520treatment%26jtitle%3DPain.%2520Pract.%26date%3D2014%26volume%3D14%26spage%3D283%26epage%3D295%26doi%3D10.1111%2Fpapr.12085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">van Hecke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, N.</span><span> </span><span class="NLM_article-title">Neuropathic pain in the general population: a systematic review of epidemiological studies</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pain.2013.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24291734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC2c3itVOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=654-662&author=O.+van+Heckeauthor=S.+K.+Austinauthor=R.+A.+Khanauthor=B.+H.+Smithauthor=N.+Torrance&title=Neuropathic+pain+in+the+general+population%3A+a+systematic+review+of+epidemiological+studies&doi=10.1016%2Fj.pain.2013.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain in the general population: a systematic review of epidemiological studies</span></div><div class="casAuthors">van Hecke O; Austin Sophie K; Khan Rafi A; Smith B H; Torrance N</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">654-662</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Most patients with neuropathic pain symptoms present and are managed in primary care, with only a minority being referred for specialist clinical assessment and diagnoses.  Previous reviews have focused mainly on specific neuropathic pain conditions based in specialist settings.  This is the first systematic review of epidemiological studies of neuropathic pain in the general population.  Electronic databases were searched from January 1966 to December 2012, and studies were included where the main focus was on neuropathic pain prevalence and/or incidence, either as part of a specific neuropathic pain-related condition or as a global entity in the general population.  We excluded studies in which data were extracted from pain or other specialist clinics or focusing on specific population subgroups.  Twenty-one articles were identified and underwent quality assessment and data extraction.  Included studies differed in 3 main ways: method of data retrieval, case ascertainment tool used, and presentation of prevalence/incidence rates.  This heterogeneity precluded any meta-analysis.  We categorised comparable incidence and prevalence rates into 2 main subgroups: (1) chronic pain with neuropathic characteristics (range 3-17%), and (2) neuropathic pain associated with a specific condition, including postherpetic neuralgia (3.9-42.0/100,000 person-years [PY]), trigeminal neuralgia (12.6-28.9/100,000 PY), painful diabetic peripheral neuropathy (15.3-72.3/100,000 PY), glossopharyngeal neuralgia (0.2-0.4/100,000 PY).  These differences highlight the importance of a standardised approach for identifying neuropathic pain in future epidemiological studies.  A best estimate of population prevalence of pain with neuropathic characteristics is likely to lie between 6.9% and 10%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcdtpdgNQC5D69zv1FsJFMfW6udTcc2eZpVl8ip28cJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3itVOguw%253D%253D&md5=6d7456ae9aedd996fac515a1c683c83a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.11.013%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHecke%26aufirst%3DO.%26aulast%3DAustin%26aufirst%3DS.%2BK.%26aulast%3DKhan%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DTorrance%26aufirst%3DN.%26atitle%3DNeuropathic%2520pain%2520in%2520the%2520general%2520population%253A%2520a%2520systematic%2520review%2520of%2520epidemiological%2520studies%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D654%26epage%3D662%26doi%3D10.1016%2Fj.pain.2013.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A. H.</span><span> </span><span class="NLM_article-title">Emerging drugs for neuropathic pain</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1517/14728214.2014.915025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F14728214.2014.915025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24793304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=329-341&author=I.+Gilronauthor=A.+H.+Dickenson&title=Emerging+drugs+for+neuropathic+pain&doi=10.1517%2F14728214.2014.915025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs for neuropathic pain</span></div><div class="casAuthors">Gilron, Ian; Dickenson, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-341</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Neuropathic pain is a costly and disabling condition, which affects up to 8% of the population.  Available therapies often provide incomplete pain relief and treatment-related side effects are common.  Preclin. neuropathic pain models have facilitated identification of several promising targets, which have progressed to human clin. phases of evaluation.  Areas covered: A systematic database search yielded 25 new mol. entities with specified pharmacol. mechanisms that have reached Phase II or III clin. trials.  These include calcium channel antagonists, vanilloid receptor antagonists, potassium channel agonists, NMDA antagonists, novel opioid receptor agonists, histamine H3 receptor antagonists, a novel sodium channel antagonist, serotonin modulators, a novel acetylcholine receptor agonist, α-2b adrenoreceptor agonist, cannabinoid CB2 receptor agonist, nitric oxide synthase inhibitor, orexin receptor antagonist, angiotensin II 2 antagonist, imidazoline I2 receptor agonist, apoptosis inhibitor and fatty acid amide hydrolase inhibitor.  Expert opinion: Although the diversity of pharmacol. mechanisms of interest emphasize the complexity of neuropathic pain transmission, the considerable no. of agents under development reflect a continued enthusiasm in drug development for neuropathic pain.  Ongoing enhancements in methodol. of both preclin. and clin. research and closer translation in both directions are expected to more efficiently identify new agents, which will improve the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJawa4UZNs67Vg90H21EOLACvtfcHk0lj28wlPdP2yeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjtb3J&md5=b2f98de7e03fb2835986a1b232ab7000</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728214.2014.915025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2014.915025%26sid%3Dliteratum%253Aachs%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26atitle%3DEmerging%2520drugs%2520for%2520neuropathic%2520pain%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2014%26volume%3D19%26spage%3D329%26epage%3D341%26doi%3D10.1517%2F14728214.2014.915025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahana, A.</span><span> </span><span class="NLM_article-title">Treatment of chronic non-cancer pain</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">2226</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60402-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2FS0140-6736%2811%2960402-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=21704872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=2226-2235&author=D.+C.+Turkauthor=H.+D.+Wilsonauthor=A.+Cahana&title=Treatment+of+chronic+non-cancer+pain&doi=10.1016%2FS0140-6736%2811%2960402-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of chronic non-cancer pain</span></div><div class="casAuthors">Turk, Dennis C.; Wilson, Hilary D.; Cahana, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">9784</span>),
    <span class="NLM_cas:pages">2226-2235</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Chronic pain is a pervasive problem that affects the patient, their significant others, and society in many ways.  The past decade has seen advances in our understanding of the mechanisms underlying pain and in the availability of tech. advanced diagnostic procedures; however, the most notable therapeutic changes have not been the development of novel evidenced-based methods, but rather changing trends in applications and practices within the available clin. armamentarium.  We provide a general overview of empirical evidence for the most commonly used interventions in the management of chronic non-cancer pain, including pharmacol., interventional, phys., psychol., rehabilitative, and alternative modalities.  Overall, currently available treatments provide modest improvements in pain and min. improvements in phys. and emotional functioning.  The quality of evidence is mediocre and has not improved substantially during the past decade.  There is a crucial need for assessment of combination treatments, identification of indicators of treatment response, and assessment of the benefit of matching of treatments to patient characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCxyG7QutTErVg90H21EOLACvtfcHk0lj28wlPdP2yeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejsbg%253D&md5=55b3b3e920ec253406736fcee3337754</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960402-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960402-9%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DH.%2BD.%26aulast%3DCahana%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520chronic%2520non-cancer%2520pain%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D2226%26epage%3D2235%26doi%3D10.1016%2FS0140-6736%2811%2960402-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kissin, I.</span><span> </span><span class="NLM_article-title">The development of new analgesics over the past 50 years: a lack of real breakthrough drugs</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1213/ANE.0b013e3181cde882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1213%2FANE.0b013e3181cde882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=20185657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFejs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=780-789&author=I.+Kissin&title=The+development+of+new+analgesics+over+the+past+50+years%3A+a+lack+of+real+breakthrough+drugs&doi=10.1213%2FANE.0b013e3181cde882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The Development of New Analgesics Over the Past 50 Years: A Lack of Real Breakthrough Drugs</span></div><div class="casAuthors">Kissin, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia & Analgesia (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">AACRAT</span>;
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Fifty-nine drugs identified as analgesics were introduced from 1960 to 2009 and remain in use.  Seven can be regarded as having novel mol. targets; however, only one, sumatriptan, was sufficiently effective to motivate the introduction of many similar drugs acting at the same target (triptans).  Publication productivity in the area of pain grew exponentially during this period.  Pain-related publications on morphine were dominant among other analgesics.  Very intensive research efforts directed at diverse mol. targets related to pain mechanisms produced thousands of publications, but those efforts have not yet yielded new analgesics with sufficient effectiveness to change the share of publications on opioids or nonsteroidal antiinflammatory drugs.  Morphine and aspirin, introduced for the treatment of pain more than a century ago, continue to dominate biomedical publications despite their limited effectiveness in many areas (e.g., neuropathic pain) and multiple serious adverse effects.  The present assessment reveals the lack of real breakthroughs in analgesic drug development despite intense research efforts.  Possible factors contributing to the apparent drought of novel analgesics are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsccjveSEq7Vg90H21EOLACvtfcHk0lj28wlPdP2yeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFejs70%253D&md5=a96605c8f1c3a55f84c2605f0917273b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1213%2FANE.0b013e3181cde882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252FANE.0b013e3181cde882%26sid%3Dliteratum%253Aachs%26aulast%3DKissin%26aufirst%3DI.%26atitle%3DThe%2520development%2520of%2520new%2520analgesics%2520over%2520the%2520past%252050%2520years%253A%2520a%2520lack%2520of%2520real%2520breakthrough%2520drugs%26jtitle%3DAnesth.%2520Analg.%26date%3D2010%26volume%3D110%26spage%3D780%26epage%3D789%26doi%3D10.1213%2FANE.0b013e3181cde882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burgess, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span> </span><span class="NLM_article-title">The discovery and development of analgesics: new mechanisms, new modalities</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3753</span><span class="NLM_x">–</span> <span class="NLM_lpage">3759</span><span class="refDoi"> DOI: 10.1172/JCI43195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1172%2FJCI43195" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=3753-3759&author=G.+Burgessauthor=D.+Williams&title=The+discovery+and+development+of+analgesics%3A+new+mechanisms%2C+new+modalities&doi=10.1172%2FJCI43195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1172%2FJCI43195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI43195%26sid%3Dliteratum%253Aachs%26aulast%3DBurgess%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520analgesics%253A%2520new%2520mechanisms%252C%2520new%2520modalities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2010%26volume%3D120%26spage%3D3753%26epage%3D3759%26doi%3D10.1172%2FJCI43195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Investigational sigma-1 receptor antagonists for the treatment of pain</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1048334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F13543784.2015.1048334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=883-896&author=J.+M.+Velaauthor=M.+Merlosauthor=C.+Almansa&title=Investigational+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.1517%2F13543784.2015.1048334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1048334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1048334%26sid%3Dliteratum%253Aachs%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DInvestigational%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D883%26epage%3D896%26doi%3D10.1517%2F13543784.2015.1048334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davis, M. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors and animal studies centered on pain and analgesia</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span><span class="refDoi"> DOI: 10.1517/17460441.2015.1051961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F17460441.2015.1051961" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=885-900&author=M.+P.+Davis&title=Sigma-1+receptors+and+animal+studies+centered+on+pain+and+analgesia&doi=10.1517%2F17460441.2015.1051961"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1051961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1051961%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BP.%26atitle%3DSigma-1%2520receptors%2520and%2520animal%2520studies%2520centered%2520on%2520pain%2520and%2520analgesia%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D885%26epage%3D900%26doi%3D10.1517%2F17460441.2015.1051961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backonja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnerup, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portenoy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. S.</span><span> </span><span class="NLM_article-title">Pharmacologic management of neuropathic pain: evidence-based recommendations</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1016/j.pain.2007.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pain.2007.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=17920770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=237-251&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=M.+Backonjaauthor=J.+T.+Farrarauthor=N.+B.+Finnerupauthor=T.+S.+Jensenauthor=E.+A.+Kalsoauthor=J.+D.+Loeserauthor=C.+Miaskowskiauthor=T.+J.+Nurmikkoauthor=R.+K.+Portenoyauthor=A.+S.+Riceauthor=B.+R.+Staceyauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=M.+S.+Wallace&title=Pharmacologic+management+of+neuropathic+pain%3A+evidence-based+recommendations&doi=10.1016%2Fj.pain.2007.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic management of neuropathic pain: Evidence-based recommendations</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Backonja, Miroslav; Farrar, John T.; Finnerup, Nanna B.; Jensen, Troels S.; Kalso, Eija A.; Loeser, John D.; Miaskowski, Christine; Nurmikko, Turo J.; Portenoy, Russell K.; Rice, Andrew S. C.; Stacey, Brett R.; Treede, Rolf-Detlef; Turk, Dennis C.; Wallace, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-251</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Patients with neuropathic pain (NP) are challenging to manage and evidence-based clin. recommendations for pharmacol. management are needed.  Systematic literature reviews, randomized clin. trials, and existing guidelines were evaluated at a consensus meeting.  Medications were considered for recommendation if their efficacy was supported by at least one methodol.-sound, randomized clin. trial (RCT) demonstrating superiority to placebo or a relevant comparison treatment.  Recommendations were based on the amt. and consistency of evidence, degree of efficacy, safety, and clin. experience of the authors.  Available RCTs typically evaluated chronic NP of moderate to severe intensity.  Recommended first-line treatments include certain antidepressants (i.e., tricyclic antidepressants and dual reuptake inhibitors of both serotonin and norepinephrine), calcium channel α2-δ ligands (i.e., gabapentin and pregabalin), and topical lidocaine.  Opioid analgesics and tramadol are recommended as generally second-line treatments that can be considered for first-line use in select clin. circumstances.  Other medications that would generally be used as third-line treatments but that could also be used as second-line treatments in some circumstances include certain antiepileptic and antidepressant medications, mexiletine, N-methyl-D-aspartate receptor antagonists, and topical capsaicin.  Medication selection should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary.  To date, no medications have demonstrated efficacy in lumbosacral radiculopathy, which is probably the most common type of NP.  Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examg. treatment of central NP are lacking and should be a priority for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNM2xlrhF4ZrVg90H21EOLACvtfcHk0liSdWvZjD9Beg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN&md5=dfa9749c8bb2a828419a7d0cfd62c9b4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2007.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2007.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DBackonja%26aufirst%3DM.%26aulast%3DFarrar%26aufirst%3DJ.%2BT.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26aulast%3DLoeser%26aufirst%3DJ.%2BD.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DNurmikko%26aufirst%3DT.%2BJ.%26aulast%3DPortenoy%26aufirst%3DR.%2BK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DStacey%26aufirst%3DB.%2BR.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWallace%26aufirst%3DM.%2BS.%26atitle%3DPharmacologic%2520management%2520of%2520neuropathic%2520pain%253A%2520evidence-based%2520recommendations%26jtitle%3DPain%26date%3D2007%26volume%3D132%26spage%3D237%26epage%3D251%26doi%3D10.1016%2Fj.pain.2007.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Attal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruccu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">European Federation of Neurological Societies.</span><span> </span><span class="NLM_article-title">EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1111/j.1468-1331.2010.02999.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1111%2Fj.1468-1331.2010.02999.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=20402746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC3cjls1ymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1113-1123&author=N.+Attalauthor=G.+Cruccuauthor=R.+Baronauthor=M.+Haanp%C3%A4%C3%A4author=P.+Hanssonauthor=T.+S.+Jensenauthor=T.+Nurmikkoauthor=European+Federation+of+Neurological+Societies.&title=EFNS+guidelines+on+the+pharmacological+treatment+of+neuropathic+pain%3A+2010+revision&doi=10.1111%2Fj.1468-1331.2010.02999.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision</span></div><div class="casAuthors">Attal N; Cruccu G; Baron R; Haanpaa M; Hansson P; Jensen T S; Nurmikko T</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1113-e88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVES:  This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005.  METHODS:  Studies were identified using the Cochrane Database and Medline.  Trials were classified according to the aetiological condition.  All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies.  Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting.  RESULTS:  Most large RCTs included patients with diabetic polyneuropathies and post-herpetic neuralgia, while an increasing number of smaller studies explored other conditions.  Drugs generally have similar efficacy in various conditions, except in trigeminal neuralgia, chronic radiculopathy and HIV neuropathy, with level A evidence in support of tricyclic antidepressants (TCA), pregabalin, gabapentin, tramadol and opioids (in various conditions), duloxetine, venlafaxine, topical lidocaine and capsaicin patches (in restricted conditions).  Combination therapy appears useful for TCA-gabapentin and gabapentin-opioids (level A).  CONCLUSIONS:  There are still too few large-scale comparative studies.  For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuuyCz0eaE0e-MdeMhXAHkfW6udTcc2ea2HxsFZu8aKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjls1ymsg%253D%253D&md5=13990136dfe522922579642e2c3d7b57</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2010.02999.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2010.02999.x%26sid%3Dliteratum%253Aachs%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DCruccu%26aufirst%3DG.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DNurmikko%26aufirst%3DT.%26aulast%3D%26atitle%3DEFNS%2520guidelines%2520on%2520the%2520pharmacological%2520treatment%2520of%2520neuropathic%2520pain%253A%25202010%2520revision%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2010%26volume%3D17%26spage%3D1113%26epage%3D1123%26doi%3D10.1111%2Fj.1468-1331.2010.02999.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Moulin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furlan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley-Forster, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessle, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taenzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, O. D.</span><span> </span><span class="NLM_article-title">Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society</span> <span class="citation_source-journal">Pain. Res. Manag.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1155/2014/754693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1155%2F2014%2F754693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25479151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC2Mzmt1SgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=328-335&author=D.+Moulinauthor=A.+Boulangerauthor=A.+J.+Clarkauthor=H.+Clarkeauthor=T.+Daoauthor=G.+A.+Finleyauthor=A.+Furlanauthor=I.+Gilronauthor=A.+Gordonauthor=P.+K.+Morley-Forsterauthor=B.+J.+Sessleauthor=P.+Squireauthor=J.+Stinsonauthor=P.+Taenzerauthor=A.+Vellyauthor=M.+A.+Wareauthor=E.+L.+Weinbergauthor=O.+D.+Williamson&title=Pharmacological+management+of+chronic+neuropathic+pain%3A+revised+consensus+statement+from+the+Canadian+Pain+Society&doi=10.1155%2F2014%2F754693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society</span></div><div class="casAuthors">Moulin Dwight; Boulanger Aline; Clark A J; Clarke Hance; Dao Thuan; Finley G A; Furlan Andrea; Gilron Ian; Gordon Allan; Morley-Forster Patricia K; Sessle Barry J; Squire Pamela; Stinson Jennifer; Taenzer Paul; Velly Ana; Ware Mark A; Weinberg Erica L; Williamson Owen D</div><div class="citationInfo"><span class="NLM_cas:title">Pain research & management</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">328-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians.  OBJECTIVE:  To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence-based consensus statement on its management.  METHODS:  RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013.  Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group.  Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use.  RESULTS:  Analgesic agents recommended for first-line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors.  Tramadol and controlled-release opioid analgesics are recommended as second-line treatments for moderate to severe pain.  Cannabinoids are now recommended as third-line treatments.  Recommended fourth-line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacosamide), tapentadol and botulinum toxin.  There is support for some analgesic combinations in selected NeP conditions.  CONCLUSIONS:  These guidelines provide an updated, stepwise approach to the pharmacological management of NeP.  Treatment should be individualized for each patient based on efficacy, side-effect profile and drug accessibility, including cost.  Additional studies are required to examine head-to-head comparisons among analgesics, combinations of analgesics, long-term outcomes and treatment of pediatric, geriatric and central NeP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJ0cKBpOR1j7HHuJhbyicZfW6udTcc2eZk_CsgNtEVw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mzmt1SgtA%253D%253D&md5=cb2a7af345f10b7b7b78a13c475ae024</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2014%2F754693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F754693%26sid%3Dliteratum%253Aachs%26aulast%3DMoulin%26aufirst%3DD.%26aulast%3DBoulanger%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DClarke%26aufirst%3DH.%26aulast%3DDao%26aufirst%3DT.%26aulast%3DFinley%26aufirst%3DG.%2BA.%26aulast%3DFurlan%26aufirst%3DA.%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DMorley-Forster%26aufirst%3DP.%2BK.%26aulast%3DSessle%26aufirst%3DB.%2BJ.%26aulast%3DSquire%26aufirst%3DP.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DTaenzer%26aufirst%3DP.%26aulast%3DVelly%26aufirst%3DA.%26aulast%3DWare%26aufirst%3DM.%2BA.%26aulast%3DWeinberg%26aufirst%3DE.%2BL.%26aulast%3DWilliamson%26aufirst%3DO.%2BD.%26atitle%3DPharmacological%2520management%2520of%2520chronic%2520neuropathic%2520pain%253A%2520revised%2520consensus%2520statement%2520from%2520the%2520Canadian%2520Pain%2520Society%26jtitle%3DPain.%2520Res.%2520Manag.%26date%3D2014%26volume%3D19%26spage%3D328%26epage%3D335%26doi%3D10.1155%2F2014%2F754693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cohen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span> </span><span class="NLM_article-title">Neuropathic pain: mechanisms and their clinical implications</span> <span class="citation_source-journal">BMJ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">f7656</span><span class="refDoi"> DOI: 10.1136/bmj.f7656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1136%2Fbmj.f7656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=f7656&author=S.+P.+Cohenauthor=J.+Mao&title=Neuropathic+pain%3A+mechanisms+and+their+clinical+implications&doi=10.1136%2Fbmj.f7656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f7656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f7656%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BP.%26aulast%3DMao%26aufirst%3DJ.%26atitle%3DNeuropathic%2520pain%253A%2520mechanisms%2520and%2520their%2520clinical%2520implications%26jtitle%3DBMJ.%26date%3D2014%26volume%3D348%26spage%3Df7656%26doi%3D10.1136%2Fbmj.f7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourlay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walco, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span> </span><span class="NLM_article-title">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">s3</span><span class="NLM_x">–</span> <span class="NLM_lpage">s14</span><span class="refDoi"> DOI: 10.4065/mcp.2009.0649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.4065%2Fmcp.2009.0649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=20194146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=s3-s14&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=J.+Audetteauthor=R.+Baronauthor=G.+K.+Gourlayauthor=M.+L.+Haanp%C3%A4%C3%A4author=J.+L.+Kentauthor=E.+J.+Kraneauthor=A.+A.+Lebelauthor=R.+M.+Levyauthor=S.+C.+Mackeyauthor=J.+Mayerauthor=C.+Miaskowskiauthor=S.+N.+Rajaauthor=A.+S.+Riceauthor=K.+E.+Schmaderauthor=B.+Staceyauthor=S.+Stanosauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=G.+A.+Walcoauthor=C.+D.+Wells&title=Recommendations+for+the+pharmacological+management+of+neuropathic+pain%3A+an+overview+and+literature+update&doi=10.4065%2Fmcp.2009.0649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C.; Walco, Gary A.; Wells, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S3-S14</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Dowden Health Media, Inc.</span>)
        </div><div class="casAbstract">A review.  The Neuropathic Pain Special Interest Group of the International Assocn. for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacol. treatment of neuropathic pain.  Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (le, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clin. trials.  Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clin. circumstances.  Results of several recent clin. trials have become available since the development of these guidelines.  These studies have examd. botulinum toxin, high-concn. capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions.  The increasing no. of neg. clin. trials of pharmacol. treatments for neuropathic pain and ambiguities in the interpretation of these neg. trials must also be considered in developing treatment guidelines.  The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacol. management of neuropathic pain and to provide a brief overview of these recent studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_qlufOfrkLVg90H21EOLACvtfcHk0ljVG4IWEwKWyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D&md5=749b581e00c2be99ae45dbf54de0bca3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2009.0649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2009.0649%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DAudette%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGourlay%26aufirst%3DG.%2BK.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%2BL.%26aulast%3DKent%26aufirst%3DJ.%2BL.%26aulast%3DKrane%26aufirst%3DE.%2BJ.%26aulast%3DLebel%26aufirst%3DA.%2BA.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26aulast%3DMackey%26aufirst%3DS.%2BC.%26aulast%3DMayer%26aufirst%3DJ.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DSchmader%26aufirst%3DK.%2BE.%26aulast%3DStacey%26aufirst%3DB.%26aulast%3DStanos%26aufirst%3DS.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWalco%26aufirst%3DG.%2BA.%26aulast%3DWells%26aufirst%3DC.%2BD.%26atitle%3DRecommendations%2520for%2520the%2520pharmacological%2520management%2520of%2520neuropathic%2520pain%253A%2520an%2520overview%2520and%2520literature%2520update%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26spage%3Ds3%26epage%3Ds14%26doi%3D10.4065%2Fmcp.2009.0649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zukin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balster, R. L.</span><span> </span><span class="NLM_article-title">Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1016/0006-8993(84)91326-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0006-8993%2884%2991326-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=6199090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=1984&pages=174-177&author=S.+R.+Zukinauthor=K.+T.+Bradyauthor=B.+L.+Sliferauthor=R.+L.+Balster&title=Behavioral+and+biochemical+stereoselectivity+of+sigma+opiate%2FPCP+receptors&doi=10.1016%2F0006-8993%2884%2991326-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors</span></div><div class="casAuthors">Zukin, Stephen R.; Brady, Kathleen T.; Slifer, Barbara L.; Balster, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-7</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The relative potencies of (±)-ketamine [(±)-I]  [6740-88-1], (+)-I  [33643-49-1], (-)-I  [33643-46-8], (±)-N-allylnormetazocine [(±)-II]  [7313-95-3], (+)-II  [58640-82-7], (-)-II  [14198-28-8], (±)-cyclazocine [(±)-III]  [7346-09-0], (+)-III  [7313-87-3], and (-)-III  [7313-86-2] at μ opiate receptors and at σ opiate/phencyclidine (PCP)  [77-10-1] receptors were detd. in vitro in rat brain homogenates (displacement of labeled dihydromorphine  [509-60-4] and PCP for the μ and PCP receptors, resp.) and in a discriminative stimulus behavioral paradigm in rats (PCP vs. saline).  In all cases the in vitro and in vivo data were in agreement.  (+)-II and (+)-III were highly specific σ opiate/PCP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7YsmwYzvSm7Vg90H21EOLACvtfcHk0ljVG4IWEwKWyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D&md5=06d1ca0c2d406f214ea9fd43b1e9c7c6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2884%2991326-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252884%252991326-X%26sid%3Dliteratum%253Aachs%26aulast%3DZukin%26aufirst%3DS.%2BR.%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DSlifer%26aufirst%3DB.%2BL.%26aulast%3DBalster%26aufirst%3DR.%2BL.%26atitle%3DBehavioral%2520and%2520biochemical%2520stereoselectivity%2520of%2520sigma%2520opiate%252FPCP%2520receptors%26jtitle%3DBrain%2520Res.%26date%3D1984%26volume%3D294%26spage%3D174%26epage%3D177%26doi%3D10.1016%2F0006-8993%2884%2991326-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mendelsohn, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerchner, G. A.</span><span> </span><span class="NLM_article-title">Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2989489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1985&pages=597-602&author=L.+G.+Mendelsohnauthor=V.+Kalraauthor=B.+G.+Johnsonauthor=G.+A.+Kerchner&title=Sigma+opioid+receptor%3A+characterization+and+co-identity+with+the+phencyclidine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma opioid receptor:  characterization and co-identity with the phencyclidine receptor</span></div><div class="casAuthors">Mendelsohn, Laurane G.; Kalra, Vin; Johnson, Bryan G.; Kerchner, Gail A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The properties of the σ opioid receptor of rat brain cortex were characterized using the prototypic ligand 3H-labeled (+)-SKF 10,047  [58640-82-7].  Binding to this receptor was rapid, and equil. was obtained within 30 min at 37°.  Specific binding was linear with protein concn. up to 500 μg/2 mL and was dependent upon protein integrity.  Denaturation by boiling destroyed >95% of the specific binding.  A high-affinity binding site with a dissocn. const. of 150 nM and a max. binding of 2.91 pmol/mg of protein was detd. from a Scatchard plot of the binding data.  The addn. of NaCl or CaCl2 to the buffers markedly decreased binding, with CaCl2 being more potent than NaCl.  A broad pH optimum for specific binding was obsd.; max. binding was at pH 9.0.  The affinity of a no. of ligands for the site and the phencyclidine  [77-10-1] receptor were compared.  The binding (IC50) of 13 ligands to the sigma site showed a correlation of 0.86 with binding to the phencyclidine site.  Thus, the biochem. properties of the σ and phencyclidine receptors are similar, and these receptors may be one and the same site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyw4zOY5vN17Vg90H21EOLACvtfcHk0lgSdoQuwde4EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D&md5=20db7f5ed4690c03d95050799953f992</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendelsohn%26aufirst%3DL.%2BG.%26aulast%3DKalra%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26atitle%3DSigma%2520opioid%2520receptor%253A%2520characterization%2520and%2520co-identity%2520with%2520the%2520phencyclidine%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D233%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hellewell, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1016/0006-8993(90)91143-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0006-8993%2890%2991143-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2174717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=1990&pages=244-253&author=S.+B.+Hellewellauthor=W.+D.+Bowen&title=A+sigma-like+binding+site+in+rat+pheochromocytoma+%28PC12%29+cells%3A+decreased+affinity+for+%28%2B%29-benzomorphans+and+lower+molecular+weight+suggest+a+different+sigma+receptor+form+from+that+of+guinea+pig+brain&doi=10.1016%2F0006-8993%2890%2991143-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A sigma-like binding site in rat pheochromocytoma (PC12) cells:  decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain</span></div><div class="casAuthors">Hellewell, Susan B.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">527</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">244-53</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Two highly selective radiolabeled probes for sigma receptors were found to bind with high affinity and capacity to membranes from undifferentiated PC12 cells 1,3-di-o-[3H]tolylguanidine ([1H]DTG) bound with Kd = 23.7 nM and Bmax = 2025 fmol/mg protein.  The Kd and Bmax for 3H-labeled (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) were 86.3 nM and 1539 fmol/mg protein, resp.  These binding parameters were comparable to those obsd. in guinea pig brain sites exhibited high affinity for haloperidol, moderate affinity for phencyclidine (PCP), and negligible affinity for MK-801, apomorphine, and (-)-sulpiride.  These data suggest a relationship of the PC12 site to sigma receptors.  However, all (+)-opiates ((+)-benzomorphans and (+)-morphinans) tested bound with markedly lower affinity to the PC12 site compared to guinea pig brain.  These include (+)-N-allylnormetazocine ((+)-SKF 10,047), (+)-pentazocine, and dextrallorphan.  In fact, PC12 sites exhibited preference for (-)-benzomorphans, the reverse stereoselectivity of guinea pig brain sites.  Binding of 3H-labeled N-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP) could not be detected, demonstrating absence of PCP receptors on this cell line.  Differentiation of cells by treatment with nerve growth factor had no effect on sigma binding parameters.  Membranes from guinea pig brain and PC12 cells were photoaffinity-labeled using azido-di-o [3H]tolylguanidine.  In guinea pig brain, a polypeptide of 25 kDa was specifically labeled.  However, label was incorporated into polypeptides of 18 kDa and 21 kDa in membranes from PC12 cells.  In view of the otherwise similar binding characteristics, the marked differences in affinity for (+)-benzomorphans and mol. wt. suggest that PC12 cells contain a mol. form of sigma receptor distinct from that predominant in guinea pig brain.  This raises the possibility of multiple sigma receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSWLms51RjbVg90H21EOLACvtfcHk0lgSdoQuwde4EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D&md5=cdb78ce18d40ae20a42e7215a3cbd0a6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2890%2991143-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252890%252991143-5%26sid%3Dliteratum%253Aachs%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DA%2520sigma-like%2520binding%2520site%2520in%2520rat%2520pheochromocytoma%2520%2528PC12%2529%2520cells%253A%2520decreased%2520affinity%2520for%2520%2528%252B%2529-benzomorphans%2520and%2520lower%2520molecular%2520weight%2520suggest%2520a%2520different%2520sigma%2520receptor%2520form%2520from%2520that%2520of%2520guinea%2520pig%2520brain%26jtitle%3DBrain%2520Res.%26date%3D1990%26volume%3D527%26spage%3D244%26epage%3D253%26doi%3D10.1016%2F0006-8993%2890%2991143-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Quirion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzhak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. P.</span><span> </span><span class="NLM_article-title">A proposal for the classification of sigma binding sites</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1016/0165-6147(92)90030-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0165-6147%2892%2990030-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1315463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=85-86&author=R.+Quirionauthor=W.+D.+Bowenauthor=Y.+Itzhakauthor=J.+L.+Junienauthor=J.+M.+Musacchioauthor=R.+B.+Rothmanauthor=T.+P.+Suauthor=S.+W.+Tamauthor=D.+P.+Taylor&title=A+proposal+for+the+classification+of+sigma+binding+sites&doi=10.1016%2F0165-6147%2892%2990030-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A proposal for the classification of sigma binding sites</span></div><div class="casAuthors">Quirion R; Bowen W D; Itzhak Y; Junien J L; Musacchio J M; Rothman R B; Su T P; Tam S W; Taylor D P</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">85-6</span>
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9QiJWG_oOy3p3bfzSLaX5fW6udTcc2ebDgrx7nIW3ULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D&md5=bdbde1d04c3c3e627e4ff512102ddf5d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2892%2990030-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252892%252990030-A%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DItzhak%26aufirst%3DY.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DMusacchio%26aufirst%3DJ.%2BM.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26atitle%3DA%2520proposal%2520for%2520the%2520classification%2520of%2520sigma%2520binding%2520sites%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1992%26volume%3D13%26spage%3D85%26epage%3D86%26doi%3D10.1016%2F0165-6147%2892%2990030-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">The pharmacology of sigma-1 receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2009.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pharmthera.2009.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=19619582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGktLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=195-206&author=T.+Mauriceauthor=T.+P.+Su&title=The+pharmacology+of+sigma-1+receptors&doi=10.1016%2Fj.pharmthera.2009.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of sigma-1 receptors</span></div><div class="casAuthors">Maurice, Tangui; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-206</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Originally considered an enigmatic protein, the sigma-1 receptor has recently been identified as a unique ligand-regulated mol. chaperone in the endoplasmic reticulum of cells.  This discovery causes us to look back at the many proposed roles of this receptor, even before its mol. function was identified, in many diseases such as methamphetamine or cocaine addiction, amnesia, pain, depression, Alzheimer's disease, stroke, retinal neuroprotection, HIV infection, and cancer.  In this review, we examine the reports that have clearly shown an agonist-antagonist relationship regarding sigma-1 receptors in models of those diseases and also review the relatively known mechanisms of action of sigma-1 receptors in an attempt to spur the speculation of readers on how the sigma-1 receptor at the endoplasmic reticulum might relate to so many diseases.  We found that the most prominent action of sigma-1 receptors in biol. systems including cell lines, primary cultures, and animals is the regulation and modulation of voltage-regulated and ligand-gated ion channels, including Ca2+-, K+-, Na+, Cl-, and SK channels, and NMDA and IP3 receptors.  We found that the final output of the action of sigma-1 receptor agonists is to inhibit all above-mentioned voltage-gated ion channels, while they potentiate ligand-gated channels.  The inhibition or potentiation induced by agonists is blocked by sigma-1 receptor antagonists.  Other mechanisms of action of sigma-1 receptors, and to some extent those of sigma-2 receptors, were also considered.  We conclude that the sigma-1 and sigma-2 receptors represent potential fruitful targets for therapeutic developments in combating many human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4d_UAy6J4KbVg90H21EOLACvtfcHk0li4SCOD_45CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGktLnM&md5=7b5e251decc29edef42ffef1d65dd487</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2009.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2009.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DThe%2520pharmacology%2520of%2520sigma-1%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2009%26volume%3D124%26spage%3D195%26epage%3D206%26doi%3D10.1016%2Fj.pharmthera.2009.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma 1 receptor: a new therapeutic target for pain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">716</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2013.01.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+receptor%3A+a+new+therapeutic+target+for+pain&doi=10.1016%2Fj.ejphar.2013.01.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0li4SCOD_45CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520receptor%253A%2520a%2520new%2520therapeutic%2520target%2520for%2520pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2013.01.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Monnet, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title">N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1016/0014-2999(90)90186-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0014-2999%2890%2990186-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2163857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1990&pages=441-445&author=F.+P.+Monnetauthor=G.+Debonnelauthor=J.+L.+Junienauthor=C.+De+Montigny&title=N-methyl-D-aspartate-induced+neuronal+activation+is+selectively+modulated+by+sigma+receptors&doi=10.1016%2F0014-2999%2890%2990186-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors</span></div><div class="casAuthors">Monnet, Francois P.; Debonnel, Guy; Junien, Jean Louis; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-5</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of 2 high-affinity σ ligands, DTG (1,3-di(2-tolyl)guanidine) and haloperidol, on the activation of dorsal hippocampus pyramidal neurons induced by microiontophoretic application of N-methyl-D-aspartate (NMDA) were assessed electrophysiol.  Low doses of DTG (0.5-3 μg/kg, i.v.) potentiated the NMDA response.  This effect of DTG was blocked by haloperidol (10 μg/kg i.v.), but not by spiperone, a potent dopamine antagonist with low affinity for σ receptors.  Apparently, σ receptors modulate the NMDA-induced neuronal activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTAVkVDgk_ebVg90H21EOLACvtfcHk0li4SCOD_45CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D&md5=415aeb364969efa07c6149f19404209f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2890%2990186-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252890%252990186-A%26sid%3Dliteratum%253Aachs%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26aulast%3DDebonnel%26aufirst%3DG.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DN-methyl-D-aspartate-induced%2520neuronal%2520activation%2520is%2520selectively%2520modulated%2520by%2520sigma%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1990%26volume%3D179%26spage%3D441%26epage%3D445%26doi%3D10.1016%2F0014-2999%2890%2990186-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Cheng, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, P.</span><span> </span><span class="NLM_article-title">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.expneurol.2007.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.expneurol.2007.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=18035354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2008&pages=128-136&author=Z.+X.+Chengauthor=D.+M.+Lanauthor=P.+Y.+Wuauthor=Y.+H.+Zhuauthor=Y.+Dongauthor=L.+Maauthor=P.+Zheng&title=Neurosteroid+dehydroepiandrosterone+sulphate+inhibits+persistent+sodium+currents+in+rat+medial+prefrontal+cortex+via+activation+of+sigma-1+receptors&doi=10.1016%2Fj.expneurol.2007.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span></div><div class="casAuthors">Cheng, Zheng-Xiang; Lan, Dan-Mei; Wu, Pei-Ying; Zhu, Yan-Hua; Dong, Yi; Ma, Lan; Zheng, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-136</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dehydroepiandrosterone sulfate is one of the most important neurosteroids.  In the present paper, we studied the effect of dehydroepiandrosterone sulfate on persistent sodium currents and its mechanism and functional consequence with whole-cell patch clamp recording method combined with a pharmacol. approach in the rat medial prefrontal cortex slices.  The results showed that dehydroepiandrosterone sulfate inhibited the amplitude of persistent sodium currents and the inhibitory effect was significant at 0.1 μM, reached max. at 1 μM and decreased with the increase in the concns. of above 1 μM.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was canceled by the Gi protein inhibitor and the protein kinase C inhibitor, but not by the protein kinase A inhibitor.  The effect of dehydroepiandrosterone sulfate on persistent sodium currents was also canceled by the sigma-1 receptor blockers and the sigma-1 receptor agonist could mimic the effect of dehydroepiandrosterone sulfate.  Dehydroepiandrosterone sulfate had no significant influence on neuronal excitability but could significantly inhibit chem. inhibition of mitochondria-evoked increase in persistent sodium currents.  These results suggest that dehydroepiandrosterone sulfate inhibits persistent sodium currents via the activation of sigma-1 receptors-Gi protein-protein kinase C-coupled signaling pathway, and the main functional consequence of this effect of DHEAS is presumably to protect neurons under ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo69uQz-5-SLVg90H21EOLACvtfcHk0li4SCOD_45CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWis7o%253D&md5=c79ecd56505459124cca3431353b9b1e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.%2BX.%26aulast%3DLan%26aufirst%3DD.%2BM.%26aulast%3DWu%26aufirst%3DP.%2BY.%26aulast%3DZhu%26aufirst%3DY.%2BH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DNeurosteroid%2520dehydroepiandrosterone%2520sulphate%2520inhibits%2520persistent%2520sodium%2520currents%2520in%2520rat%2520medial%2520prefrontal%2520cortex%2520via%2520activation%2520of%2520sigma-1%2520receptors%26jtitle%3DExp.%2520Neurol.%26date%3D2008%26volume%3D210%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.expneurol.2007.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Aydar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyachko, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. B.</span><span> </span><span class="NLM_article-title">The sigma receptor as a ligand-regulated auxiliary potassium channel subunit</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span><span class="refDoi"> DOI: 10.1016/S0896-6273(02)00677-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2FS0896-6273%2802%2900677-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=399-410&author=E.+Aydarauthor=C.+P.+Palmerauthor=V.+A.+Klyachkoauthor=M.+B.+Jackson&title=The+sigma+receptor+as+a+ligand-regulated+auxiliary+potassium+channel+subunit&doi=10.1016%2FS0896-6273%2802%2900677-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2802%2900677-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252802%252900677-3%26sid%3Dliteratum%253Aachs%26aulast%3DAydar%26aufirst%3DE.%26aulast%3DPalmer%26aufirst%3DC.%2BP.%26aulast%3DKlyachko%26aufirst%3DV.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26atitle%3DThe%2520sigma%2520receptor%2520as%2520a%2520ligand-regulated%2520auxiliary%2520potassium%2520channel%2520subunit%26jtitle%3DNeuron%26date%3D2002%26volume%3D34%26spage%3D399%26epage%3D410%26doi%3D10.1016%2FS0896-6273%2802%2900677-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Ca<sup>2+</sup> signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca<sup>2+</sup> concentration</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10869377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2000&pages=788-798&author=T.+Hayashiauthor=T.+Mauriceauthor=T.+P.+Su&title=Ca2%2B+signaling+via+sigma%281%29-receptors%3A+novel+regulatory+mechanism+affecting+intracellular+Ca2%2B+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ signaling via σ1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration</span></div><div class="casAuthors">Hayashi, Teruo; Maurice, Tangui; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">788-798</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ1-receptor is a one-transmembrane endoplasmic reticulum protein that binds neurosteroids and dextrorotatory benzomorphans.  The roles of σ1-receptors in regulating intracellular Ca2+ in NG108 cells were examd. in this study.  σ1-Ligands pregnenolone sulfate, (+)-pentazocine, and 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride modulate Ca2+ signaling in NG 108 cells via two modes of action.  First, nanomolar concns. of the ligands, without effect by themselves, potentiated the bradykinin-induced increase of the cytosolic free Ca2+ concn. in a bell-shaped manner.  This effect of σ1-ligands was unaffected by depletion of Ca2+ from perfusion buffer and was blocked by a 21-mer antisense oligodeoxynucleotide against the cloned σ1-receptors.  Second, after the cells were depleted of the endoplasmic reticulum Ca2+ stores, the depolarization (75 mM KCl)-induced increase in cytosolic free Ca2+ was potentiated by 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride, whereas it was inhibited by pregnenolone sulfate and (+)-pentazocine.  These effects, albeit opposite in direction, were blocked by both the 21-mer antisense oligodeoxynucleotide and pertussis toxin.  Western blotting indicates that σ1-receptors are increased on the plasma membrane and the nuclear membrane in the presence of σ1-ligand.  These results suggest that Ca2+ signaling via σ1-receptors may represent a novel mechanism that affects intracellular Ca2+ concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5UrPmwIQdrVg90H21EOLACvtfcHk0lghfkXP5fuV5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D&md5=de8007846ac5a0a4292c2f501a049a7c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DCa2%252B%2520signaling%2520via%2520sigma%25281%2529-receptors%253A%2520novel%2520regulatory%2520mechanism%2520affecting%2520intracellular%2520Ca2%252B%2520concentration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D293%26spage%3D788%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sánchez-Fernández, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montilla-García, Á.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Cano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artacho-Cordón, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Pastor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span> </span><span class="NLM_article-title">Modulation of peripheral mu-opioid analgesia by σ<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1124/jpet.113.208272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1124%2Fjpet.113.208272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24155346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=32-45&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=%C3%81.+Montilla-Garc%C3%ADaauthor=R.+Gonz%C3%A1lez-Canoauthor=F.+R.+Nietoauthor=L.+Romeroauthor=A.+Artacho-Cord%C3%B3nauthor=R.+Montesauthor=B.+Fern%C3%A1ndez-Pastorauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Modulation+of+peripheral+mu-opioid+analgesia+by+%CF%831+receptors&doi=10.1124%2Fjpet.113.208272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of peripheral μ-opioid analgesia by σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Montilla-Garcia, Angeles; Gonzalez-Cano, Rafael; Nieto, Francisco Rafael; Romero, Lucia; Artacho-Cordon, Antonia; Montes, Rosa; Fernandez-Pastor, Begona; Merlos, Manuel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We evaluated the effects of σ1-receptor inhibition on μ-opioid-induced mech. antinociception and constipation. σ1-Knockout mice exhibited marked mech. antinociception in response to several μ-opioid analgesics (fentanyl, oxycodone, morphine, buprenorphine, and tramadol) at systemic (s.c.) doses that were inactive in wild-type mice and even unmasked the antinociceptive effects of the peripheral μ-opioid agonist loperamide.  Likewise, systemic (s.c.) or local (intraplantar) treatment of wild-type mice with the selective σ1 antagonists BD-1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine dihydrochloride] or S1RA [4-[2-[[5-methyl-1-(2-naphthalenyl)1H-pyrazol-3-yl]oxy]ethyl] morpholine hydrochloride] potentiated μ-opioid antinociception; these effects were fully reversed by the σ1 agonist PRE-084 [2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate) hydrochloride], showing the selectivity of the pharmacol. approach.  The μ-opioid antinociception potentiated by σ1 inhibition (by σ1-receptor knockout or σ1-pharmacol. antagonism) was more sensitive to the peripherally restricted opioid antagonist naloxone methiodide than opioid antinociception under normal conditions, indicating a key role for peripheral opioid receptors in the enhanced antinociception.  Direct interaction between the opioid drugs and σ1 receptor cannot account for our results, since the former lacked affinity for σ1 receptors (labeled with [3H](+)-pentazocine).  A peripheral role for σ1 receptors was also supported by their higher d. (Western blot results) in peripheral nervous tissue (dorsal root ganglia) than in several central areas involved in opioid antinociception (dorsal spinal cord, basolateral amygdala, periaqueductal gray, and rostroventral medulla).  In contrast to its effects on nociception, σ1-receptor inhibition did not alter fentanyl- or loperamide-induced constipation, a peripherally mediated nonanalgesic opioid effect.  Therefore, σ1-receptor inhibition may be used as a systemic or local adjuvant to enhance peripheral μ-opioid analgesia without affecting opioid-induced constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXDUF69QHTL7Vg90H21EOLACvtfcHk0lghfkXP5fuV5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D&md5=3448ecaf8c215210a48a8413b89db2a5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.208272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.208272%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3D%25C3%2581.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DMontes%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DModulation%2520of%2520peripheral%2520mu-opioid%2520analgesia%2520by%2520%25CF%25831%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D32%26epage%3D45%26doi%3D10.1124%2Fjpet.113.208272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Roh, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beitz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span> </span><span class="NLM_article-title">Intrathecal injection of the σ<sub>1</sub> receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span><span class="refDoi"> DOI: 10.1097/ALN.0b013e3181895a83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1097%2FALN.0b013e3181895a83" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2008&pages=879-889&author=D.+H.+Rohauthor=H.+W.+Kimauthor=S.+Y.+Yoonauthor=H.+S.+Seoauthor=Y.+B.+Kwonauthor=K.+W.+Kimauthor=H.+J.+Hanauthor=A.+J.+Beitzauthor=H.+S.+Naauthor=J.+H.+Lee&title=Intrathecal+injection+of+the+%CF%831+receptor+antagonist+BD1047+blocks+both+mechanical+allodynia+and+increases+in+spinal+NR1+expression+during+the+induction+phase+of+rodent+neuropathic+pain&doi=10.1097%2FALN.0b013e3181895a83"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2FALN.0b013e3181895a83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FALN.0b013e3181895a83%26sid%3Dliteratum%253Aachs%26aulast%3DRoh%26aufirst%3DD.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26aulast%3DSeo%26aufirst%3DH.%2BS.%26aulast%3DKwon%26aufirst%3DY.%2BB.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DHan%26aufirst%3DH.%2BJ.%26aulast%3DBeitz%26aufirst%3DA.%2BJ.%26aulast%3DNa%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26atitle%3DIntrathecal%2520injection%2520of%2520the%2520%25CF%25831%2520receptor%2520antagonist%2520BD1047%2520blocks%2520both%2520mechanical%2520allodynia%2520and%2520increases%2520in%2520spinal%2520NR1%2520expression%2520during%2520the%2520induction%2520phase%2520of%2520rodent%2520neuropathic%2520pain%26jtitle%3DAnesthesiology%26date%3D2008%26volume%3D109%26spage%3D879%26epage%3D889%26doi%3D10.1097%2FALN.0b013e3181895a83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1002/jlcr.3010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1002%2Fjlcr.3010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24285328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=215-224&author=S.+D.+Banisterauthor=M.+Manoliauthor=M.+Kassiou&title=The+development+of+radiotracers+for+imaging+sigma+%28%CF%83%29+receptors+in+the+central+nervous+system+%28CNS%29+using+positron+emission+tomography+%28PET%29&doi=10.1002%2Fjlcr.3010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)</span></div><div class="casAuthors">Banister, Samuel D.; Manoli, Miral; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">215-224</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors are unique mammalian proteins, distributed in the central nervous system and elsewhere, which are increasingly implicated in the pathophysiol. of virtually all major central nervous system disorders.  The heterogeneous but wide distribution of σ1 in the brain has prompted the development of selective radiotracers for imaging these sites using positron emission tomog. (PET).  To date, some 50 carbon-11-labeled and fluorine-18-labeled candidate PET radioligands targeting σ receptors have been reported.  The historical development of selective σ1 receptor ligands as potential PET imaging agents, as well as the radiochem. and application of the most recently developed examples, is described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0i6wNldBzpLVg90H21EOLACvtfcHk0lh9GLN6ECmDmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtrw%253D&md5=358f9647c85deedeb2e28ebe0ef844a2</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3010%26sid%3Dliteratum%253Aachs%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DManoli%26aufirst%3DM.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520development%2520of%2520radiotracers%2520for%2520imaging%2520sigma%2520%2528%25CF%2583%2529%2520receptors%2520in%2520the%2520central%2520nervous%2520system%2520%2528CNS%2529%2520using%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D215%26epage%3D224%26doi%3D10.1002%2Fjlcr.3010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">van Waarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybczynska, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A.</span><span> </span><span class="NLM_article-title">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3519</span><span class="NLM_x">–</span> <span class="NLM_lpage">3537</span><span class="refDoi"> DOI: 10.2174/138161210793563365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F138161210793563365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=21050178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3519-3537&author=A.+van+Waardeauthor=A.+A.+Rybczynskaauthor=N.+Ramakrishnanauthor=K.+Ishiwataauthor=P.+H.+Elsingaauthor=R.+A.+Dierckx&title=Sigma+receptors+in+oncology%3A+therapeutic+and+diagnostic+applications+of+sigma+ligands&doi=10.2174%2F138161210793563365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span></div><div class="casAuthors">van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3519-3537</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed throughout the mammalian body.  The endogenous ligand for these sites has not been identified, but steroid hormones (particularly progesterone), sphingolipid-derived amines and N,N-dimethyltryptamine can bind with fairly high affinity.  Sigma receptors are overexpressed in rapidly proliferating cells, like cancer cells.  Particularly the sigma-2 subtype is upregulated when cells divide and down regulated when they become quiescent.  Sigma ligands, esp. sigma-2 agonists, can inhibit proliferation and induce apoptosis by a mechanism involving changes in cytosolic Ca2+, ceramide and sphingolipid levels.  Tumor cells are much more sensitive to such treatment than cells from their tissue of origin.  Sigma ligands induce apoptosis not only in drug-sensitive but also in drug-resistant cancer cells (e.g., cells with p53 mutations, or caspase dysfunction).  Moreover, sigma ligands may abrogate P-glycoprotein-mediated drug resistance and at subtoxic doses, they can potentiate the effect of conventional cytostatics.  Thus, sigma-2 agonists may be developed as antineoplastic agents for the treatment of drug-resistant tumors.  A large no. of radiolabeled sigma ligands has been prepd. for SPECT (single-photon emission computed tomog.) and PET (positron emission tomog.) imaging.  Such radiopharmaceuticals can be used for tumor detection, tumor staging, and evaluation of anti-tumor therapy.  There is still a need for the development of ligands with (1) high selectivity for the sigma-2 subtype, (2) defined action (agonist or antagonist) and (3) optimal pharmacokinetics (low affinity for P-glycoprotein, high and specific tumor uptake, and rapid washout from non-target tissues).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-vSPpRtU37Vg90H21EOLACvtfcHk0lh9GLN6ECmDmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D&md5=e77adeaf932e2fa8eca70ec0e4e84ec6</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.2174%2F138161210793563365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793563365%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DRybczynska%26aufirst%3DA.%2BA.%26aulast%3DRamakrishnan%26aufirst%3DN.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%26atitle%3DSigma%2520receptors%2520in%2520oncology%253A%2520therapeutic%2520and%2520diagnostic%2520applications%2520of%2520sigma%2520ligands%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3519%26epage%3D3537%26doi%3D10.2174%2F138161210793563365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Crawford, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=11782394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD38XntV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=313-322&author=K.+W.+Crawfordauthor=W.+D.+Bowen&title=Sigma-2+receptor+agonists+activate+a+novel+apoptotic+pathway+and+potentiate+antineoplastic+drugs+in+breast+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines</span></div><div class="casAuthors">Crawford, Keith W.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">313-322</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have reported previously that sigma-2 receptors are expressed in high densities in a variety of tumor cell types and that various sigma ligands have cytotoxic effects.  Other investigators have demonstrated increased expression of sigma-2 receptors in rapidly proliferating tumors and the ability of some sigma ligands to inhibit proliferation.  We demonstrate here the ability of sigma-2 receptor agonists to induce cell death by a mechanism consistent with apoptosis.  In breast tumor cell lines that are sensitive (MCF-7) and resistant (MCF-7/Adr-, T47D, and SKBr3) to antineoplastic agents, incubation with the sigma-2 subtype-selective agonists CB-64D and CB-184 produced dose-dependent cytotoxicity (measured by lactate dehydrogenase release into medium).  The EC50 for this response was similar across cell lines, irresp. of p53 genotype and drug-resistance phenotype.  CB-64D and the subtype nonselective sigma-2 agonists haloperidol and reduced haloperidol induced terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining in MCF-7 and T47D cells, indicating that cell death occurs via apoptosis.  Apoptosis was also indicated by increases in Annexin V binding caused by CB-64D.  In MCF-7 cells, cytotoxicity and Annexin V binding induced by the antineoplastics doxorubicin and actinomycin D was partially or completely abrogated by certain specific and general inhibitors of caspases.  In contrast, caspase inhibitors had no effect on sigma-2 receptor-mediated (CB-64D and CB-184) cytotoxicity or Annexin V binding.  Marked potentiation of cytotoxicity was obsd. when a subtoxic dose of CB-184 was combined with doxorubicin or actinomycin D, both in drug-sensitive (MCF-7) and drug-resistant (MCF-7/Adr-) cell lines.  Haloperidol potentiated doxorubicin only in drug-resistant cells.  These findings suggest the involvement of a novel p53- and caspase-independent apoptotic pathway used by sigma-2 receptors, which is distinct from mechanisms used by some DNA-damaging, antineoplastic agents and other apoptotic stimuli.  These observations further suggest that sigma-2 receptors may be targets that can be therapeutically exploited in the treatment of both drug-sensitive and drug-resistant metastatic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJugG63Xfy7Vg90H21EOLACvtfcHk0lh9GLN6ECmDmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntV2gug%253D%253D&md5=89feb1caf2fa574ba2f49aff8be7d920</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DK.%2BW.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma-2%2520receptor%2520agonists%2520activate%2520a%2520novel%2520apoptotic%2520pathway%2520and%2520potentiate%2520antineoplastic%2520drugs%2520in%2520breast%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D313%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The sigma-2 receptor: a novel protein for the imaging and treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span><span class="refDoi"> DOI: 10.1021/jm301545c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+Zengauthor=W.+G.+Hawkins&title=The+sigma-2+receptor%3A+a+novel+protein+for+the+imaging+and+treatment+of+cancer&doi=10.1021%2Fjm301545c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520sigma-2%2520receptor%253A%2520a%2520novel%2520protein%2520for%2520the%2520imaging%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160%26doi%3D10.1021%2Fjm301545c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucke-Wold, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookerjee, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavendish, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandinaro, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Role of sigma-1 receptors in neurodegenerative diseases</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.jphs.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.jphs.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25704014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=17-29&author=L.+Nguyenauthor=B.+P.+Lucke-Woldauthor=S.+A.+Mookerjeeauthor=J.+Z.+Cavendishauthor=M.+J.+Robsonauthor=A.+L.+Scandinaroauthor=R.+R.+Matsumoto&title=Role+of+sigma-1+receptors+in+neurodegenerative+diseases&doi=10.1016%2Fj.jphs.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sigma-1 receptors in neurodegenerative diseases</span></div><div class="casAuthors">Nguyen, Linda; Lucke-Wold, Brandon P.; Mookerjee, Shona A.; Cavendish, John Z.; Robson, Matthew J.; Scandinaro, Anna L.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases with distinct genetic etiologies and pathol. phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction.  Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration.  Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biol. mechanisms assocd. with neurodegeneration.  These receptors therefore represent compelling putative targets for pharmacol. treating neurodegenerative disorders.  In this review, we provide an overview of the biol. mechanisms frequently assocd. with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function.  In addn., we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBzbVUAlU9rVg90H21EOLACvtfcHk0lhfnaNrlzWFEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D&md5=1aa1ab1a9eb49ef2d69eef975a568a2d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DLucke-Wold%26aufirst%3DB.%2BP.%26aulast%3DMookerjee%26aufirst%3DS.%2BA.%26aulast%3DCavendish%26aufirst%3DJ.%2BZ.%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DScandinaro%26aufirst%3DA.%2BL.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D17%26epage%3D29%26doi%3D10.1016%2Fj.jphs.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Robson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naser, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1016/j.expneurol.2014.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.expneurol.2014.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24508558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVWgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2014&pages=180-189&author=M.+J.+Robsonauthor=R.+C.+Turnerauthor=Z.+J.+Naserauthor=C.+R.+McCurdyauthor=J.+P.+O%E2%80%99Callaghanauthor=J.+D.+Huberauthor=R.+R.+Matsumoto&title=SN79%2C+a+sigma+receptor+antagonist%2C+attenuates+methamphetamine-induced+astrogliosis+through+a+blockade+of+OSMR%2Fgp130+signaling+and+STAT3+phosphorylation&doi=10.1016%2Fj.expneurol.2014.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation</span></div><div class="casAuthors">Robson, Matthew J.; Turner, Ryan C.; Naser, Zachary J.; McCurdy, Christopher R.; O'Callaghan, James P.; Huber, Jason D.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-189</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Methamphetamine (METH) exposure results in dopaminergic neurotoxicity in striatal regions of the brain, an effect that has been linked to an increased risk of Parkinson's disease.  Various aspects of neuroinflammation, including astrogliosis, are believed to be contributory factors in METH neurotoxicity.  METH interacts with sigma receptors at physiol. relevant concns. and treatment with sigma receptor antagonists has been shown to mitigate METH-induced neurotoxicity in rodent models.  Whether these compds. alter the responses of glial cells within the central nervous system to METH however has yet to be detd.  Therefore, the purpose of the current study was to det. whether the sigma receptor antagonist, SN79, mitigates METH-induced striatal reactive astrogliosis.  Male, Swiss Webster mice treated with a neurotoxic regimen of METH exhibited time-dependent increases in striatal gfap mRNA and concomitant increases in GFAP protein, indicative of astrogliosis.  This is the first report that similar to other neurotoxicants that induce astrogliosis through the activation of JAK2/STAT3 signaling by stimulating gp-130-linked cytokine signaling resulting from neuroinflammation, METH treatment also increases astrocytic oncostatin m receptor (OSMR) expression and the phosphorylation of STAT3 (Tyr-705) in vivo.  Pretreatment with SN79 blocked METH-induced increases in OSMR, STAT3 phosphorylation and astrocyte activation within the striatum.  Addnl., METH treatment resulted in striatal cellular degeneration as measured by Fluoro-Jade B, an effect that was mitigated by SN79.  The current study provides evidence that sigma receptor antagonists attenuate METH-induced astrocyte activation through a pathway believed to be shared by various neurotoxicants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz1dxu9rYPSbVg90H21EOLACvtfcHk0lhfnaNrlzWFEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVWgu78%253D&md5=8aed60d9e659cbf14050df4e57b5fd4b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2014.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2014.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DNaser%26aufirst%3DZ.%2BJ.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DJ.%2BP.%26aulast%3DHuber%26aufirst%3DJ.%2BD.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DSN79%252C%2520a%2520sigma%2520receptor%2520antagonist%252C%2520attenuates%2520methamphetamine-induced%2520astrogliosis%2520through%2520a%2520blockade%2520of%2520OSMR%252Fgp130%2520signaling%2520and%2520STAT3%2520phosphorylation%26jtitle%3DExp.%2520Neurol.%26date%3D2014%26volume%3D254%26spage%3D180%26epage%3D189%26doi%3D10.1016%2Fj.expneurol.2014.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1038/npp.2012.224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1038%2Fnpp.2012.224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=605-615&author=T.+Hiranitaauthor=M.+Mereuauthor=P.+L.+Sotoauthor=G.+Tandaauthor=J.+L.+Katz&title=Self-administration+of+cocaine+induces+dopamine-independent+self-administration+of+sigma+agonists&doi=10.1038%2Fnpp.2012.224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2012.224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2012.224%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DSelf-administration%2520of%2520cocaine%2520induces%2520dopamine-independent%2520self-administration%2520of%2520sigma%2520agonists%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D605%26epage%3D615%26doi%3D10.1038%2Fnpp.2012.224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dual DAT/σ<sub>1</sub> receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5238</span><span class="NLM_x">–</span> <span class="NLM_lpage">5241</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.bmcl.2008.08.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5238-5241&author=J.+Caoauthor=T.+Kopajticauthor=J.+L.+Katzauthor=A.+H.+Newman&title=Dual+DAT%2F%CF%831+receptor+ligands+based+on+3-%284-%283-%28bis%284-fluorophenyl%29amino%29propyl%29piperazin-1-yl%29-1-phenylpropan-1-ol&doi=10.1016%2Fj.bmcl.2008.08.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDual%2520DAT%252F%25CF%25831%2520receptor%2520ligands%2520based%2520on%25203-%25284-%25283-%2528bis%25284-fluorophenyl%2529amino%2529propyl%2529piperazin-1-yl%2529-1-phenylpropan-1-ol%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5238%26epage%3D5241%26doi%3D10.1016%2Fj.bmcl.2008.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1038/npp.2012.224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1038%2Fnpp.2012.224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=605-615&author=T.+Hiranitaauthor=M.+Mereuauthor=P.+L.+Sotoauthor=G.+Tandaauthor=J.+L.+Katz&title=Self-administration+of+cocaine+induces+dopamine-independent+self-administration+of+sigma+agonists&doi=10.1038%2Fnpp.2012.224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2012.224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2012.224%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DSelf-administration%2520of%2520cocaine%2520induces%2520dopamine-independent%2520self-administration%2520of%2520sigma%2520agonists%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D605%26epage%3D615%26doi%3D10.1038%2Fnpp.2012.224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">James, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavaleta, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesangeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppala, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishback, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, F. T.</span><span> </span><span class="NLM_article-title">New positron emission tomography (PET) radioligand for imaging sigma-1 receptors in living subjects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8272</span><span class="NLM_x">–</span> <span class="NLM_lpage">8282</span><span class="refDoi"> DOI: 10.1021/jm300371c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300371c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8272-8282&author=M.+L.+Jamesauthor=B.+Shenauthor=C.+L.+Zavaletaauthor=C.+H.+Nielsenauthor=C.+Mesangeauauthor=P.+K.+Vuppalaauthor=C.+Chanauthor=B.+A.+Averyauthor=J.+A.+Fishbackauthor=R.+R.+Matsumotoauthor=S.+S.+Gambhirauthor=C.+R.+McCurdyauthor=F.+T.+Chin&title=New+positron+emission+tomography+%28PET%29+radioligand+for+imaging+sigma-1+receptors+in+living+subjects&doi=10.1021%2Fjm300371c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjm300371c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300371c%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DM.%2BL.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DZavaleta%26aufirst%3DC.%2BL.%26aulast%3DNielsen%26aufirst%3DC.%2BH.%26aulast%3DMesangeau%26aufirst%3DC.%26aulast%3DVuppala%26aufirst%3DP.%2BK.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DAvery%26aufirst%3DB.%2BA.%26aulast%3DFishback%26aufirst%3DJ.%2BA.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DChin%26aufirst%3DF.%2BT.%26atitle%3DNew%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520radioligand%2520for%2520imaging%2520sigma-1%2520receptors%2520in%2520living%2520subjects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8272%26epage%3D8282%26doi%3D10.1021%2Fjm300371c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Poupaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yous, S.</span><span> </span><span class="NLM_article-title">2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span><span class="refDoi"> DOI: 10.2174/0929867053507388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F0929867053507388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15853716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVCqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=877-885&author=J.+Poupaertauthor=P.+Caratoauthor=E.+Colacinoauthor=S.+Yous&title=2%283H%29-benzoxazolone+and+bioisosters+as+%22privileged+scaffold%22+in+the+design+of+pharmacological+probes&doi=10.2174%2F0929867053507388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes</span></div><div class="casAuthors">Poupaert, Jacques; Carato, Pascal; Colacino, Evelina</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 2(3H)-benzoxazolone heterocycle and its bioisosteric surrogates (such as 2(3H)-benzothiazolinone, benzoxazinone, etc.) have received considerable attention from the medicinal chemists owing to their capacity to mimic a phenol or a catechol moiety in a metabolically stable template.  These heterocycles and pyrocatechol have indeed similar pKa's, electronic charge distribution, and chem. reactivity.  Therapeutic applications of this template are very broad, and range from analgesic anti-inflammatory compds. (including PPAR-gamma antagonists) to antipsychotic and neuroprotective anticonvulsant compds.  High affinity ligands have been obtained also for dopaminergic (D2 and D4). serotoninergic (5-HT1A and 5-HT-2A), sigma-1 and sigma-2 receptors.  Owing to the high no. of pos. hits encountered with this heterocycle and its congeners, 2(3H)-benzoxazolone template certainly deserves the title of "privileged scaffold" in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0F0n_89K5rVg90H21EOLACvtfcHk0lgdxPXHWetzzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVCqur4%253D&md5=0365a0fcfc6ff313369d5686d079a0d7</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F0929867053507388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053507388%26sid%3Dliteratum%253Aachs%26aulast%3DPoupaert%26aufirst%3DJ.%26aulast%3DCarato%26aufirst%3DP.%26aulast%3DColacino%26aufirst%3DE.%26aulast%3DYous%26aufirst%3DS.%26atitle%3D2%25283H%2529-benzoxazolone%2520and%2520bioisosters%2520as%2520%2522privileged%2520scaffold%2522%2520in%2520the%2520design%2520of%2520pharmacological%2520probes%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D877%26epage%3D885%26doi%3D10.2174%2F0929867053507388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belloir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span> </span><span class="NLM_article-title">Novel 2(3H)-benzothiazolones as highly potent and selective sigma-1 receptor ligands</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1007/s00044-005-0131-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1007%2Fs00044-005-0131-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=158-168&author=S.+Yousauthor=V.+Wallezauthor=M.+Belloirauthor=D.+H.+Caignardauthor=C.+R.+McCurdyauthor=J.+H.+Poupaert&title=Novel+2%283H%29-benzothiazolones+as+highly+potent+and+selective+sigma-1+receptor+ligands&doi=10.1007%2Fs00044-005-0131-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2(3H)-benzothiazolones as highly potent and selective sigma-1 receptor ligands</span></div><div class="casAuthors">Yous, Said; Wallez, Valerie; Belloir, Mirabelle; Caignard, Daniel H.; McCurdy, Christopher R.; Poupaert, Jacques H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">158-168</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">In an effort to produce a new pharmacol. probe with high affinity and selectivity for the sigma-1 receptor, we have synthesized a series of original 2(3H)-benzothiazolones utilizing compd. 4 [3-(1-piperidinoethyl)-6-propylbenzothiazolin-2-one] as a lead.  Receptor binding affinities were detd. at sigma-1 and sigma-2 receptors.  The best ligand (I, sigma-1 Ki = 0.56 nM, selectivity ratio >1000) was obtained with an azepine side-chain.  When tested on a wide battery of receptors, including 5HT2A(h), 5HT3(h), α1, α2, β1, β2, H1, H2, opioids, D1(h), D2(h), 5HT uptake, and DOPA uptake, compd. I showed submicromolar affinity only for α2 (Ki = 205 nM) and H1 (Ki = 311 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-b1rFEdR7bVg90H21EOLACvtfcHk0lgdxPXHWetzzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVSqtg%253D%253D&md5=afe46b38390ffb821c11798cafe6619b</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1007%2Fs00044-005-0131-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-005-0131-1%26sid%3Dliteratum%253Aachs%26aulast%3DYous%26aufirst%3DS.%26aulast%3DWallez%26aufirst%3DV.%26aulast%3DBelloir%26aufirst%3DM.%26aulast%3DCaignard%26aufirst%3DD.%2BH.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26atitle%3DNovel%25202%25283H%2529-benzothiazolones%2520as%2520highly%2520potent%2520and%2520selective%2520sigma-1%2520receptor%2520ligands%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2005%26volume%3D14%26spage%3D158%26epage%3D168%26doi%3D10.1007%2Fs00044-005-0131-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tsai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokrass, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauer, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Credico, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1476</span><span class="refDoi"> DOI: 10.1517/14728222.2014.972939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1517%2F14728222.2014.972939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25331742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGhu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=1461-1476&author=S.+Y.+Tsaiauthor=M.+J.+Pokrassauthor=N.+R.+Klauerauthor=N.+E.+De+Credicoauthor=T.+P.+Su&title=Sigma-1+receptor+chaperones+in+neurodegenerative+and+psychiatric+disorders&doi=10.1517%2F14728222.2014.972939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders</span></div><div class="casAuthors">Tsai, Shang-Yi A.; Pokrass, Michael J.; Klauer, Neal R.; De Credico, Nicole E.; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1461-1476</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Sigma-1 receptors (Sig-1Rs) are mol. chaperones that reside mainly in the endoplasmic reticulum (ER) but exist also in the proximity of the plasma membrane.  Sig-1Rs are highly expressed in the CNS and are involved in many cellular processes including cell differentiation, neuritogenesis, microglia activation, protein quality control, calcium-mediated ER stress and ion channel modulation.  Disturbance in any of the above cellular processes can accelerate the progression of many neurol. disorders; therefore, the Sig-1R has been implicated in several neurol. diseases.  Areas covered: This review broadly covers the functions of Sig-1Rs including several neurodegenerative disorders in humans and drug addiction-assocd. neurol. disturbance in the case of HIV infection.  We discuss how several Sig-1R ligands could be utilized in therapeutic approaches to treat those disorders.  Expert opinion: Emerging understanding of the cellular functions of this unique transmembrane chaperone may lead to the use of new agents or broaden the use of certain available ligands as therapeutic targets in those neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6GRApLYpd7Vg90H21EOLACvtfcHk0lgJoPYK0FS67w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGhu7bO&md5=f08044c72c2305c1574d2a1c35a643e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.972939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.972939%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BY.%26aulast%3DPokrass%26aufirst%3DM.%2BJ.%26aulast%3DKlauer%26aufirst%3DN.%2BR.%26aulast%3DDe%2BCredico%26aufirst%3DN.%2BE.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520in%2520neurodegenerative%2520and%2520psychiatric%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D1461%26epage%3D1476%26doi%3D10.1517%2F14728222.2014.972939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bermack, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span> </span><span class="NLM_article-title">The role of sigma receptors in depression</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1254/jphs.CRJ04005X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1254%2Fjphs.CRJ04005X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15750289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=317-336&author=J.+E.+Bermackauthor=G.+Debonnel&title=The+role+of+sigma+receptors+in+depression&doi=10.1254%2Fjphs.CRJ04005X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The role of sigma receptors in depression</span></div><div class="casAuthors">Bermack, Jordanna E.; Debonnel, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-336</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  Behavioral models used to test potential antidepressants have shown that ligands that bind to sigma receptors possess "antidepressant-like" properties.  The focus of this review is to discuss the literature concerning sigma receptors and their ligands, with respect to their antidepressants properties.  In addn. to the behavioral data, we discuss electrophysiol. and biochem. models demonstrating sigma receptors' ability to modulate important factors in the pathophysiol. of depression and/or the mechanisms of action of antidepressants such as the serotonergic neurotransmission in the dorsal raphe nucleus (DRN) and the glutamatergic transmission in the hippocampus.  We also discuss the significance of these two systems in the mechanism of action of antidepressants.  Sigma ligands have potential as antidepressant medications with a fast onset of action as they produce a rapid modulation of the serotonergic system in the DRN and the glutamatergic transmission in the hippocampus.  As these effects of sigma ligands may produce antidepressant properties by completely novel mechanisms of action, they may provide an alternative to the antidepressants currently available and may prove to be beneficial for treatment-resistant depressed patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTc8adYlmpSrVg90H21EOLACvtfcHk0lgJoPYK0FS67w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D&md5=1cdda174b9b1e5087118ae49526b3eb0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1254%2Fjphs.CRJ04005X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.CRJ04005X%26sid%3Dliteratum%253Aachs%26aulast%3DBermack%26aufirst%3DJ.%2BE.%26aulast%3DDebonnel%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520sigma%2520receptors%2520in%2520depression%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D97%26spage%3D317%26epage%3D336%26doi%3D10.1254%2Fjphs.CRJ04005X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ovalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitart, X.</span><span> </span><span class="NLM_article-title">Effect of the novel σ<sub>1</sub> receptor ligand and putative atypical antipsychotic E-5842 on BDNF mRNA expression in the rat brain</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span><span class="refDoi"> DOI: 10.1097/00001756-200212030-00035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1097%2F00001756-200212030-00035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=2345-2348&author=S.+Ovalleauthor=F.+Andreuauthor=M.+P.+P%C3%A9rezauthor=D.+Zamanilloauthor=X.+Guitart&title=Effect+of+the+novel+%CF%831+receptor+ligand+and+putative+atypical+antipsychotic+E-5842+on+BDNF+mRNA+expression+in+the+rat+brain&doi=10.1097%2F00001756-200212030-00035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1097%2F00001756-200212030-00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200212030-00035%26sid%3Dliteratum%253Aachs%26aulast%3DOvalle%26aufirst%3DS.%26aulast%3DAndreu%26aufirst%3DF.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%2BP.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DGuitart%26aufirst%3DX.%26atitle%3DEffect%2520of%2520the%2520novel%2520%25CF%25831%2520receptor%2520ligand%2520and%2520putative%2520atypical%2520antipsychotic%2520E-5842%2520on%2520BDNF%2520mRNA%2520expression%2520in%2520the%2520rat%2520brain%26jtitle%3DNeuroReport%26date%3D2002%26volume%3D13%26spage%3D2345%26epage%3D2348%26doi%3D10.1097%2F00001756-200212030-00035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span><span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.lfs.2005.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1612-1624&author=T.+Hayashiauthor=T.+P.+Su&title=The+potential+role+of+sigma-1+receptors+in+lipid+transport+and+lipid+raft+reconstitution+in+the+brain%3A+implication+for+drug+abuse&doi=10.1016%2Fj.lfs.2005.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DThe%2520potential%2520role%2520of%2520sigma-1%2520receptors%2520in%2520lipid%2520transport%2520and%2520lipid%2520raft%2520reconstitution%2520in%2520the%2520brain%253A%2520implication%2520for%2520drug%2520abuse%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1612%26epage%3D1624%26doi%3D10.1016%2Fj.lfs.2005.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Meunier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gué, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Récasens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span> </span><span class="NLM_article-title">Attenuation by a sigma-1 (σ<sub>1</sub>) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1038%2Fsj.bjp.0705835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15205309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2004&pages=689-700&author=J.+Meunierauthor=M.+Gu%C3%A9author=M.+R%C3%A9casensauthor=T.+Maurice&title=Attenuation+by+a+sigma-1+%28%CF%831%29+receptor+agonist+of+the+learning+and+memory+deficits+induced+by+a+prenatal+restraint+stress+in+juvenile+rats&doi=10.1038%2Fsj.bjp.0705835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation by a sigma1 (σ1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats</span></div><div class="casAuthors">Meunier, Johann; Gue, Michele; Recasens, Max; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1: Stress during pregnancy results in complex neurochem. and behavioral alterations throughout the offspring lifetime.  We here examd. the impact of prenatal stress (PS) on memory functions in male and female offspring and report the efficacy of a selective sigma1 (σ1) receptor agonist, igmesine, in alleviating the obsd. deficits.  2: Dams received an unpredictable 90-min duration restraint stress from gestational day E17 to E20.  Learning was examd. in offspring between day P24 and P36 using spontaneous alternation in the Y-maze, delayed alternation in the T-maze, water-maze learning and passive avoidance.  3: Both male and female PS rats showed impairments of spontaneous and delayed alternation performances.  Acquisition of a fixed platform position in the water-maze was unchanged in PS rats, but the probe test revealed a diminution of time spent in the training quadrant.  Acquisition of a daily changing platform position demonstrated impaired working memory for male and female PS rats.  Finally, passive avoidance deficits were obsd.  4: Pretreatment with the selective σ1 agonist igmesine (1-10 mg kg-1 i.p.) reversed the PS-induced learning deficits in offspring rats for each test.  The σ1 antagonist BD1063 failed to affect performances alone but blocked the igmesine effect, confirming the involvement of the σ1 receptor.  5: PS thus induces delayed memory deficits, affecting spatial and nonspatial, short- and long-term memories in juvenile male and female offspring rats.  Activation of the σ1 neuromodulatory receptor allows a significant recovery of the memory functions in PS rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhtHAjlawprVg90H21EOLACvtfcHk0lhB1NqA10muRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D&md5=cc7f51d2bef3acb88732499642b49a77</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705835%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DGu%25C3%25A9%26aufirst%3DM.%26aulast%3DR%25C3%25A9casens%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DAttenuation%2520by%2520a%2520sigma-1%2520%2528%25CF%25831%2529%2520receptor%2520agonist%2520of%2520the%2520learning%2520and%2520memory%2520deficits%2520induced%2520by%2520a%2520prenatal%2520restraint%2520stress%2520in%2520juvenile%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D142%26spage%3D689%26epage%3D700%26doi%3D10.1038%2Fsj.bjp.0705835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ronsisvalle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezzavento, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoto, G. M.</span><span> </span><span class="NLM_article-title">Opioid and sigma receptor studies. New developments in the design of selective sigma ligands</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1509</span><span class="refDoi"> DOI: 10.1351/pac200173091499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1351%2Fpac200173091499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFGls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2001&pages=1499-1509&author=G.+Ronsisvalleauthor=A.+Marrazzoauthor=O.+Prezzaventoauthor=A.+Cagnottoauthor=T.+Menniniauthor=C.+Parentiauthor=G.+M.+Scoto&title=Opioid+and+sigma+receptor+studies.+New+developments+in+the+design+of+selective+sigma+ligands&doi=10.1351%2Fpac200173091499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid and sigma receptor studies. New developments in the design of selective sigma ligands</span></div><div class="casAuthors">Ronsisvalle, Giuseppe; Marrazzo, Agostino; Prezzavento, Orazio; Cagnotto, Alfredo; Mennini, Tiziana; Parenti, Carmela; Scoto, Giovanna M.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1499-1509</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">International Union of Pure and Applied Chemistry</span>)
        </div><div class="casAbstract">New racemic and chiral Me 2-{[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate derivs. were synthesized in order to obtain sigma ligands with increased affinity and selectivity compared to (+)-MPCB and haloperidol.  The cis-(+)-7 racemic mixt. showed a better binding affinity and selectivity than the (±)-8 trans isomers.  Between the two cis enantiomers, (+)-7, with configuration (IR,2S), showed a very high affinity and the best selectivity for σ1.  All compds. synthesized (7-9) showed a reduced or negligible affinity for opioid and dopaminergic D1 and D2 receptors.  Nociceptive in vivo test confirms that (+±)-7 (namely MR200), such as non-selective antagonist haloperidol. increased the analgesic effect induced by the Kt opioid selective ligand U50,4881I and reversed the inhibiting effect of (+)-pentazocine on analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxo_t5PAwF-rVg90H21EOLACvtfcHk0lhB1NqA10muRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFGls78%253D&md5=3557731c2bb275e5642787ee5a2c5fea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1351%2Fpac200173091499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac200173091499%26sid%3Dliteratum%253Aachs%26aulast%3DRonsisvalle%26aufirst%3DG.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DScoto%26aufirst%3DG.%2BM.%26atitle%3DOpioid%2520and%2520sigma%2520receptor%2520studies.%2520New%2520developments%2520in%2520the%2520design%2520of%2520selective%2520sigma%2520ligands%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2001%26volume%3D73%26spage%3D1499%26epage%3D1509%26doi%3D10.1351%2Fpac200173091499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1021/jm00079a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00079a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1KhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=38-47&author=B.+R.+de+Costaauthor=L.+Radescaauthor=L.+Di+Paoloauthor=W.+D.+Bowen&title=Synthesis%2C+characterization%2C+and+biological+evaluation+of+a+novel+class+of+N-%28arylethyl%29-N-alkyl-2-%281-pyrrolidinyl%29ethylamines%3A+structural+requirements+and+binding+affinity+at+the+sigma+receptor&doi=10.1021%2Fjm00079a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines:  structural requirements and binding affinity at the σ receptor</span></div><div class="casAuthors">De Costa, Brian R.; Radesca, Lilian; Di Paolo, Lisa; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Title compds., e.g. I (R = H, Me, Et, Pr, allyl, Bu, R1 = R2 = Cl; R = Me, R1, R2 = H, Cl; R1R2 = benzo), were prepd. and their binding affinity for σ-, phencyclidine, kappa opiate, and dopamine D2 receptors was measured.  Thus, pyrrolidine II (R3 = Cl) was aminated with H2NR to give II (R3 = NHR) which reacted with 3,4-dichlorophenylacetic acid and was reduced with AlH3/THF to give I (R = H, Me, Et, Pr, allyl, Bu, R1 = R2 = Cl).  When I (R = Me, R1 = R2 = Cl) was tested for its capacity to displace [3H]-(+)-3-PPP (PPP = 1-n-propyl-3-(3-hydroxyphenyl)piperidine) from guinea pig brain membranes, it exhibited a Ki of 0.34 nM.  Structure activity relationships were also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMksg4R4UY9LVg90H21EOLACvtfcHk0lhB1NqA10muRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1KhsLo%253D&md5=47f25860bff66bed7175f73cc44012a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00079a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00079a004%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DRadesca%26aufirst%3DL.%26aulast%3DDi%2BPaolo%26aufirst%3DL.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520class%2520of%2520N-%2528arylethyl%2529-N-alkyl-2-%25281-pyrrolidinyl%2529ethylamines%253A%2520structural%2520requirements%2520and%2520binding%2520affinity%2520at%2520the%2520sigma%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D38%26epage%3D47%26doi%3D10.1021%2Fjm00079a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+Del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lhB1NqA10muRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Díaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuberes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrocal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contijoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of σ<sub>1</sub> receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8211</span><span class="NLM_x">–</span> <span class="NLM_lpage">8224</span><span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+%CF%831+receptor+antagonists%3A+identification+of+4-%7B2-%5B5-methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span></div><div class="casAuthors">Diaz, Jose Luis; Cuberes, Rosa; Berrocal, Joana; Contijoch, Montserrat; Christmann, Ute; Fernandez, Ariadna; Port, Adriana; Holenz, Jorg; Buschmann, Helmut; Laggner, Christian; Serafini, Maria Teresa; Burgueno, Javier; Zamanillo, Daniel; Merlos, Manuel; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8211-8224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-arylpyrazoles as potent σ1 receptor (σ1R) antagonists are reported.  The new compds. were evaluated in vitro in human σ1R and guinea pig σ2 receptor (σ2R) binding assays.  The nature of the pyrazole substituents was crucial for activity, and a basic amine was shown to be necessary, in accordance with known receptor pharmacophores.  A wide variety of amines and spacer lengths between the amino and pyrazole groups was tolerated, but only the ethylenoxy spacer and small cyclic amines provided compds. with sufficient selectivity for σ1R vs σ2R.  The most selective compds. were further profiled, and 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862, I), which showed high activity in the mouse capsaicin model of neurogenic pain, emerged as the most interesting candidate.  In addn., compd. I exerted dose-dependent antinociceptive effects in several neuropathic pain models.  This, together with its good physicochem., safety, and ADME properties, led compd. I to be selected as clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQxd7-vnvc7Vg90H21EOLACvtfcHk0lg5-JzhTNBcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI&md5=0d6a5c8008d27635117c3901ec1db3c4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520%25CF%25831%2520receptor%2520antagonists%253A%2520identification%2520of%25204-%257B2-%255B5-methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arroyos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera-Arconada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segalés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laloya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escriche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plata-Salamán, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2306</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01942.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-2306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+Giraldoauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+R.+Plata-Salam%C3%A1nauthor=J.+M.+Vela&title=Pharmacological+properties+of+S1RA%2C+a+new+sigma-1+receptor+antagonist+that+inhibits+neuropathic+pain+and+activity-induced+spinal+sensitization&doi=10.1111%2Fj.1476-5381.2012.01942.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0lg5-JzhTNBcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DPharmacological%2520properties%2520of%2520S1RA%252C%2520a%2520new%2520sigma-1%2520receptor%2520antagonist%2520that%2520inhibits%2520neuropathic%2520pain%2520and%2520activity-induced%2520spinal%2520sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D2306%26doi%3D10.1111%2Fj.1476-5381.2012.01942.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Diáz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Álvarez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship study of a new series of selective σ<sub>1</sub> receptor ligands for the treatment of pain: 4-aminotriazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span><span class="refDoi"> DOI: 10.1021/jm501920g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501920g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2441-2451&author=J.+L.+Di%C3%A1zauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Torrensauthor=A.+Portauthor=R.+Pascualauthor=I.+%C3%81lvarezauthor=J.+Burgue%C3%B1oauthor=X.+Monroyauthor=A.+Monteroauthor=A.+Baladaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+structure-activity+relationship+study+of+a+new+series+of+selective+%CF%831+receptor+ligands+for+the+treatment+of+pain%3A+4-aminotriazoles&doi=10.1021%2Fjm501920g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm501920g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501920g%26sid%3Dliteratum%253Aachs%26aulast%3DDi%25C3%25A1z%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3D%25C3%2581lvarez%26aufirst%3DI.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DBalada%26aufirst%3DA.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520study%2520of%2520a%2520new%2520series%2520of%2520selective%2520%25CF%25831%2520receptor%2520ligands%2520for%2520the%2520treatment%2520of%2520pain%253A%25204-aminotriazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2441%26epage%3D2451%26doi%3D10.1021%2Fjm501920g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(<i>1H</i>)-quinolinone scaffold as a potential analgesic</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.ejmech.2014.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=24735647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=216-230&author=Y.+Lanauthor=Y.+Chenauthor=X.+Xuauthor=Y.+Qiuauthor=S.+Liuauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+a+novel+sigma-1+receptor+antagonist+based+on+3%2C4-dihydro-2%281H%29-quinolinone+scaffold+as+a+potential+analgesic&doi=10.1016%2Fj.ejmech.2014.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Xu, Xiangqing; Qiu, Yinli; Liu, Shicheng; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216-230</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis and sigma-1 receptor (σ1R) antagonist activity of a new series of 3,4-dihydro-2(1H)-quinolinones, e.g. I [R = PhCH2, 4-MeC6H4CH2, 4-FC6H4CH2, etc.] are reported.  The new compds. were evaluated in vitro in sigma-1 and sigma-2 receptor-binding assays in guinea pig brain membranes.  The structure-activity relationship led us to the promising deriv. I [R = 4-FC6H4CH2].  The compds. with highest affinity and greatest selectivity were further profiled, and compd. I [R = 4-FC6H4CH2] had a high binding const. for sigma-1 receptor (Kiσ1 = 1.22 nM) and high sigma-1/2 selectivity (1066-fold).  Thus, this compd., which proved to be an antagonist of sigma-1 receptor, emerged as the most interesting candidate.  In addn., this compd. exerted dose-dependent antinociceptive effects in the formalin test.  These characteristics suggested that the potent and selective compd. I [R = 4-FC6H4CH2] could be a potent candidate for pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo56iTGYzwCw7Vg90H21EOLACvtfcHk0lgKyS4wjvTUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D&md5=04009cdd675bf12a18a5869979c2cf10</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520sigma-1%2520receptor%2520antagonist%2520based%2520on%25203%252C4-dihydro-2%25281H%2529-quinolinone%2520scaffold%2520as%2520a%2520potential%2520analgesic%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D216%26epage%3D230%26doi%3D10.1016%2Fj.ejmech.2014.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10404</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span><span class="refDoi"> DOI: 10.1021/jm501207r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501207r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10404-10423&author=Y.+Lanauthor=Y.+Chenauthor=X.+Caoauthor=J.+Zhangauthor=J.+Wangauthor=X.+Xuauthor=Y.+Qiuauthor=T.+Zhangauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+sigma-1+receptor+antagonists+based+on+pyrimidine+scaffold+as+agents+for+treating+neuropathic+pain&doi=10.1021%2Fjm501207r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Cao, Xudong; Zhang, Juecheng; Wang, Jie; Xu, Xiangqing; Qiu, Yinli; Zhang, Tan; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10404-10423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, assocd. with pharmacol. antineuropathic pain activity, are the focus of this article.  The new compds. were evaluated in vitro in σ-1 and σ-2 receptor binding assays.  The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model.  The most promising deriv. was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (I), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold).  In in vivo tests, I exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain.  In addn., no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted.  These data suggest I may constitute a novel class of drugs for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dkiomNDrPLVg90H21EOLACvtfcHk0lgKyS4wjvTUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsbbE&md5=bd003488b014b40e739cc42c825424ce</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm501207r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501207r%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520sigma-1%2520receptor%2520antagonists%2520based%2520on%2520pyrimidine%2520scaffold%2520as%2520agents%2520for%2520treating%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10404%26epage%3D10423%26doi%3D10.1021%2Fjm501207r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaiel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">el-Ashmawy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howie, K. B.</span><span> </span><span class="NLM_article-title">Structural features important for σ<sub>1</sub> receptor binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span><span class="refDoi"> DOI: 10.1021/jm00034a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1214-1219&author=R.+A.+Glennonauthor=S.+Y.+Ablordeppeyauthor=A.+M.+Ismaielauthor=M.+B.+el-Ashmawyauthor=J.+B.+Fischerauthor=K.+B.+Howie&title=Structural+features+important+for+%CF%831+receptor+binding&doi=10.1021%2Fjm00034a020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features Important for σ1 Receptor Binding</span></div><div class="casAuthors">Glennon, Richard A.; Ablordeppey, Seth Y.; Ismaiel, Abd M.; El-Ashmawy, Mahmoud B.; Fischer, James B.; Howie, Kathleen Burke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1214-19</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Two problems that have hampered σ receptor research are a lack of high-affinity agents and the recent identification of multiple populations of σ receptors (i.e., σ1 and σ2 sites).  Recently, several high-affinity σ ligands have been identified, and the term superpotent σ ligands has been coined to describe agents with Ki values of <1 nM.  It was previously shown that appropriately N-substituted phenylalkylamines bind at σ receptors with high affinity.  The structure-affinity relationships of these phenylalkylamine derivs. for σ1 binding are examd. and some of the first superpotent σ1 ligands described.  A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with σ1 sites.  Some of the amines were prepd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nnZHspQ0MLVg90H21EOLACvtfcHk0ljmKovHTrDIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksV2lsrY%253D&md5=3c9b4ff203d7c304da3779a874837bf5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a020%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DIsmaiel%26aufirst%3DA.%2BM.%26aulast%3Del-Ashmawy%26aufirst%3DM.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DHowie%26aufirst%3DK.%2BB.%26atitle%3DStructural%2520features%2520important%2520for%2520%25CF%25831%2520receptor%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1214%26epage%3D1219%26doi%3D10.1021%2Fjm00034a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore identification for sigma-1 (σ<sub>1</sub>) receptor binding: application of the “deconstruction-reconstruction-elaboration” approach</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.2174/138955705774329519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F138955705774329519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=16250835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=927-940&author=R.+A.+Glennon&title=Pharmacophore+identification+for+sigma-1+%28%CF%831%29+receptor+binding%3A+application+of+the+%E2%80%9Cdeconstruction-reconstruction-elaboration%E2%80%9D+approach&doi=10.2174%2F138955705774329519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore identification for sigma-1 (σ1) receptor binding: Application of the deconstruction - reconstruction - elaboration approach</span></div><div class="casAuthors">Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-940</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  At least two different types of sigma σ (σ1 and σ2) receptors have been identified.  A structural feature common to high-affinity (Ki <10 nM) σ1 ligands is: C-N(R)-X-Ph; both C and Ph are assocd. with regions of bulk tolerance.  Numerous other ligands bind, but typically do so with lower affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_9JlDBLhrbVg90H21EOLACvtfcHk0ljmKovHTrDIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM&md5=66ae2e51d57fa97cd3954ae90e7e3167</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F138955705774329519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955705774329519%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DPharmacophore%2520identification%2520for%2520sigma-1%2520%2528%25CF%25831%2529%2520receptor%2520binding%253A%2520application%2520of%2520the%2520%25E2%2580%259Cdeconstruction-reconstruction-elaboration%25E2%2580%259D%2520approach%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D927%26epage%3D940%26doi%3D10.2174%2F138955705774329519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Asif, M.</span><span> </span><span class="NLM_article-title">Some recent approaches of biologically active substituted pyridazine and phthalazine drugs</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2984</span><span class="NLM_x">–</span> <span class="NLM_lpage">2991</span><span class="refDoi"> DOI: 10.2174/092986712800672139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F092986712800672139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=22519394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFersbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=2984-2991&author=M.+Asif&title=Some+recent+approaches+of+biologically+active+substituted+pyridazine+and+phthalazine+drugs&doi=10.2174%2F092986712800672139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Some recent approaches of biologically active substituted pyridazine and phthalazine drugs</span></div><div class="casAuthors">Asif, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2984-2991</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitrogen atom contg. heterocyclic compds., pyridazines, pyridazinones and phthalazines are important structural feature of many biol. active compds. and show diverse pharmacol. properties.  Pyridazines and phthalazines hold considerable interest relative to the prepn. of org. intermediates and physiol. active compds.  On the basis of literature, pyridazines, pyridazinone and phthalazines further focus our attention because of their easy fictionalization at various ring positions, which makes them attractive synthetic compds. for designing and development of the novel pyridazines and phthalazines drugs in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1NS6SepR4RrVg90H21EOLACvtfcHk0ljmKovHTrDIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFersbc%253D&md5=ee1620d7f24e12f7f2f28e65bc24a806</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F092986712800672139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712800672139%26sid%3Dliteratum%253Aachs%26aulast%3DAsif%26aufirst%3DM.%26atitle%3DSome%2520recent%2520approaches%2520of%2520biologically%2520active%2520substituted%2520pyridazine%2520and%2520phthalazine%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D2984%26epage%3D2991%26doi%3D10.2174%2F092986712800672139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Asif, M.</span><span> </span><span class="NLM_article-title">A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H<sub>3</sub>R</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.2174/1389557514666141127143133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F1389557514666141127143133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=25429662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BC2MzhtFeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=1093-1103&author=M.+Asif&title=A+mini+review+on+biological+activities+of+pyridazinone+derivatives+as+antiulcer%2C+antisecretory%2C+antihistamine+and+particularly+against+histamine+H3R&doi=10.2174%2F1389557514666141127143133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H3R</span></div><div class="casAuthors">Asif Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Mini reviews in medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1093-103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pyridazinone derivatives and their related analoges were introduced for gastric antiulcer and antisecretory activities.  Selected compounds were applied to ulcer models and showed their antiulcer and anti secretary activities.  Some pyridazinone compounds are recently reported as H3R antagonists.  Some amine analogs of pyridazinones, pyridazinone- phenethylamines and 4,5-fused pyridazinones showed histamine H3R antagonist activity with significant affinity for rat and human H3R.  These pyridazinone analogs also showed excellent selectivity and metabolic stability, with adequate pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwDyBbwL36aC86Js-BCLiifW6udTcc2eZTQkGF2Emch7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzhtFeisA%253D%253D&md5=1b10b8379cca26cc3cffb0dd1701d3f7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F1389557514666141127143133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557514666141127143133%26sid%3Dliteratum%253Aachs%26aulast%3DAsif%26aufirst%3DM.%26atitle%3DA%2520mini%2520review%2520on%2520biological%2520activities%2520of%2520pyridazinone%2520derivatives%2520as%2520antiulcer%252C%2520antisecretory%252C%2520antihistamine%2520and%2520particularly%2520against%2520histamine%2520H3R%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2015%26volume%3D14%26spage%3D1093%26epage%3D1103%26doi%3D10.2174%2F1389557514666141127143133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushimi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span> </span><span class="NLM_article-title">Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyri dazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9627</span><span class="NLM_x">–</span> <span class="NLM_lpage">9643</span><span class="refDoi"> DOI: 10.1021/jm5013648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5013648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9627-9643&author=J.+Kunitomoauthor=M.+Yoshikawaauthor=M.+Fushimiauthor=A.+Kawadaauthor=J.+F.+Quinnauthor=H.+Okiauthor=H.+Kokuboauthor=M.+Kondoauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=K.+Suzukiauthor=H.+Kimuraauthor=T.+Taniguchi&title=Discovery+of+1-%5B2-fluoro-4-%281H-pyrazol-1-yl%29phenyl%5D-5-methoxy-3-%281-phenyl-1H-pyrazol-5-yl%29pyri+dazin-4%281H%29-one+%28TAK-063%29%2C+a+highly+potent%2C+selective%2C+and+orally+active+phosphodiesterase+10A+%28PDE10A%29+inhibitor&doi=10.1021%2Fjm5013648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1021%2Fjm5013648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013648%26sid%3Dliteratum%253Aachs%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DFushimi%26aufirst%3DM.%26aulast%3DKawada%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25201-%255B2-fluoro-4-%25281H-pyrazol-1-yl%2529phenyl%255D-5-methoxy-3-%25281-phenyl-1H-pyrazol-5-yl%2529pyri%2520dazin-4%25281H%2529-one%2520%2528TAK-063%2529%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9627%26epage%3D9643%26doi%3D10.1021%2Fjm5013648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmait, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester-Zeiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Able, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cueva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talreja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornecook, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)e thanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6632</span><span class="NLM_x">–</span> <span class="NLM_lpage">6641</span><span class="refDoi"> DOI: 10.1021/jm500713j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500713j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6632-6641&author=E.+Huauthor=N.+Chenauthor=M.+P.+Bourbeauauthor=P.+E.+Harringtonauthor=K.+Biswasauthor=R.+K.+Kunzauthor=K.+L.+Andrewsauthor=S.+Chmaitauthor=X.+Zhaoauthor=C.+Davisauthor=J.+Maauthor=J.+Shiauthor=D.+Lester-Zeinerauthor=J.+Danaoauthor=J.+Ableauthor=M.+Cuevaauthor=S.+Talrejaauthor=T.+Kornecookauthor=H.+Chenauthor=A.+Porterauthor=R.+Hungateauthor=J.+Treanorauthor=J.+R.+Allen&title=Discovery+of+clinical+candidate+1-%284-%283-%284-%281H-benzo%5Bd%5Dimidazole-2-carbonyl%29phenoxy%29pyrazin-2-yl%29piperidin-1-yl%29e+thanone+%28AMG+579%29%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+phosphodiesterase+10A+%28PDE10A%29&doi=10.1021%2Fjm500713j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1021%2Fjm500713j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500713j%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DDanao%26aufirst%3DJ.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DCueva%26aufirst%3DM.%26aulast%3DTalreja%26aufirst%3DS.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%25284-%25283-%25284-%25281H-benzo%255Bd%255Dimidazole-2-carbonyl%2529phenoxy%2529pyrazin-2-yl%2529piperidin-1-yl%2529e%2520thanone%2520%2528AMG%2520579%2529%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6632%26epage%3D6641%26doi%3D10.1021%2Fjm500713j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lima, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a useful strategy for molecular modification and drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span><span class="refDoi"> DOI: 10.2174/0929867053363540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F0929867053363540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15638729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=23-49&author=L.+M.+Limaauthor=E.+J.+Barreiro&title=Bioisosterism%3A+a+useful+strategy+for+molecular+modification+and+drug+design&doi=10.2174%2F0929867053363540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A useful strategy for molecular modification and drug design</span></div><div class="casAuthors">Lima, Lidia Moreira; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-49</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review aims to demonstrate the role of bioisosterism in rational drug design as well as in the mol. modification and optimization process aiming to improve pharmacodynamic and pharmacokinetic properties of lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7625guUbh7Vg90H21EOLACvtfcHk0ljgQys1RVP_sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D&md5=4836e1d51143b240e357548b39f04251</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2174%2F0929867053363540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053363540%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DL.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520useful%2520strategy%2520for%2520molecular%2520modification%2520and%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D23%26epage%3D49%26doi%3D10.2174%2F0929867053363540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Viegas-Junior, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danuello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Silva Bolzani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A.</span><span> </span><span class="NLM_article-title">Molecular hybridization: a useful tool in the design of new drug prototypes</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span><span class="refDoi"> DOI: 10.2174/092986707781058805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.2174%2F092986707781058805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=17627520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFanuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1829-1852&author=C.+Viegas-Juniorauthor=A.+Danuelloauthor=V.+da+Silva+Bolzaniauthor=E.+J.+Barreiroauthor=C.+A.+Fraga&title=Molecular+hybridization%3A+a+useful+tool+in+the+design+of+new+drug+prototypes&doi=10.2174%2F092986707781058805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular hybridization: a useful tool in the design of new drug prototypes</span></div><div class="casAuthors">Viegas-Junior, Claudio; Danuello, Amanda; da Silva Bolzani, Vanderlan; Barreiro, Eliezer J.; Fraga, Carlos Alberto Manssour</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1829-1852</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mol. hybridization is a new concept in drug design and development based on the combination of pharmacophoric moieties of different bioactive substances to produce a new hybrid compd. with improved affinity and efficacy, when compared to the parent drugs.  Addnl., this strategy can result in compds. presenting modified selectivity profile, different and/or dual modes of action and reduced undesired side effects.  So, in this paper, we described several examples of different strategies for drug design, discovery and pharmacomodulation focused on new innovative hybrid compds. presenting analgesic, anti-inflammatory, platelet anti-aggregating, anti-infectious, anticancer, cardio- and neuroactive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvbzA71FPqLVg90H21EOLACvtfcHk0lgWB3Oon4OLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFanuro%253D&md5=7d3a16e3deeacb735bc0357fc6a99c37</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2174%2F092986707781058805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707781058805%26sid%3Dliteratum%253Aachs%26aulast%3DViegas-Junior%26aufirst%3DC.%26aulast%3DDanuello%26aufirst%3DA.%26aulast%3Dda%2BSilva%2BBolzani%26aufirst%3DV.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DFraga%26aufirst%3DC.%2BA.%26atitle%3DMolecular%2520hybridization%253A%2520a%2520useful%2520tool%2520in%2520the%2520design%2520of%2520new%2520drug%2520prototypes%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D1829%26epage%3D1852%26doi%3D10.2174%2F092986707781058805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johnston, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allcock, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosair, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, D. R.</span><span> </span><span class="NLM_article-title">Concise routes to pyrazolo[1,5-a]pyridin-3-yl pyridazin-3-ones</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1039/B713638B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1039%2FB713638B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=175-186&author=K.+A.+Johnstonauthor=R.+W.+Allcockauthor=Z.+Jiangauthor=I.+D.+Collierauthor=H.+Blakliauthor=G.+M.+Rosairauthor=P.+D.+Baileyauthor=K.+M.+Morganauthor=Y.+Kohnoauthor=D.+R.+Adams&title=Concise+routes+to+pyrazolo%5B1%2C5-a%5Dpyridin-3-yl+pyridazin-3-ones&doi=10.1039%2FB713638B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51a&amp;dbid=16384&amp;doi=10.1039%2FB713638B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB713638B%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DK.%2BA.%26aulast%3DAllcock%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DCollier%26aufirst%3DI.%2BD.%26aulast%3DBlakli%26aufirst%3DH.%26aulast%3DRosair%26aufirst%3DG.%2BM.%26aulast%3DBailey%26aufirst%3DP.%2BD.%26aulast%3DMorgan%26aufirst%3DK.%2BM.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26atitle%3DConcise%2520routes%2520to%2520pyrazolo%255B1%252C5-a%255Dpyridin-3-yl%2520pyridazin-3-ones%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D175%26epage%3D186%26doi%3D10.1039%2FB713638B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit51b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Druey, J.; Hucni, A.; Ringier, B. H.; Staehelin, A.</span><span> </span><span class="NLM_article-title">Halogen pyridazines</span>. US 2963477 A,<span class="NLM_x"> </span><span class="NLM_year">1960</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1960&author=J.+Druey&author=A.+Hucni&author=B.+H.+Ringier&author=A.+Staehelin&title=Halogen+pyridazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDruey%26aufirst%3DJ.%26atitle%3DHalogen%2520pyridazines%26date%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kowalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrosz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charakchieva-Minol, S.</span><span> </span><span class="NLM_article-title">Biologically active 1-arylpiperazines. synthesis of new N-(4-aryl-1-piperazinyl)alkyl derivatives of quinazolidin-4(<i>3H</i>)-one, 2,3-dihydrophthalazine-1,4-dione and 1,2-dihydropyridazine-3,6-dione as potential serotonin receptor ligands</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span><span class="refDoi"> DOI: 10.3390/60900784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.3390%2F60900784" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=784-795&author=P.+Kowalskiauthor=T.+Kowalskaauthor=M.+J.+Mokroszauthor=A.+J.+Bojarskiauthor=S.+Charakchieva-Minol&title=Biologically+active+1-arylpiperazines.+synthesis+of+new+N-%284-aryl-1-piperazinyl%29alkyl+derivatives+of+quinazolidin-4%283H%29-one%2C+2%2C3-dihydrophthalazine-1%2C4-dione+and+1%2C2-dihydropyridazine-3%2C6-dione+as+potential+serotonin+receptor+ligands&doi=10.3390%2F60900784"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2F60900784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252F60900784%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DP.%26aulast%3DKowalska%26aufirst%3DT.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26atitle%3DBiologically%2520active%25201-arylpiperazines.%2520synthesis%2520of%2520new%2520N-%25284-aryl-1-piperazinyl%2529alkyl%2520derivatives%2520of%2520quinazolidin-4%25283H%2529-one%252C%25202%252C3-dihydrophthalazine-1%252C4-dione%2520and%25201%252C2-dihydropyridazine-3%252C6-dione%2520as%2520potential%2520serotonin%2520receptor%2520ligands%26jtitle%3DMolecules%26date%3D2001%26volume%3D6%26spage%3D784%26epage%3D795%26doi%3D10.3390%2F60900784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszynska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charakchieva-Minol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatarczynska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klodzinska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacka-Wojcik, E.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT<sub>1A</sub>/5-HT<sub>2A</sub> receptor ligand with an anxiolytic-like activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3817</span><span class="NLM_x">–</span> <span class="NLM_lpage">3827</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00349-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2FS0968-0896%2802%2900349-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3817-3827&author=A.+J.+Bojarskiauthor=P.+Kowalskiauthor=T.+Kowalskaauthor=B.+Duszynskaauthor=S.+Charakchieva-Minolauthor=E.+Tatarczynskaauthor=A.+Klodzinskaauthor=E.+Chojnacka-Wojcik&title=Synthesis+and+pharmacological+evaluation+of+new+arylpiperazines.+3-%5B4-%5B4-%283-chlorophenyl%29-1-piperazinyl%5Dbutyl%5D-quinazolidin-4-one+-+a+dual+serotonin+5-HT1A%2F5-HT2A+receptor+ligand+with+an+anxiolytic-like+activity&doi=10.1016%2FS0968-0896%2802%2900349-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900349-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900349-8%26sid%3Dliteratum%253Aachs%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DKowalski%26aufirst%3DP.%26aulast%3DKowalska%26aufirst%3DT.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DKlodzinska%26aufirst%3DA.%26aulast%3DChojnacka-Wojcik%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520new%2520arylpiperazines.%25203-%255B4-%255B4-%25283-chlorophenyl%2529-1-piperazinyl%255Dbutyl%255D-quinazolidin-4-one%2520-%2520a%2520dual%2520serotonin%25205-HT1A%252F5-HT2A%2520receptor%2520ligand%2520with%2520an%2520anxiolytic-like%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3817%26epage%3D3827%26doi%3D10.1016%2FS0968-0896%2802%2900349-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">DeHaven-Hudkins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleissner, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Rice, F. Y.</span><span> </span><span class="NLM_article-title">Characterization of the binding of [<sup>3</sup>H](+)-pentazocine to sigma recognition sites in guinea pig brain</span> <span class="citation_source-journal">Eur. J. Pharmacol., Mol. Pharmacol. Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span><span class="refDoi"> DOI: 10.1016/0922-4106(92)90153-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+binding+of+%5B3H%5D%28%2B%29-pentazocine+to+sigma+recognition+sites+in+guinea+pig+brain&doi=10.1016%2F0922-4106%2892%2990153-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0lhshDSy-MPFUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255D%2528%252B%2529-pentazocine%2520to%2520sigma%2520recognition%2520sites%2520in%2520guinea%2520pig%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378%26doi%3D10.1016%2F0922-4106%2892%2990153-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Balasuriya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Sa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwardson, J. M.</span><span> </span><span class="NLM_article-title">A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF(R))</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">32353</span><span class="NLM_x">–</span> <span class="NLM_lpage">32363</span><span class="refDoi"> DOI: 10.1074/jbc.M114.603506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1074%2Fjbc.M114.603506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=32353-32363&author=D.+Balasuriyaauthor=L.+D%E2%80%99Saauthor=R.+Talkerauthor=E.+Dupuisauthor=F.+Maurinauthor=P.+Martinauthor=F.+Borgeseauthor=O.+Sorianiauthor=J.+M.+Edwardson&title=A+direct+interaction+between+the+sigma-1+receptor+and+the+hERG+voltage-gated+K%2B+channel+revealed+by+atomic+force+microscopy+and+homogeneous+time-resolved+fluorescence+%28HTRF%28R%29%29&doi=10.1074%2Fjbc.M114.603506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.603506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.603506%26sid%3Dliteratum%253Aachs%26aulast%3DBalasuriya%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Sa%26aufirst%3DL.%26aulast%3DTalker%26aufirst%3DR.%26aulast%3DDupuis%26aufirst%3DE.%26aulast%3DMaurin%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DBorgese%26aufirst%3DF.%26aulast%3DSoriani%26aufirst%3DO.%26aulast%3DEdwardson%26aufirst%3DJ.%2BM.%26atitle%3DA%2520direct%2520interaction%2520between%2520the%2520sigma-1%2520receptor%2520and%2520the%2520hERG%2520voltage-gated%2520K%252B%2520channel%2520revealed%2520by%2520atomic%2520force%2520microscopy%2520and%2520homogeneous%2520time-resolved%2520fluorescence%2520%2528HTRF%2528R%2529%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D32353%26epage%3D32363%26doi%3D10.1074%2Fjbc.M114.603506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]<sub>o</sub></span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1016/j.vascn.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5Ddofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+Comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do&doi=10.1016%2Fj.vascn.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55bR"><div class="casContent"><span class="casTitleNuber">55b</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lhshDSy-MPFUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255Ddofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520Comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ponti, F.</span><span> </span><span class="NLM_article-title">QT prolongation through hERG K (+) channel blockade: current knowledge and strategies for the early prediction during drug development</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1002/med.20019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1002%2Fmed.20019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=15389727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlWhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=133-166&author=M.+Recanatiniauthor=E.+Poluzziauthor=M.+Masettiauthor=A.+Cavalliauthor=F.+De+Ponti&title=QT+prolongation+through+hERG+K+%28%2B%29+channel+blockade%3A+current+knowledge+and+strategies+for+the+early+prediction+during+drug+development&doi=10.1002%2Fmed.20019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55cR"><div class="casContent"><span class="casTitleNuber">55c</span><div class="casTitle"><span class="NLM_cas:atitle">QT prolongation through hERG K+ channel blockade: current knowledge and strategies for the early prediction during drug development</span></div><div class="casAuthors">Recanatini, Maurizio; Poluzzi, Elisabetta; Masetti, Matteo; Cavalli, Andrea; de Ponti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-166</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Prolongation of the QT interval of the ECG is a typical effect of Class III antiarrhythmic drugs, achieved through blockade of potassium channels.  In the past decade, evidence has accrued that several classes of drugs used for non-cardiovascular indications may prolong the QT interval with the same mechanism (namely, human ether-a-go-go-related gene (hERG) K+ channel blockade).  The great interest in QT prolongation is because of several reasons.  First, drug-induced QT prolongation increases the likelihood of a polymorphous ventricular arrhythmia (namely, torsades de pointes, TdP), which may cause syncope and degenerate into ventricular fibrillation and sudden death.  Second, the fact that several classes of drugs, such as antihistamines, fluoroquinolones, macrolides, and neuroleptics may cause the long QT syndrome (LQTS) raises the question whether this is a class effect (e.g., shared by all agents of a given pharmacol. class) or a specific effect of single agents within a class.  There is now consensus that, in most cases, only a few agents within a therapeutic class share the ability to significantly affect hERG K+ channels.  These compds. should be identified as early as possible during drug development.  Third, QT prolongation and interaction with hERG K+ channels have become surrogate markers of cardiotoxicity and have received increasing regulatory attention.  This review briefly outlines the mechanisms leading to QT prolongation and the different strategies that can be followed to predict this unwanted effect.  In particular, it will focus on the approaches recently proposed for the in silico screening of new compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7B-6DBAFeLVg90H21EOLACvtfcHk0lhshDSy-MPFUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlWhs7Y%253D&md5=aa5aea37c667b4f35546259cc2593c6d</span></div><a href="/servlet/linkout?suffix=cit55c&amp;dbid=16384&amp;doi=10.1002%2Fmed.20019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20019%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DPoluzzi%26aufirst%3DE.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DDe%2BPonti%26aufirst%3DF.%26atitle%3DQT%2520prolongation%2520through%2520hERG%2520K%2520%2528%252B%2529%2520channel%2520blockade%253A%2520current%2520knowledge%2520and%2520strategies%2520for%2520the%2520early%2520prediction%2520during%2520drug%2520development%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D133%26epage%3D166%26doi%3D10.1002%2Fmed.20019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Regulating ankyrin dynamics: Roles of sigma-1 receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1073/pnas.98.2.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1073%2Fpnas.98.2.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=11149946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=491-496&author=T.+Hayashiauthor=T.+P.+Su&title=Regulating+ankyrin+dynamics%3A+Roles+of+sigma-1+receptors&doi=10.1073%2Fpnas.98.2.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56aR"><div class="casContent"><span class="casTitleNuber">56a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating ankyrin dynamics: roles of sigma-1 receptors</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ankyrin is a cytoskeletal adaptor protein that controls important cellular functions, including Ca2+ efflux at inositol 1,4,5-trisphosphate receptors (IP3R) on the endoplasmic reticulum.  The present study found that sigma-1 receptors (Sig-1R), unique endoplasmic reticulum proteins that bind certain steroids, neuroleptics, and psychotropic drugs, form a trimeric complex with ankyrin B and IP3R type 3 (IP3R-3) in NG-108 cells.  The trimeric complex could be coimmunopptd. by antibodies against any of the three proteins.  Sig-1R agonists such as pregenolone sulfate and cocaine caused the dissocn. of an ankyrin B isoform (ANK 220) from IP3R-3.  This effect caused by Sig-1R agonists was blocked by a Sig-1R antagonist.  The degree of dissocn. of ANK 220 from IP3R-3 caused by Sig-1R ligands correlates excellently with the ligands' efficacies in potentiating the bradykinin-induced increase in cytosolic free Ca2+ concn.  Immunocytohistochem. showed that Sig-1R, ankyrin B, and IP3R-3 are colocalized in NG-108 cells in perinuclear areas and in regions of cell-to-cell communication.  These results suggest that Sig-1R and assocd. ligands may play important roles in cells by controlling the function of cytoskeletal proteins and that the Sig-1R/ANK220/IP3R-3 complex regulating Ca2+ signaling may represent a site of action for neurosteroids and cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ424uZx5ag7Vg90H21EOLACvtfcHk0ljReb4aLiW-Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslKhsA%253D%253D&md5=2fc5684bc59fa8d0c69494de29847681</span></div><a href="/servlet/linkout?suffix=cit56a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.98.2.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.98.2.491%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DRegulating%2520ankyrin%2520dynamics%253A%2520Roles%2520of%2520sigma-1%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D491%26epage%3D496%26doi%3D10.1073%2Fpnas.98.2.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit56b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tsai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokrass, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauer, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">6742</span><span class="NLM_x">–</span> <span class="NLM_lpage">6747</span><span class="refDoi"> DOI: 10.1073/pnas.1422001112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1073%2Fpnas.1422001112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=6742-6747&author=S.+Y.+Tsaiauthor=M.+J.+Pokrassauthor=N.+R.+Klauerauthor=H.+Noharaauthor=T.+P.+Su&title=Sigma-1+receptor+regulates+Tau+phosphorylation+and+axon+extension+by+shaping+p35+turnover+via+myristic+acid&doi=10.1073%2Fpnas.1422001112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422001112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422001112%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BY.%26aulast%3DPokrass%26aufirst%3DM.%2BJ.%26aulast%3DKlauer%26aufirst%3DN.%2BR.%26aulast%3DNohara%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DSigma-1%2520receptor%2520regulates%2520Tau%2520phosphorylation%2520and%2520axon%2520extension%2520by%2520shaping%2520p35%2520turnover%2520via%2520myristic%2520acid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D6742%26epage%3D6747%26doi%3D10.1073%2Fpnas.1422001112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">28198</span><span class="NLM_x">–</span> <span class="NLM_lpage">28215</span><span class="refDoi"> DOI: 10.1074/jbc.M802099200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1074%2Fjbc.M802099200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=18539593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ans7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=28198-28215&author=Z.+Wuauthor=W.+D.+Bowen&title=Role+of+sigma-1+receptor+C-terminal+segment+in+inositol+1%2C4%2C5-trisphosphate+receptor+activation%3A+constitutive+enhancement+of+calcium+signaling+in+MCF-7+tumor+cells&doi=10.1074%2Fjbc.M802099200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells</span></div><div class="casAuthors">Wu, Zhiping; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">28198-28215</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sigma-1 receptor (sigma-1R) agonists enhance inositol 1,4,5-trisphosphate (IP3)-dependent calcium release from endoplasmic reticulum by inducing dissocn. of ankyrin B 220 (ANK 220) from the IP3 receptor (IP3R-3), releasing it from inhibition.  MCF-7 breast tumor cells express little or no sigma-1R and were used here to investigate the effect of receptor overexpression and the role of its N- and C-terminal segments in function.  The authors stably expressed intact sigma-1R (amino acids (aa) 1-223; lines 11 and 41), N-fragment (aa 1-100; line K3), or C-fragment (aa 102-223; line sg101).  C-fragment expressed as a peripheral membrane-bound protein that was removable from the endoplasmic reticulum membrane by chaotropic salt wash, consistent with lack of a putative transmembrane domain.  The expressed sigma-1R, N-fragment, and C-fragment exhibited normal, low affinity, and no [3H](+)-pentazocine binding activity, resp.  All transfected lines showed constitutive enhancement of bradykinin (BDK)-induced calcium release, because of a decrease in BDK ED50 values.  Interestingly, sigma-1R and C-fragment had high activities, whereas the N-fragment was much less active.  The antagonist BD1063 behaved as an inverse agonist in sigma-1R cells, whereas C-fragment was insensitive to ligand regulation.  Like BDK, vasopressin- and ATP-induced calcium release was enhanced with the same pattern in cell lines.  Anti-IP3R-3 immunoppts. from cells expressing sigma-1R or C-fragment contained significantly less ANK 220 compared with untransfected or N-fragment cells, indicating a higher amt. of ankyrin-free IP3R-3.  Anti-ankyrin B immunoppts. contained sigma-1R or C-fragment, with markedly lower levels of N-fragment present.  These results suggest that sigma-1R overexpression drives sigma agonist-independent dissocn. of ANK 220 from IP3R-3, resulting in activation.  The C-terminal segment plays a key role in the interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGownHr4IKNWMLVg90H21EOLACvtfcHk0ljReb4aLiW-Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ans7zJ&md5=d8f6ea2b4e7ee33042d13956f9b38f13</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802099200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802099200%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DRole%2520of%2520sigma-1%2520receptor%2520C-terminal%2520segment%2520in%2520inositol%25201%252C4%252C5-trisphosphate%2520receptor%2520activation%253A%2520constitutive%2520enhancement%2520of%2520calcium%2520signaling%2520in%2520MCF-7%2520tumor%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D28198%26epage%3D28215%26doi%3D10.1074%2Fjbc.M802099200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca<sup>2+</sup> signaling and cell survival</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.+P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-mitochondrion+interface+regulate+Ca2%2B+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0ljReb4aLiW-Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-mitochondrion%2520interface%2520regulate%2520Ca2%252B%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma-1 receptors of guinea pig brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma-1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59a&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma-1%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit59b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maricel, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Víctor, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrique, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, C.</span><span> </span><span class="NLM_article-title">Predicting the antinociceptive efficacy of σ1 receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1021/jm401529t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401529t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=238-242&author=G.+S.+Maricelauthor=F.+D.+V%C3%ADctorauthor=P.+S.+Enriqueauthor=P.+Pilarauthor=Z.+Danielauthor=J.+M.+Velaauthor=B.+Javierauthor=C.+Francisco&title=Predicting+the+antinociceptive+efficacy+of+%CF%831+receptor+ligands+by+a+novel+receptor+fluorescence+resonance+energy+transfer+%28FRET%29+based+biosensor&doi=10.1021%2Fjm401529t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59b&amp;dbid=16384&amp;doi=10.1021%2Fjm401529t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401529t%26sid%3Dliteratum%253Aachs%26aulast%3DMaricel%26aufirst%3DG.%2BS.%26aulast%3DV%25C3%25ADctor%26aufirst%3DF.%2BD.%26aulast%3DEnrique%26aufirst%3DP.%2BS.%26aulast%3DPilar%26aufirst%3DP.%26aulast%3DDaniel%26aufirst%3DZ.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DJavier%26aufirst%3DB.%26aulast%3DFrancisco%26aufirst%3DC.%26atitle%3DPredicting%2520the%2520antinociceptive%2520efficacy%2520of%2520%25CF%25831%2520receptor%2520ligands%2520by%2520a%2520novel%2520receptor%2520fluorescence%2520resonance%2520energy%2520transfer%2520%2528FRET%2529%2520based%2520biosensor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D238%26epage%3D242%26doi%3D10.1021%2Fjm401529t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Rosland, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjolsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maehle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hole, K.</span><span> </span><span class="NLM_article-title">The formalin test in mice: effect of formalin concentration</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1016/0304-3959(90)91167-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0304-3959%2890%2991167-H" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=235-242&author=J.+H.+Roslandauthor=A.+Tjolsenauthor=B.+Maehleauthor=K.+Hole&title=The+formalin+test+in+mice%3A+effect+of+formalin+concentration&doi=10.1016%2F0304-3959%2890%2991167-H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2890%2991167-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252890%252991167-H%26sid%3Dliteratum%253Aachs%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DTjolsen%26aufirst%3DA.%26aulast%3DMaehle%26aufirst%3DB.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%2520in%2520mice%253A%2520effect%2520of%2520formalin%2520concentration%26jtitle%3DPain%26date%3D1990%26volume%3D42%26spage%3D235%26epage%3D242%26doi%3D10.1016%2F0304-3959%2890%2991167-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span><span class="refDoi"> DOI: 10.1007/s00213-005-0127-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1007%2Fs00213-005-0127-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=16075285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=485-493&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=J.+M.+Baeyens&title=Antinociceptive+effects+of+haloperidol+and+its+metabolites+in+the+formalin+test+in+mice&doi=10.1007%2Fs00213-005-0127-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice</span></div><div class="casAuthors">Cendan, Cruz M.; Pujalte, Jose M.; Portillo-Salido, Enrique; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-493</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Formalin-induced pain is reduced in sigma-1 (σ1) receptor knockout mice; therefore, the authors hypothesized that haloperidol and its metabolites I and II, which have affinity for σ1 receptors, may modulate formalin-induced pain.  Results: Intraplantar administration of formalin (2.5%) to CD-1 mice produced a biphasic period of pain.  Haloperidol (0.03-1 mg/kg, s.c.) and reduced haloperidol (metabolite II, 0.25-8 mg/kg, s.c.) dose-dependently inhibited both phases of formalin-induced pain.  Haloperidol metabolite I (4-128 mg/kg, s.c.) also produced dose-dependent antinociception in the second phase of the formalin test, but was less potent and effective against first-phase pain.  Haloperidol metabolite III (16 and 128 mg/kg) and (-)sulpiride (200 mg/kg), which have no affinity for σ1 receptors, did not produce significant antinociception in either phase of the formalin test.  The order of potency of the drugs to produce their antinociceptive effect [haloperidol > metabolite II > metabolite I » metabolite III= (-)sulpiride=inactive] correlated with their affinity for σ1 receptors, but not with their affinity for σ2 or dopamine D2 receptors.  Naloxone (1 mg/kg, s.c.) did not antagonize the antinociception induced by haloperidol and its metabolites.  None of the antinociceptive drugs in the formalin test produced any antinociception in the tail flick test.  Conclusion: These results suggest that the antinociceptive effect of haloperidol and its metabolites in the formalin test is not due to unspecific/generalized inhibition of nociception or modulation of opioid receptors, and that it may be related, at least partially, to the ability of these drugs to interact with σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFuqvqHXFzk7Vg90H21EOLACvtfcHk0lhfIjKGwxCjvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahtbzP&md5=3d55ac20e082e77f70769659224994f1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-0127-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-0127-z%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DAntinociceptive%2520effects%2520of%2520haloperidol%2520and%2520its%2520metabolites%2520in%2520the%2520formalin%2520test%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D182%26spage%3D485%26epage%3D493%26doi%3D10.1007%2Fs00213-005-0127-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/0304-3959(88)90209-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+peripheral+mononeuropathy+in+rat+that+produces+disorders+of+pain+sensation+like+those+seen+in+man&doi=10.1016%2F0304-3959%2888%2990209-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62aR"><div class="casContent"><span class="casTitleNuber">62a</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett Gary J; Xie Y-K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eYPDKD9hGeNOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520peripheral%2520mononeuropathy%2520in%2520rat%2520that%2520produces%2520disorders%2520of%2520pain%2520sensation%2520like%2520those%2520seen%2520in%2520man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107%26doi%3D10.1016%2F0304-3959%2888%2990209-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogrel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaksh, T. L.</span><span> </span><span class="NLM_article-title">Quantitative assessment of tactile allodynia in the rat paw</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62bR"><div class="casContent"><span class="casTitleNuber">62b</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eZsJhw7ua70yLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520assessment%2520of%2520tactile%2520allodynia%2520in%2520the%2520rat%2520paw%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Caspani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span> </span><span class="NLM_article-title">Tramadol reduced anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1016/j.pbb.2014.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2Fj.pbb.2014.06.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=290-296&author=O.+Caspaniauthor=M.+C.+Reitzauthor=A.+Ceciauthor=A.+Kremerauthor=R.+D.+Treede&title=Tramadol+reduced+anxiety-related+and+depression-associated+behaviors+presumably+induced+by+pain+in+the+chronic+constriction+injury+model+of+neuropathic+pain+in+rats&doi=10.1016%2Fj.pbb.2014.06.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2014.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2014.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DCaspani%26aufirst%3DO.%26aulast%3DReitz%26aufirst%3DM.%2BC.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26atitle%3DTramadol%2520reduced%2520anxiety-related%2520and%2520depression-associated%2520behaviors%2520presumably%2520induced%2520by%2520pain%2520in%2520the%2520chronic%2520constriction%2520injury%2520model%2520of%2520neuropathic%2520pain%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2014%26volume%3D124%26spage%3D290%26epage%3D296%26doi%3D10.1016%2Fj.pbb.2014.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Chou, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czobor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charles, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuma, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winsberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volavka, J.</span><span> </span><span class="NLM_article-title">Acute mania: haloperidol dose and augmentation with lithium or lorazepam</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span><span class="refDoi"> DOI: 10.1097/00004714-199912000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1097%2F00004714-199912000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10587284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaK1MXotVertbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=500-505&author=J.+C.+Chouauthor=P.+Czoborauthor=O.+Charlesauthor=I.+Tumaauthor=B.+Winsbergauthor=M.+H.+Allenauthor=M.+Trujilloauthor=J.+Volavka&title=Acute+mania%3A+haloperidol+dose+and+augmentation+with+lithium+or+lorazepam&doi=10.1097%2F00004714-199912000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Acute mania: haloperidol dose and augmentation with lithium or lorazepam</span></div><div class="casAuthors">Chou, James C.-Y.; Czobor, Pal; Charles, Owen; Tuma, Ivan; Winsberg, Bertrand; Allen, Michael H.; Trujillo, Manuel; Volavka, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">500-505</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Antipsychotic dosing for acute mania has not been well studied.  Combined treatment with lithium and an antipsychotic is the most common treatment, but addnl. antimanic efficacy of a lithium-antipsychotic combination beyond that of an antipsychotic alone has not been well demonstrated.  Furthermore, the possibility that lithium could affect antipsychotic dose requirement is believed to have never been studied.  In this study, 63 acutely psychotic bipolar manic inpatients were randomly assigned to receive double-blind treatment with 1 or 2 haloperidol doses, 25 mg/day or 5 mg/day, for 21 days.  In addn. to haloperidol, subjects were randomly assigned to receive concomitant treatment with placebo, std. lithium, or lorazepam 4 mg/day.  The high haloperidol dose produced greater improvement and more side effects than did the low dose.  Lithium added to the low dose produced a markedly greater clin. response than did the low dose alone.  Lorazepam did not improve the outcome for the patients receiving low-dose haloperidol.  The clin. response produced by high-dose haloperidol was not enhanced by adding either lithium or lorazepam.  All treatment effects emerged by the fourth day of treatment and persisted.  Used alone, a haloperidol dose of 5 mg/day is too low for most manic patients, but concomitant lithium produces a dose-dependent enhancement of haloperidol response.  Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdrupkYRajCLVg90H21EOLACvtfcHk0liqITPoKOMHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVertbY%253D&md5=067de789f28fce3bd389993eae0ed7f1</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1097%2F00004714-199912000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199912000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DJ.%2BC.%26aulast%3DCzobor%26aufirst%3DP.%26aulast%3DCharles%26aufirst%3DO.%26aulast%3DTuma%26aufirst%3DI.%26aulast%3DWinsberg%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DM.%2BH.%26aulast%3DTrujillo%26aufirst%3DM.%26aulast%3DVolavka%26aufirst%3DJ.%26atitle%3DAcute%2520mania%253A%2520haloperidol%2520dose%2520and%2520augmentation%2520with%2520lithium%2520or%2520lorazepam%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1999%26volume%3D19%26spage%3D500%26epage%3D505%26doi%3D10.1097%2F00004714-199912000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Kiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daskalakis, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=12921224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A280%3ADC%252BD3szosVOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=293-299&author=M.+Kiangauthor=Z.+J.+Daskalakisauthor=B.+K.+Christensenauthor=G.+Remingtonauthor=S.+Kapur&title=Actigraphic+measurement+of+the+effects+of+single-dose+haloperidol+and+olanzapine+on+spontaneous+motor+activity+in+normal+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects</span></div><div class="casAuthors">Kiang Michael; Daskalakis Z Jeff; Christensen Bruce K; Remington Gary; Kapur Shitij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-9</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">OBJECTIVE:  To quantitatively examine the effects of haloperidol and olanzapine on spontaneous motor activity in normal subjects.  DESIGN:  Randomized, double-blind, placebo-controlled medication study.  PARTICIPANTS:  Normal volunteers (n = 30).  INTERVENTIONS:  Subjects received 1 dose of either haloperidol 2 mg (n = 9), olanzapine 10 mg (n = 10) or placebo (n = 10) and were admitted to hospital for the next 24 hours.  OUTCOME MEASURES:  Subjects wore an actigraphic monitor, which recorded movement in 15-second epochs.  The Simpson-Angus Extrapyramidal Side Effect Scale (SAS) and the Barnes Akathisia Scale (BAS) were administered before and 7 and 24 hours after medication was given.  RESULTS:  Compared with placebo, total motor activity was decreased by 41% with olanzapine (p = 0.004) and by 12% with haloperidol (NS).  There were significantly more epochs with zero movement with olanzapine than with haloperidol or placebo.  For non-zero epochs, the mean activity count and the distribution of activity counts did not differ significantly among groups.  There were no positive findings on the SAS or the BAS.  CONCLUSIONS:  Olanzapine decreased total motor activity by increasing the amount of time during which subjects were immobile, rather than by affecting the magnitude of movement during periods in which there was activity.  This effect occurred at a dose of olanzapine low enough not to cause clinically observed extrapyramidal side effects.  Our results suggest that actigraphy is useful as a sensitive, noninvasive tool for measuring the effect of antipsychotics on spontaneous motor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnV369ou3mIjC850By6mxpfW6udTcc2ebg5yLXCU_yl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szosVOnsw%253D%253D&md5=90c78e6941be51b1dc4fb434b9638d93</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiang%26aufirst%3DM.%26aulast%3DDaskalakis%26aufirst%3DZ.%2BJ.%26aulast%3DChristensen%26aufirst%3DB.%2BK.%26aulast%3DRemington%26aufirst%3DG.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DActigraphic%2520measurement%2520of%2520the%2520effects%2520of%2520single-dose%2520haloperidol%2520and%2520olanzapine%2520on%2520spontaneous%2520motor%2520activity%2520in%2520normal%2520subjects%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2003%26volume%3D28%26spage%3D293%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><div class="note"><p class="first last">(SHELXTL versions 6.12 and 6.14)</p></div><span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lhxQXpA2KICGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0lhxQXpA2KICGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Diáz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrech, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet-Buchholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerón-Bertran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinoso, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández de Henestrosa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective σ<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3656</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span><span class="refDoi"> DOI: 10.1021/jm400181k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400181k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3656-3665&author=J.+L.+Di%C3%A1zauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=M.+Luengoauthor=M.+Bordasauthor=R.+Enrechauthor=M.+Carroauthor=R.+Pascualauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+Benet-Buchholzauthor=J.+Cer%C3%B3n-Bertranauthor=J.+Ram%C3%ADrezauthor=R.+F.+Reinosoauthor=A.+R.+Fern%C3%A1ndez+de+Henestrosaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+a+new+series+of+hexahydro-2H-pyrano%5B3%2C2-c%5Dquinolines+as+novel+selective+%CF%831+receptor+ligands&doi=10.1021%2Fjm400181k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm400181k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400181k%26sid%3Dliteratum%253Aachs%26aulast%3DDi%25C3%25A1z%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DLuengo%26aufirst%3DM.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DEnrech%26aufirst%3DR.%26aulast%3DCarro%26aufirst%3DM.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBenet-Buchholz%26aufirst%3DJ.%26aulast%3DCer%25C3%25B3n-Bertran%26aufirst%3DJ.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DFern%25C3%25A1ndez%2Bde%2BHenestrosa%26aufirst%3DA.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520hexahydro-2H-pyrano%255B3%252C2-c%255Dquinolines%2520as%2520novel%2520selective%2520%25CF%25831%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3656%26epage%3D3665%26doi%3D10.1021%2Fjm400181k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i122"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01416">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23616"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01416">10.1021/acs.jmedchem.5b01416</a>. CCDC 1423214 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via <a class="extLink" href="http://www.ccdc.cam.ac.uk/conts/retrieving.html">www.ccdc.cam.ac.uk/conts/retrieving.html</a> (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, U.K. (fax (+44) 1223-336-033, e-mail <a href="/cdn-cgi/l/email-protection#bedadbced1cdd7cafedddddadd90dddfd390dfdd90cbd5"><span class="__cf_email__" data-cfemail="7612130619051f0236151512155815171b58171558031d">[email protected]</span></a>). <ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Inhibition curves of functional profile of σ<sub>1</sub> receptor; additional receptors binding affinities of compound <b>54</b>; data of compound 54 in phase I of the mouse formalin test; <sup>1</sup>H NMR, HR-MS, and HPLC of compound <b>54</b>; X-ray crystal data of compound <b>54</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_001.pdf">jm5b01416_si_001.pdf (666.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01416/suppl_file/jm5b01416_si_002.csv">jm5b01416_si_002.csv (2.93 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01416%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01416" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a8705ab253cb2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
